,Start Date,Start Price,End Date,End Price,Weekly Returns,Bin Label,News,Basics
0,2023-01-08,201.8699951171875,2023-01-15,201.11000061035156,-0.003764772007819994,D1,[],"{""assetTurnoverTTM"": 0.338, ""bookValue"": 6599, ""cashRatio"": 0.7252073566534439, ""currentRatio"": 1.2842, ""ebitPerShare"": -0.8089, ""eps"": -0.8854, ""ev"": 32530.1, ""fcfMargin"": 0.0545, ""fcfPerShareTTM"": -0.4684, ""grossMargin"": 0.6205, ""inventoryTurnoverTTM"": 3.2272, ""longtermDebtTotalAsset"": 0.1214, ""longtermDebtTotalCapital"": 0.1593, ""longtermDebtTotalEquity"": 0.2253, ""netDebtToTotalCapital"": 0.0776, ""netDebtToTotalEquity"": 0.1097, ""netMargin"": -0.1283, ""operatingMargin"": -0.1173, ""pb"": 4.8198, ""pfcfTTM"": 141.9915, ""pretaxMargin"": -0.1551, ""psTTM"": 6.94, ""ptbv"": 9.5975, ""quickRatio"": 0.9827, ""receivablesTurnoverTTM"": 6.8608, ""roaTTM"": -0.3248, ""roeTTM"": -0.5081, ""roicTTM"": -0.4133, ""rotcTTM"": -0.3922, ""salesPerShare"": 6.8981, ""sgaToSale"": 0.3795, ""tangibleBookValue"": 3314, ""totalDebtToEquity"": 0.4145, ""totalDebtToTotalAsset"": 0.2232, ""totalDebtToTotalCapital"": 0.293, ""totalRatio"": 2.1673, ""period"": ""2023-01-01""}"
1,2023-01-15,201.11000061035156,2023-01-22,204.38999938964844,0.016309476253504762,U2,[],"{""assetTurnoverTTM"": 0.338, ""bookValue"": 6599, ""cashRatio"": 0.7252073566534439, ""currentRatio"": 1.2842, ""ebitPerShare"": -0.8089, ""eps"": -0.8854, ""ev"": 32530.1, ""fcfMargin"": 0.0545, ""fcfPerShareTTM"": -0.4684, ""grossMargin"": 0.6205, ""inventoryTurnoverTTM"": 3.2272, ""longtermDebtTotalAsset"": 0.1214, ""longtermDebtTotalCapital"": 0.1593, ""longtermDebtTotalEquity"": 0.2253, ""netDebtToTotalCapital"": 0.0776, ""netDebtToTotalEquity"": 0.1097, ""netMargin"": -0.1283, ""operatingMargin"": -0.1173, ""pb"": 4.8198, ""pfcfTTM"": 141.9915, ""pretaxMargin"": -0.1551, ""psTTM"": 6.94, ""ptbv"": 9.5975, ""quickRatio"": 0.9827, ""receivablesTurnoverTTM"": 6.8608, ""roaTTM"": -0.3248, ""roeTTM"": -0.5081, ""roicTTM"": -0.4133, ""rotcTTM"": -0.3922, ""salesPerShare"": 6.8981, ""sgaToSale"": 0.3795, ""tangibleBookValue"": 3314, ""totalDebtToEquity"": 0.4145, ""totalDebtToTotalAsset"": 0.2232, ""totalDebtToTotalCapital"": 0.293, ""totalRatio"": 2.1673, ""period"": ""2023-01-01""}"
2,2023-01-22,204.38999938964844,2023-01-29,214.02999877929688,0.04716473124142828,U5,[],{}
3,2023-01-29,214.02999877929688,2023-02-05,214.25999450683594,0.001074595752234897,U1,"[{""date"": ""2023-01-29"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-29"", ""headline"": ""Tracking Baillie Gifford's 13F Portfolio - Q4 2022 Update"", ""summary"": ""Baillie Gifford\u00e2\u0080\u0099s 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. Click here for a detailed analysis.""}, {""date"": ""2023-01-30"", ""headline"": ""Illumina Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Bionano's Balance Sheet Challenges: History Repeating Itself"", ""summary"": ""Aggressive expansion into capital-intensive markets will likely put significant pressure on BNGO's balance sheet. Click here to read my analysis of Bionano.""}, {""date"": ""2023-01-30"", ""headline"": ""Bionano`s Balance Sheet Challenges: History Repeating Itself"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Illumina Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Video: UK Festival of Genomics & Biodata Inspires and Connects Genomics Leaders"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / January 31, 2023 / Illumina Originally published on Illumina News Center The Festival of Genomics & Biodata 2023, held in London in January, is the largest event in the UK's genomics events calendar. More than 4000 ...""}, {""date"": ""2023-01-31"", ""headline"": ""Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for"", ""summary"": ""Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""2023-01-31"", ""headline"": ""GE HealthCare Technologies: Still Significantly Undervalued"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-01"", ""headline"": ""RBC Capital Sticks to Their Buy Rating for Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-01"", ""headline"": ""Illumina Inc. stock rises Thursday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-01"", ""headline"": ""Illumina Named to Bloomberg Gender Equality Index for Fifth Consecutive Year"", ""summary"": ""Illumina has been included in the 2023 Bloomberg Gender-Equality Index for the fifth consecutive year.""}, {""date"": ""2023-02-01"", ""headline"": ""Top 25 Smartest Companies To Buy According To Hedge Funds"", ""summary"": ""In this piece, we will take a look at the top 25 smartest companies to buy according to hedge funds. For more companies, head on over to Top 5 Smartest Companies To Buy According To Hedge Funds. Surviving in the modern day corporate world is not for the faint of heart. Business is a ruthless [\u2026]""}, {""date"": ""2023-02-01"", ""headline"": ""Illumina Appoints Joydeep Goswami Chief Financial Officer"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Joydeep Goswami has been appointed Chief Financial Officer, effective immediately. Goswami previously served as Illumina's Chief Strategy and Corporate Development Officer and interim Chief Financial Officer. As CFO, Goswami will be responsible for the Company's financial planning and analysis, accounting, investor relations, internal audit, tax, and treasury functions. He will also con""}, {""date"": ""2023-02-01"", ""headline"": ""Illumina Makes Its Interim CFO Permanent"", ""summary"": ""Joydeep Goswami, Illumina\u2019s interim finance chief since July, will take over the role on a permanent basis.""}, {""date"": ""2023-02-01"", ""headline"": ""Illumina appoints new chief financial officer, effective immediately"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-01"", ""headline"": ""Ensemble Capital Fourth Quarter 2022 Investor Letter"", ""summary"": ""Ensemble Capital Management, LLC is based in Burlingame, California, midway between Silicon Valley and San Francisco.""}, {""date"": ""2023-02-01"", ""headline"": ""Joydeep Goswami is the new finance chief of Illumina"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-01"", ""headline"": ""Illumina appoints Joydeep Goswami as CFO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-02"", ""headline"": ""Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?"", ""summary"": ""Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""2023-02-02"", ""headline"": ""Interesting ILMN Put And Call Options For March 24th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-02"", ""headline"": ""Guardant Health `pleased` with ruling in Illumina case"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-03"", ""headline"": ""How Organizations Around the World Are Closing the Cancer Care Gap"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / February 3, 2023 / Illumina Originally published on Illumina News Center According to the World Health Organization, half the world's population does not have access to essential health services. At a time when advances ...""}, {""date"": ""2023-02-03"", ""headline"": ""Notable Two Hundred Day Moving Average Cross - ILMN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
4,2023-02-05,214.25999450683594,2023-02-12,196.5800018310547,-0.08251653658666169,D5+,"[{""date"": ""2023-02-05"", ""headline"": ""Illumina Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-05"", ""headline"": ""Illumina, Pacific Biosciences, And Oxford Nanopore Market Position Comparison"", ""summary"": ""The gene sequencing market is ripe for disruption. Click here for a complete analysis of Illumina, Pacific Biosciences, And Oxford Nanopore.""}, {""date"": ""2023-02-06"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-06"", ""headline"": ""Illumina Non-GAAP EPS of $0.14 misses by $0.05, revenue of $1.08B beats by $10M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-06"", ""headline"": ""Illumina  sees FY23 adjusted EPS $1.25-$1.50, consensus $1.98"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-06"", ""headline"": ""Illumina  reports Q4 adjusted EPS 14c, consensus 10c"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-06"", ""headline"": ""Illumina options imply 6.4% move in share price post-earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-06"", ""headline"": ""GLOBAL BRIEFING: Australia lifts interest rates by 25 basis points"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-06"", ""headline"": ""Global company events calendar - next 7 days"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-07"", ""headline"": ""Illumina price target lowered to $150 from $160 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-07"", ""headline"": ""Illumina Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-07"", ""headline"": ""Illumina swings to net loss in 2022; fourth quarter revenue drops 10%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-07"", ""headline"": ""Top 5 4th Quarter Trades of SECTOR GAMMA AS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-07"", ""headline"": ""Illumina (ILMN) Misses Q4 Earnings Estimates"", ""summary"": ""Illumina (ILMN) delivered earnings and revenue surprises of -26.32% and 1.54%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""2023-02-07"", ""headline"": ""DNA-Reading Giant Illumina Topples On Wide Profit Miss"", ""summary"": ""Illumina beat sales estimates, but profit came in light during the fourth quarter. That led ILMN stock to fall in late action Tuesday.""}, {""date"": ""2023-02-07"", ""headline"": ""Illumina, Inc. (ILMN) Q4 2022 Earnings Call Transcript"", ""summary"": ""Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Q4 2022 Earnings Conference Call February 7, 2023 5:00 PM ETCompany ParticipantsSallilyn Schwartz - VP, IRJoydeep Goswami - CFO, Chief Strategy &...""}, {""date"": ""2023-02-07"", ""headline"": ""Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022"", ""summary"": ""Illumina, Inc. (Nasdaq: ILMN) today announced its financial results for the fourth quarter and fiscal year 2022, which include consolidated financial results for GRAIL.""}, {""date"": ""2023-02-07"", ""headline"": ""Cramer's lightning round: Parker-Hannifin is a buy"", ""summary"": ""\""Mad Money\"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.""}, {""date"": ""2023-02-07"", ""headline"": ""Illumina: Q4 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-07"", ""headline"": ""Illumina Attracts Challengers for DNA Sequencing Ahead of Earnings"", ""summary"": ""Illumina competitors are out in force this week at the sequencing industry's annual gathering. The company reports fourth-quarter and year earnings after Tuesday's close.""}, {""date"": ""2023-02-07"", ""headline"": ""Notable companies reporting after market close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-07"", ""headline"": ""SECTOR GAMMA AS Buys 3, Sells 2 in 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-07"", ""headline"": ""Illumina faces low-cost rival as BGI touts sub $100 gene sequencing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-07"", ""headline"": ""Fly Intel: After-Hours Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-07"", ""headline"": ""Illumina boosts spending on US lobbying amid opposition to Grail acquisition"", ""summary"": ""Illumina sharply increased its spending on lobbying over the past two years as it tried to build support against antitrust regulators in the US and Europe that have attempted to block its $8bn acquisition of cancer testing company Grail.  The world\u2019s biggest genome sequencing company and its subsidiary Grail spent a combined $14.6mn in 2021 and 2022 on federal lobbying in the US, more than five times the $2.72mn combined they spent in the previous two years, according to public disclosures.  Illumina was the fourth-largest spender on lobbying among biotech and pharma companies in 2022 at $9.4mn, behind only Pfizer, Roche and Amgen, which are much larger companies, according to an analysis by OpenSecrets, a transparency group.""}, {""date"": ""2023-02-08"", ""headline"": ""Illumina Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""The Wild Card That Keeps Haunting DNA-Reading Giant Illumina"", ""summary"": ""Illumina beat sales estimates, but profit came in light during the fourth quarter. That led ILMN stock to fall Wednesday.""}, {""date"": ""2023-02-08"", ""headline"": ""Illumina delivers first NovaSeq X Plus sequencer to the Broad Institute"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first NovaSeq X Plus system was recently delivered to the Broad Institute. Alex Aravanis, PhD, chief technology officer of Illumina, made the announcement today in a presentation at the Advances in Genome Biology and Technology (AGBT) conference in Hollywood, Florida. Aravanis also announced much anticipated updates on Illumina's innovation roadmap including Illumina Complete Lo""}, {""date"": ""2023-02-08"", ""headline"": ""Illumina fights EU order to divest Grail"", ""summary"": ""U.S. life science company Illumina on Wednesday took its case to senior EU and national antitrust officials at a closed hearing to argue against an EU antitrust order that it divests cancer detection test maker Grail Inc.""}, {""date"": ""2023-02-08"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks red as markets mull Powell remarks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""Illumina (ILMN) Q4 Earnings Miss Estimates, Gross Margin Down"", ""summary"": ""Delays in recruitment for some large research projects in the Americas and Europe, the impact of COVID disruptions in China and foreign exchange woes hurt Illumina's (ILMN) Q4 revenues.""}, {""date"": ""2023-02-08"", ""headline"": ""Oxford Nanopore: Illumina`s Formidable Challenger"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""Illumina in EU hearing to fight order to divest GRAIL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), Vertex Pharmaceuticals (VRTX) and Inspire Medical Systems (INSP)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""J.P. Morgan Reaffirms Their Hold Rating on Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""Stocks making the biggest moves premarket: Uber, Chipotle, Microsoft, Lumen and more"", ""summary"": ""These are some of the stocks posting the largest moves before the stock market's opening bell.""}, {""date"": ""2023-02-08"", ""headline"": ""Illumina price target lowered to $235 from $285 at Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""Illumina (ILMN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates"", ""summary"": ""While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.""}, {""date"": ""2023-02-08"", ""headline"": ""Illumina price target raised to $303 from $284 at RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""Illumina price target raised to $230 from $210 at BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""Analysts` Opinions Are Mixed on These Healthcare Stocks: Cigna (CI), Illumina (ILMN) and Vertex Pharmaceuticals (VRTX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""The Brazilian billionaires embroiled in a $3.9bn scandal"", ""summary"": ""Plus, Illumina turns to lobbyists to back its Grail takeover and DD looks at Abu Dhabi\u2019s stock market darling""}, {""date"": ""2023-02-09"", ""headline"": ""Illumina Inc. stock rises Friday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-09"", ""headline"": ""Illumina, Inc. (NASDAQ:ILMN) Q4 2022 Earnings Call Transcript"", ""summary"": ""Illumina, Inc. (NASDAQ:ILMN) Q4 2022 Earnings Call Transcript February 7, 2023 Operator: Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2022 Illumina Earnings Conference Call. . I would now like to hand the conference over to Salli Schwartz, Vice President of Investor Relations. Sallilyn Schwartz: Hello, everyone, and welcome to our earnings [\u2026]""}, {""date"": ""2023-02-09"", ""headline"": ""A New Era for Discoveries at Admera Health"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / February 9, 2023 / Illumina Originally published on Illumina News Center What role does RNA play in regulating fat deposits? Which transcription factors affect insulin resistance and halt cancer progression? What ...""}, {""date"": ""2023-02-10"", ""headline"": ""Illumina Receives Highest Distinction in the 2023 S&P Global Sustainability Yearbook"", ""summary"": ""Illumina has been included in the 2023 S&P Global Sustainability Yearbook for the fourth consecutive year.""}, {""date"": ""2023-02-12"", ""headline"": ""7 Stocks to Buy and Hold for the Next 20 Years"", ""summary"": ""When looking for stocks to buy and hold for the next 20 years, it\u2019s essential to find ones with economic moat. After all, when it comes to picking stocks, they should strong competitive advantages that are in durable sectors. Some of the top stocks to buy and hold, include: MGM MGM. $43.83 GM General Motors $41.35 NOW ServiceNow $458.36 ILMN Illumina $196.58 BKNG Booking Holdings $2,348.37 FTNT Fortinet $59.61 PYPL PayPal $80.80 Stocks to Buy and Hold: MGM (MGM) Source: ImageFlow/Shutterstock.co""}]",{}
5,2023-02-12,196.5800018310547,2023-02-19,211.8300018310547,0.07757655843907352,U5+,"[{""date"": ""2023-02-12"", ""headline"": ""7 Stocks to Buy and Hold for the Next 20 Years"", ""summary"": ""When looking for stocks to buy and hold for the next 20 years, it\u2019s essential to find ones with economic moat. After all, when it comes to picking stocks, they should strong competitive advantages that are in durable sectors. Some of the top stocks to buy and hold, include: MGM MGM. $43.83 GM General Motors $41.35 NOW ServiceNow $458.36 ILMN Illumina $196.58 BKNG Booking Holdings $2,348.37 FTNT Fortinet $59.61 PYPL PayPal $80.80 Stocks to Buy and Hold: MGM (MGM) Source: ImageFlow/Shutterstock.co""}, {""date"": ""2023-02-13"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. advanced 9.85% to $215.94 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-13"", ""headline"": ""NEW YORK MARKET CLOSE: Shares rise ahead of key US inflation data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-13"", ""headline"": ""Stocks making the biggest moves midday: Zillow, Microsoft, Meta, Fidelity National and more"", ""summary"": ""These are the stocks posting the largest moves midday.""}, {""date"": ""2023-02-13"", ""headline"": ""Early notable gainers among liquid option names on February 13th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""Illumina Faces Rival Gene Sequencers and Price Competition"", ""summary"": ""An Illumina competitor with a less-expensive price point unveiled new technology at a recent genome biology conference.""}, {""date"": ""2023-02-14"", ""headline"": ""Illumina Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Illumina Inc. slid 1.44% to $212.83 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-02-14"", ""headline"": ""Illumina price target lowered to $240 from $255 at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""Top 5 4th Quarter Trades of MayTech Global Investments, LLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""Illumina Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Illumina Inc. inched 0.57% higher to $214.05 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-02-15"", ""headline"": ""Using Whole-Genome Sequencing To Study Early-Onset Parkinson\u2019s Disease"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / February 15, 2023 / Illumina: Originally published on Illumina News Center The Norwegian term for virgin snow, \""nysn\u00f8\"", seemed the appropriate inspiration to name Jennifer Johnston's company, NysnoBio, as it underscores ...""}, {""date"": ""2023-02-15"", ""headline"": ""Singular Genomics: Betting On Expanding Genomics Systems Market"", ""summary"": ""Singular Genomics is a unique opportunity to invest in a commercially-viable startup at the forefront of a rapidly expanding field. See why OMIC stock is a Buy.""}, {""date"": ""2023-02-15"", ""headline"": ""Using Whole-Genome Sequencing To Study Early-Onset Parkinson`s Disease"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-16"", ""headline"": ""Startups Take On Illumina in Race for Cheaper DNA Sequencing"", ""summary"": ""Startups are challenging market leader  Illumina  in the race to lower the cost of DNA sequencing and expand use of the technology throughout research and medicine.  DNA sequencing lets scientists read the individual bases, or letters, of genetic code.  San Diego-based Illumina, whose market capitalization is over $33 billion, has dominated the sector by launching instruments that have whittled the cost of sequencing the complete set of genetic material in cells, the genome, to $600.""}, {""date"": ""2023-02-16"", ""headline"": ""Illumina Inc. stock falls Thursday, still outperforms market"", ""summary"": ""Shares of Illumina Inc. slid 1.04% to $211.82 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-02-16"", ""headline"": ""Continue To Avoid Illumina Inc"", ""summary"": ""Illumina's most recent financial results were bad. Click here to find out why I recommend avoiding ILMN stock.""}, {""date"": ""2023-02-17"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. inched 0.00% higher to $211.83 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-02-17"", ""headline"": ""10 Sectors Likely To Generate Good Returns In The Next Decade"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
6,2023-02-19,211.8300018310547,2023-02-26,196.58999633789062,-0.07194450909422523,D5+,"[{""date"": ""2023-02-21"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 4.24% to $202.84 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-22"", ""headline"": ""Illumina Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 0.56% to $201.71 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-02-22"", ""headline"": ""GRAIL Teams Up with Professional Golfers David Duval and Juli Inkster to Raise Awareness of Multi-Cancer Early Detection"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Illumina Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.24% higher to $202.20 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-02-23"", ""headline"": ""John Hancock expands access to Galleri\u00ae, GRAIL's breakthrough cancer screening technology"", ""summary"": ""Today, John Hancock, a unit of Manulife (NYSE: MFC), announced it will expand access to GRAIL's Galleri\u00ae multi-cancer early detection test to eligible life insurance customers participating in the John Hancock Vitality PLUS program, a significant milestone in John Hancock's ongoing efforts to help customers live longer, healthier, better lives. The expanded access comes after John Hancock became the first life insurance carrier to make the breakthrough screening technology available to a pilot g""}, {""date"": ""2023-02-23"", ""headline"": ""Interesting ILMN Put And Call Options For April 6th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-24"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 2.77% to $196.59 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-02-25"", ""headline"": ""No Longer A Momentum Play, Pacific Biosciences Looking To Reaccelerate Growth In 2023"", ""summary"": ""PacBio's fourth quarter numbers were ugly, but that was expected as the company prepares for the launch of its next generation of long-read sequencers and its entry into short-read...""}]",{}
7,2023-02-26,196.58999633789062,2023-03-05,221.2100067138672,0.12523531631620122,U5+,"[{""date"": ""2023-02-27"", ""headline"": ""Illumina To Webcast Upcoming Investor Conference"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:""}, {""date"": ""2023-02-27"", ""headline"": ""Illumina Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.16% higher to $196.90 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-02-28"", ""headline"": ""It takes an average of 8 years for a rare disease patient to get diagnosed. Why is it so hard to get life-altering genetic testing in the U.S.?"", ""summary"": ""An increasingly inexpensive genetic test stands in the way of a diagnosis for many rare disease patients, who are as common as one in 10 worldwide.""}, {""date"": ""2023-02-28"", ""headline"": ""Working To Solve Rare Disease and Support Patients"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / February 28, 2023 / Illumina Originally published on Illumina News Center Every year on the last day of February, Rare Disease Day is celebrated worldwide in a collective effort to raise awareness and funding for ...""}, {""date"": ""2023-02-28"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. rallied 1.17% to $199.20 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-28"", ""headline"": ""11 Most Promising Cancer Stocks According to Analysts"", ""summary"": ""In this article, we discuss 11 most promising cancer stocks according to analysts. If you want to see more stocks in this selection, check out 5 Most Promising Cancer Stocks According to Analysts. The market for community oncology services worldwide is projected to experience substantial growth, with an estimated increase from $47.95 billion in 2022 [\u2026]""}, {""date"": ""2023-03-01"", ""headline"": ""Illumina Inc. stock falls Wednesday, still outperforms market"", ""summary"": ""Shares of Illumina Inc. slid 0.33% to $198.54 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-03-01"", ""headline"": ""23andMe Looking Promising For The Long Term"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-02"", ""headline"": ""Illumina Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Illumina Inc. rose 4.02% to $206.52 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-02"", ""headline"": ""A New Genomic Atlas Could Help Save Endangered Elephants"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / March 2, 2023 / Illumina: Originally published on Illumina News Center Herds of woolly mammoth once roamed the span of the Northern Hemisphere, from the British Isles across the Bering land bridge to the eastern ...""}, {""date"": ""2023-03-02"", ""headline"": ""Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States"", ""summary"": ""Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industrySALT LAKE CITY, March 02, 2023 (GLOBE NEWSWIRE) -- Myriad Genetic, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the expansion of a strategic partnership to broaden access to and availability of oncology homologous rec""}, {""date"": ""2023-03-02"", ""headline"": ""April 14th Options Now Available For Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-02"", ""headline"": ""Illumina, Myriad Genetics expand partnership to broaden access to HRD testing in U.S."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-02"", ""headline"": ""Myriad Genetics, Illumina expand partnership for HRD testing access"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-02"", ""headline"": ""Illumina and Myriad Genetics partner for HRD testing in the U.S."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-03"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. advanced 7.11% to $221.21 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-03"", ""headline"": ""Myriad Genetics' (MYGN) New Pact to Extend HRD Testing Access"", ""summary"": ""Myriad Genetics (MYGN), together with Illumina, will seek joint HRD companion diagnostics partnerships with pharmaceutical companies globally.""}, {""date"": ""2023-03-03"", ""headline"": ""Illumina Breaks Above 200-Day Moving Average - Bullish for ILMN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-04"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.""}]",{}
8,2023-03-05,221.2100067138672,2023-03-12,194.00999450683594,-0.12296013462995903,D5+,"[{""date"": ""2023-03-06"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slipped 2.52% to $215.63 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-07"", ""headline"": ""Illumina Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slipped 3.33% to $208.46 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-07"", ""headline"": ""Illumina, Inc. (ILMN) Presents at 43rd Annual TD Cowen Health Care Conference (Transcript)"", ""summary"": ""Illumina, Inc. (NASDAQ:NASDAQ:ILMN) 43rd Annual TD Cowen Health Care Conference March 7, 2023 9:50 AM ETCompany ParticipantsJoydeep Goswami - Chief Financial Officer & Chief Executive...""}, {""date"": ""2023-03-08"", ""headline"": ""Illumina Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Illumina Inc. shed 0.21% to $208.03 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-09"", ""headline"": ""Illumina Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Illumina Inc. shed 2.62% to $202.59 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-09"", ""headline"": ""Final Trades: Illumina, JPMorgan & more"", ""summary"": ""The \""Halftime Report\"" traders give their top picks to watch for the second half.""}, {""date"": ""2023-03-10"", ""headline"": ""Illumina Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 4.24% to $194.01 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-10"", ""headline"": ""Children\u2019s Mercy Kansas City Tackles the Unique Complexity of Pediatric Cancer"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / March 10, 2023 / Illumina Originally published on Illumina News Center \""Pediatricians like to say children are not little adults, and accordingly, pediatric cancer is not just the miniature form of adult cancer,\"" ...""}, {""date"": ""2023-03-10"", ""headline"": ""Children`s Mercy Kansas City Tackles the Unique Complexity of Pediatric Cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
9,2023-03-12,194.00999450683594,2023-03-19,224.5500030517578,0.1574146147601989,U5+,"[{""date"": ""2023-03-12"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-12"", ""headline"": ""Carl Icahn Pens Open Letter to Illumina Shareholders"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-12"", ""headline"": ""Carl Icahn Prepares for Proxy Fight at Illumina"", ""summary"": ""The billionaire activist is arguing the biotechnology company cost its shareholders roughly $50 billion by plowing ahead with a risky acquisition despite opposition from regulators.""}, {""date"": ""2023-03-12"", ""headline"": ""Carl Icahn prepares for proxy fight at Illumina - WSJ"", ""summary"": ""Illumina completed a takeover of cancer-detection test maker Grail in August 2021, without securing regulatory approval from the European Union.  The European Commission ordered Illumina in December to unwind the deal, three months after it had blocked the merger on concerns the deal would stifle innovation.""}, {""date"": ""2023-03-12"", ""headline"": ""UPDATE 1-Carl Icahn prepares for proxy fight at Illumina - WSJ"", ""summary"": ""Activist investor Carl Icahn is preparing a proxy fight at Illumina Inc, arguing that the life science maker's acquisition of Grail Inc cost its shareholders roughly $50 billion, the Wall Street Journal reported on Sunday.  Illumina completed a takeover of cancer-detection test maker Grail in August 2021, without securing regulatory approval from the European Union.""}, {""date"": ""2023-03-12"", ""headline"": ""Illumina: It`s not in the \ufffd\ufffd\ufffdbest interests` of shareholders to support Carl Icahn`s nominees to the board"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-12"", ""headline"": ""Illumina jumps 20%  as Carl Icahn starts proxy battle over Grail deal  (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Illumina should spin off Grail, activist Carl Icahn says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Icahn launches proxy fight at Illumina, seeks board seats"", ""summary"": ""Billionaire investor Carl Icahn is pushing for three board seats at Illumina, criticizing the biotechnology company's acquisition of a cancer test developer that cost investors $50 billion.""}, {""date"": ""2023-03-13"", ""headline"": ""Illumina Surges As Activist Carl Icahn Reportedly Steps In Over Grail"", ""summary"": ""Activist investor Carl Icahn could press Illumina to divest its controversial Grail asset, analysts said Monday as ILMN stock surged.""}, {""date"": ""2023-03-13"", ""headline"": ""Carl Icahn takes aim at genome sequencer Illumina over Grail deal"", ""summary"": ""Shares in Illumina surged more than 20 per cent on Monday following a decision by activist investor Carl Icahn to launch a proxy battle over what he described as the company\u2019s \u201creckless\u201d acquisition of cancer-screening start-up Grail.  Icahn sent a letter to Illumina shareholders alleging that its management team and the board of directors had wiped out $50bn of value at the world\u2019s biggest genome sequencing company through the \u201cill-advised\u201d purchase of Grail for $8bn in 2021.  The proxy battle follows a tumultuous 18 months for Illumina, whose market capitalisation has slumped from $75bn in August 2021 when it acquired Grail to just over $30bn last month.""}, {""date"": ""2023-03-13"", ""headline"": ""Illumina: It\u2019s not in the \u2018best interests\u2019 of shareholders to support Carl Icahn\u2019s nominees to the board"", ""summary"": ""Illumina Inc.  (ILMN)  said Monday it received notice from Icahn Partners that the organization plans to nominate three candidates to to the board over concerns about the company\u2019s $7.1 billion acquisition of Grail.  Jesse Lynn and Andrew Teno are current Icahn employees and Vincent Intrieri is a former Icahn employee.  Icahn reportedly told Illumina that the acquisition, which has faced regulatory scrutiny, cost shareholders $50 billion, according to the Wall Street Journal.""}, {""date"": ""2023-03-13"", ""headline"": ""Illumina Responds to Icahn Partners' Nomination of Directors"", ""summary"": ""Illumina, Inc. (Nasdaq: ILMN), a global leader in DNA sequencing and array-based technologies, confirmed today that it has received notice from Icahn Partners LP and certain of its affiliates of their intention to nominate three candidates\u2014two current Icahn employees, Jesse Lynn and Andrew Teno, and one former Icahn employee, Vincent Intrieri\u2014for election to the Board of Directors at Illumina's 2023 Annual Meeting of Shareholders.""}, {""date"": ""2023-03-13"", ""headline"": ""Carl Icahn Takes Aim at Illumina Over Grail Deal"", ""summary"": ""Carl Icahn said in a letter to Illumina shareholders that he plans to nominate three people to the biotech's board.""}, {""date"": ""2023-03-13"", ""headline"": ""These Stocks Are Moving the Most Today: First Republic, Seagen, Provention Bio, Illumina, Qualtrics, and More Market Movers"", ""summary"": ""First Republic shares are sinking Monday even as it received funding from JPMorgan Chase and the Federal Reserve, Pfizer announces it will acquire Seagen for $43 billion, and Provention Bio soars after agreeing to be acquired by France's Sanofi in a $2.9 billion deal.""}, {""date"": ""2023-03-13"", ""headline"": ""Illumina Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Illumina Inc. climbed 16.97% to $226.94 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-13"", ""headline"": ""KeyCorp, Philips 66 fall; Seagen, Insulet rise"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Activist investor Icahn launches proxy fight at Illumina"", ""summary"": ""Activist investor Carl Icahn on Monday launched a proxy fight at Illumina Inc, saying the life sciences company's takeover of Grail Inc had cost shareholders about $50 billion since the closing of the deal.""}, {""date"": ""2023-03-13"", ""headline"": ""Why Illumina Shares Are Soaring Today?"", ""summary"": ""Billionaire activist Carl Icahn is preparing a proxy fight at Illumina Inc (NASDAQ: ILMN), saying the company went ahead with the controversial acquisition of Grail Inc despite opposition from regulators, costing shareholders $50 billion. According to the letter viewed by Wall Street Journal, the activist plans to nominate three people to the company's board. Mr. Icahn accuses Illumina of overpaying for a business that made \""exactly zero dollars in revenue,\"" then closing the deal despite regulat""}, {""date"": ""2023-03-13"", ""headline"": ""UPDATE 1-Activist investor Icahn launches proxy battle at Illumina"", ""summary"": ""Activist investor Carl Icahn on Monday launched a proxy fight at Illumina Inc, arguing the company's takeover of Grail Inc had cost shareholders about $50 billion since the closing of the deal.  Shares of Illumina jumped 18% to $228.97 in morning trade.  Icahn plans to nominate three people to Illumina's board at the company's upcoming shareholder meeting, he said in a letter sent to the life sciences company's shareholders.""}, {""date"": ""2023-03-13"", ""headline"": ""Activist investor Icahn to nominate three people to Illumina's board"", ""summary"": ""Activist investor Carl Icahn on Monday launched a proxy battle at Illumina Inc, citing that the company's takeover of Grail Inc has cost shareholders about $50 billion since the closing of the deal.""}, {""date"": ""2023-03-13"", ""headline"": ""Midday movers: First Republic, Illumina, Seagen and more"", ""summary"": ""By Liz Moyer""}, {""date"": ""2023-03-13"", ""headline"": ""Stocks making the biggest moves midday: First Republic Bank, Moderna, Newmont, Illumina and more"", ""summary"": ""These are the stocks posting the largest moves midday.""}, {""date"": ""2023-03-13"", ""headline"": ""Illumina board recommends shareholders not support Icahn nominees"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""WSJ: Carl Icahn says Grail deal cost Illumina shareholders $50 billion"", ""summary"": ""MARKET PULSE Shares of Illumina Inc. (ILMN) were up about 8% in premarket trading on Monday after the Wall Street Journal reported Sunday that Carl Icahn is planning a proxy fight. The billionaire activist reportedly believes that the company\u2019s $7.""}, {""date"": ""2023-03-13"", ""headline"": ""HUT, NMTR and BYSI among mid-day movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Stocks Rally As Investors Bet On Rate-Hike Pause"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Illumina jumps as Carl Icahn starts proxy battle over Grail deal  (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Icahn: Nominees to bring `badly needed dose of sanity` to Illumina`s boardroom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Icahn nominates three people to Illumina`s board of directors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Carl Icahn issues open letter to Illumina shareholders"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Why Is ROKU Stock Down Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""ILMN Stock Alert: What to Know as Carl Icahn Prepares for Proxy Fight With Illumina"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Early notable gainers among liquid option names on March 13th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Stocks making the biggest moves premarket: Illumina, First Republic, Seagen and more"", ""summary"": ""Bank lenders saw major losses in early morning trading, stinging from the closure of Silicon Valley Bank and Signature Bank. ""}, {""date"": ""2023-03-13"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""MSTR, HIVE and FSM among pre market gainers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Hedge funds and C-suites: Illumina pops on Icahn news | Pro Recap"", ""summary"": ""Here is your Pro Recap of the biggest news out of hedge funds and company top brass you may have missed in the past week.  Illumina (NASDAQ:ILMN) shares rose sharply on word Carl Icahn is preparing to launch a proxy fight there, seeking three board seats, according to the Wall Street Journal.  According to Icahn, the biotech company's acquisition of Grail costed shareholders $50 billion and is now costing the company $800 million annually.""}, {""date"": ""2023-03-13"", ""headline"": ""S&P 500 Futures Climb in Premarket Trading; First Republic Bank, Western Alliance Bancorp Lag"", ""summary"": ""With U.S. stock markets set to open in two hours, (SGEN) was up 19.3% in pre-market trading, and (ILMN) was up 7.2%. (XM), (PODD), and (BILL) were all...""}, {""date"": ""2023-03-13"", ""headline"": ""Piper agrees with Icahn, says Illumina base business undervalued"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Billionaire Carl Icahn Could Lock Horns with Illumina (NASDAQ:ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Icahn planning proxy fight at Illumina, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""These Stocks Are Moving the Most Today: First Republic, Provention Bio, Roku, Illumina, Boeing, and More Market Movers"", ""summary"": ""First Republic shares are sinking Monday even as it received funding from JPMorgan Chase and the Federal Reserve, Provention Bio soars after agreeing to be...""}, {""date"": ""2023-03-14"", ""headline"": ""Illumina launches its first product enabling long- and short-read sequencing on one instrument"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Illumina Complete Long Read technology is now available to order. The high-performance, long-read, human whole-genome sequencing (WGS) assay \u2013 Illumina Complete Long Read Prep, Human \u2013 is compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. For the first time ever, it offers users access to both long- and short""}, {""date"": ""2023-03-14"", ""headline"": ""BRIEF-Carl Icahn Says We Own More Illumina Stock Than All Their Board Members Combined-CNBC Interview"", ""summary"": ""* CARL ICAHN SAYS POWELL HAS TO INCREASE INTEREST RATES SOONER OR LATER-CNBC INTERVIEW""}, {""date"": ""2023-03-14"", ""headline"": ""Illumina Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. shed 0.47% to $225.88 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-14"", ""headline"": ""Company News for Mar 14, 2023"", ""summary"": ""Companies In The News Are: SGEN, PFE, PODD, SIVB, ILMN, PNC.""}, {""date"": ""2023-03-14"", ""headline"": ""SVB May Be a Failure of Supervision. What It Means for Other Banks."", ""summary"": ""Pfizer bets $43 billion on Seagen, United Airlines projects loss on reduced demand, March Madness to draw $15.5 billion in wagers, and other news to start your day.""}, {""date"": ""2023-03-14"", ""headline"": ""Analysts` Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), Illumina (ILMN) and Arcutis Biotherapeutics (ARQT)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-15"", ""headline"": ""Icahn urges Illumina to unwind Grail deal, pushes ahead on proxy fight"", ""summary"": ""Billionaire investor Carl Icahn is urging life sciences company Illumina Inc to divest cancer test developer Grail Inc and said on Wednesday that his director candidates will be best placed to pursue this goal.""}, {""date"": ""2023-03-15"", ""headline"": ""Illumina (ILMN) Unveils Complete Long Reads Technology"", ""summary"": ""Illumina's (ILMN) Complete Long Read Prep combines Illumina sequencing by synthesis chemistry with DRAGEN secondary analysis to provide WGS with more accuracy.""}, {""date"": ""2023-03-15"", ""headline"": ""Illumina Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Illumina Inc. rose 1.00% to $228.15 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-15"", ""headline"": ""TD Cowen life science/diagnostic analyst holds analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-15"", ""headline"": ""Icahn says `only path forward` for Illumina is to divest GRAIL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-15"", ""headline"": ""ChatGPT Says These 7 Stocks Could Be the Next Trillion-Dollar Companies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-15"", ""headline"": ""Icahn Reacts Audaciously To Illumina's Audacity"", ""summary"": ""Carl Icahn wants three board seats at Illumina after it overpaid for Grail and took on too much regulatory risk. Find out more here.""}, {""date"": ""2023-03-15"", ""headline"": ""Icahn Reacts Audaciously To Illumina`s Audacity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-15"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Illumina (ILMN) and Tandem Diabetes Care (TNDM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-15"", ""headline"": ""Illumina: Promising Technology But Overvalued Company"", ""summary"": ""Illumina is the market leader in the DNA sequencing industry. See why I think ILMN stock is highly overvalued at today's prices.""}, {""date"": ""2023-03-16"", ""headline"": ""Illumina Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 1.40% to $224.95 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-16"", ""headline"": ""Buy This Magnificent Growth Stock Before It's Too Late"", ""summary"": ""Bionano Genomics (NASDAQ: BNGO) appears to be in just that place -- at the start of its growth journey -- and it could be a great way to give your portfolio some additional upside potential.  Bionano's claim to fame is its laboratory analyzer device for optical genome mapping, which it calls the Saphyr.""}, {""date"": ""2023-03-16"", ""headline"": ""Carl Icahn Responds to Illumina in Open Letter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-17"", ""headline"": ""Illumina Should Heed Carl Icahn, Give Up on Grail"", ""summary"": ""Many of  Illumina  shareholders have grown increasingly frustrated with Chief Executive  Francis deSouza\u2019s  pursuit of Grail.  The decision to close the $7.1 billion acquisition in August 2021 despite regulators\u2019 objections baffled many investors and is largely to blame for cutting the company\u2019s market capitalization in half.  Grail, which makes cancer-detection tests, lost about $600 million last year, cutting into Illumina\u2019s profit.""}, {""date"": ""2023-03-17"", ""headline"": ""Illumina Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Illumina Inc. slipped 0.18% to $224.55 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-17"", ""headline"": ""Why Is Seattle Genetics (SGEN) Up 24.6% Since Last Earnings Report?"", ""summary"": ""Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""2023-03-17"", ""headline"": ""UPDATE 1-Carl Icahn urges Fed to keep fighting inflation after SVB collapse - FT"", ""summary"": ""Activist investor Carl Icahn has urged the U.S. Federal Reserve to stay the course in the fight against the \""disease of inflation\"" despite the failure of Silicon Valley Bank and two other banks last week, the Financial Times reported on Friday.  \""I think you have to stamp out the disease of inflation,\"" Icahn told FT, ahead of Fed's rate-setting meeting next week in which the U.S. central bank is expected to raise its benchmark by 25 basis points.  The activist investor also warned of stress beyond the financial sector, saying that many companies had wasted billions of dollars on flawed acquisitions and become over indebted in the process, the report said.""}, {""date"": ""2023-03-17"", ""headline"": ""Carl Icahn urges Fed to keep fighting inflation \u2018disease\u2019 after SVB collapse"", ""summary"": ""Activist investor Carl Icahn has urged the Federal Reserve to stay the course in the fight against the \u201cdisease of inflation\u201d despite the failure of Silicon Valley Bank and two other banks last week.  \u201cI think you have to stamp out the disease of inflation,\u201d Icahn told the Financial Times.  Icahn\u2019s comments come ahead of the Fed\u2019s rate-setting meeting next week, with economists actively debating whether it will raise interest rates by 0.25 percentage points or take a pause following the SVB implosion.""}, {""date"": ""2023-03-18"", ""headline"": ""3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time"", ""summary"": ""Healthcare costs in America and the world are set to rise in the foreseeable future. All thanks to an aging population, and the expectation that healthcare companies will be able to cure more of our diseases. The companies that can break into new markets by curing new diseases are set to profit the most from the coming healthcare boom. All of which is great news for healthcare stocks. In fact, companies like CRISPR Therapeutics (NASDAQ:CRSP) need to show that their new technology is safe, effect""}, {""date"": ""2023-03-18"", ""headline"": ""Icahn proposes three candidates for Illumina\u2019s board \u2014 Here\u2019s what could be next in the battle"", ""summary"": ""A fight has broken out between veteran activist Carl Icahn and biotech company Illumina as the investor nominates three candidates to the board.""}, {""date"": ""2023-03-18"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
10,2023-03-19,224.5500030517578,2023-03-26,220.0,-0.02026276103282465,D3,"[{""date"": ""2023-03-20"", ""headline"": ""S&P 500 Losers: First Republic Crashes; Dow Giant Microsoft Slides"", ""summary"": ""First Republic is the new bank crisis epicenter, with FRC stock easily the S&P 500's biggest loser Monday. Microsoft fell below a buy point.""}, {""date"": ""2023-03-20"", ""headline"": ""Illumina Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 2.13% to $219.77 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-20"", ""headline"": ""Illumina backs Grail deal and strategy after Icahn hits out"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-20"", ""headline"": ""Biotech company Illumina pushes back against Carl Icahn\u2019s proxy fight over $7.1 billion Grail deal"", ""summary"": ""Illumina pushed back against Carl Icahn's proxy fight over the Grail deal, saying it's committed to maximizing shareholder value as it works with regulators. ""}, {""date"": ""2023-03-20"", ""headline"": ""Illumina says Icahn board nominees will damage core business"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-20"", ""headline"": ""Illumina Underscores Commitment to Shareholder Value and Responds to Carl Icahn's Statements"", ""summary"": ""Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued the following response to Carl Icahn's public statements and letters to Illumina's shareholders dated March 13 and March 15, 2023:""}, {""date"": ""2023-03-20"", ""headline"": ""Illumina says Icahn`s nominees `lack relevant skills and experience`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-21"", ""headline"": ""Illumina Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.84% higher to $221.61 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-03-22"", ""headline"": ""Illumina Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 2.00% to $217.18 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-22"", ""headline"": ""Bank of America Securities Remains a Hold on Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""Illumina says Icahn nominees `lack relevant skills and experience`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""Oxford Nanopore: Attractive Long-Term Growth, Possible Buyout Scenario"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""Illumina Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Illumina Inc. dropped 0.11% to $216.95 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-03-24"", ""headline"": ""Illumina Issues Statement in Response to Carl Icahn's Letter"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, issued the following statement in response to a letter from Carl Icahn dated March 24, 2023:""}, {""date"": ""2023-03-24"", ""headline"": ""Illumina Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Illumina Inc. advanced 1.41% to $220.00 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-24"", ""headline"": ""Illumina defends director insurance as Carl Icahn proxy battle wages"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-24"", ""headline"": ""Binance Suspends Trading, European Bank Trouble, Twitter To Remove Legacy Verified Checkmarks: Today's Top Stories"", ""summary"": ""Reuters European Bank Trouble: Deutsche Bank Stock Under Pressure Due To Higher Costs Of Default Insurance Deutsche Bank AG (NYSE: DB) shares came under pressure following a spike in credit default swaps amid persistent concerns regarding the stability of European banks. Deutsche Bank's credit default swaps (CDS) - a form of insurance for bondholders - shot up above 200 basis points (bps) - the most since early 2019 - from 142 bps, based on data from S&P Market Intelligence. SVB's Private Bank U""}, {""date"": ""2023-03-24"", ""headline"": ""Carl Icahn Steps Up Battle With Illumina, Says Directors Asked Additional Insurance For Grail Deal"", ""summary"": ""Activist Carl Icahn reportedly accused Illumina Inc (NASDAQ: ILMN) directors of demanding extra personal liability insurance before agreeing to close the $8 billion purchase of cancer screening company Grail Inc as regulators were against the deal. The claim is contained in the latest salvo of criticisms levied by the activist investor against the genome sequencing company. In a letter to Illumina shareholders, as seen by the Financial Times, Icahn alleges that Illumina directors required a comm""}, {""date"": ""2023-03-24"", ""headline"": ""UPDATE 2-Icahn claims Illumina directors asked for insurance for Grail deal approval"", ""summary"": ""Carl Icahn on Friday came down heavily on Illumina Inc, saying its directors demanded extra personal liability insurance against any potential claims related to the acquisition of Grail in 2021 before agreeing to signing off on the deal.  In response to Icahn's claims, Illumina said insurance agreements with its directors were standard and it regularly reviews them to reflect appropriate coverage.  Activist investor Icahn, who owns 1.4% of Illumina, launched a proxy battle against the company earlier this month seeking divestment of cancer test developer Grail as the $7.1-billion acquisition cost investors billions of dollars.""}, {""date"": ""2023-03-24"", ""headline"": ""Carl Icahn claims Illumina directors got extra insurance to close 'disastrous' $7.1 billion Grail deal"", ""summary"": ""Carl Icahn claims Illumina directors demanded extra personal liability insurance before the biotech company signed off on a $7.1 billion acquisition of Grail""}, {""date"": ""2023-03-24"", ""headline"": ""Carl Icahn claims Illumina directors sought extra insurance for Grail deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-24"", ""headline"": ""Icahn to investigate `massive value destruction` by Illumina"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-24"", ""headline"": ""Icahn claims Illumina directors asked for insurance for Grail deal approval"", ""summary"": ""In response to Icahn's claims, Illumina said insurance agreements with its directors were standard and it regularly reviews them to reflect appropriate coverage.  Activist investor Icahn, who owns 1.4% of Illumina, launched a proxy battle against the company earlier this month seeking divestment of cancer test developer Grail as the $7.1-billion acquisition cost investors billions of dollars.  The deal also faces antitrust opposition from the European Union, but that did not stop Illumina from going ahead and closing it.""}, {""date"": ""2023-03-24"", ""headline"": ""Icahn claims Illumina directors got insurance to close Grail deal -FT"", ""summary"": ""Carl Icahn has alleged that Illumina Inc's directors demanded extra personal liability insurance before they agreed to sign off on the life sciences company's $7.1 billion purchase of Grail in 2021, the Financial Times reported on Friday.  The billionaire investor's claims, made in a letter to Illumina's shareholder that the FT saw, come as he continues his push for board seats on the world's largest genome sequencing company and for it to unwind the Grail acquisition.  Illumina completed the takeover of Grail, which develops cancer detection tests, in August 2021, without winning U.S. or European regulatory approval, although it has since won U.S. clearance and is currently fighting for European approval.""}, {""date"": ""2023-03-24"", ""headline"": ""Carl Icahn claims Illumina directors sought extra insurance for Grail deal \ufffd\ufffd\ufffd FT"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-24"", ""headline"": ""Carl Icahn says Illumina directors demanded extra insurance for Grail deal"", ""summary"": ""Carl Icahn has alleged Illumina directors demanded the company buy them extra personal liability insurance before they agreed to close its $8bn purchase of cancer screening company Grail against the wishes of regulators.  Icahn has engaged in a proxy battle with the company over what he describes as its \u201cdisastrous\u201d acquisition of Grail in August 2021.  EU authorities raised objections with Illumina over its proposed acquisition of Grail in September 2020 and were investigating the deal when the company took the unusual step of closing the transaction.""}, {""date"": ""2023-03-24"", ""headline"": ""Illumina responds to latest salvo from Carl Icahn"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
11,2023-03-26,220.0,2023-04-02,232.5500030517578,0.05704546841708091,U5+,"[{""date"": ""2023-03-27"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Illumina Inc. sank 0.99% to $217.82 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-27"", ""headline"": ""Illumina launches new software to enable tertiary analysis for oncology applications, and soon rare disease"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the release of Connected Insights, a new cloud-based software enabling tertiary analysis for clinical next-generation sequencing (NGS) data.""}, {""date"": ""2023-03-27"", ""headline"": ""Illumina: What Is Up With The Genes?"", ""summary"": ""Illumina has seen continued uncertainty and incurred a lot of losses with GRAIL acquisition while the core business was performing soft. Learn why I'm neutral on ILMN stock.""}, {""date"": ""2023-03-27"", ""headline"": ""Hedge funds and C-suites: Trump-linked DWAC fires CEO | Pro Recap"", ""summary"": ""Digital World Acquisition  (NASDAQ:DWAC), fired Patrick Orlando from his positions as Chairman and CEO of the company, according to the Wednesday filing.  Orlando, who, together with his other company ARC Global Investments, owns 10% of DWAC, remains a director of the company.  Eric Swider, another director, was appointed to serve as interim chief executive while the board works on executing a final succession plan.""}, {""date"": ""2023-03-28"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-28"", ""headline"": ""Illumina Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 1.83% to $213.84 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-28"", ""headline"": ""Illumina Hits Back at Carl Icahn\u2019s Grail Deal Claims and His Board Nominations"", ""summary"": """"}, {""date"": ""2023-03-29"", ""headline"": ""Carl Icahn responds to Illumina `obfuscations` in open letter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-29"", ""headline"": ""Carl Icahn Wants to Bring Illumina\u2019s Old CEO Back, Disney-Style"", ""summary"": ""The activist investor signaled he wants change at the management level, and he has a candidate in mind for the top spot: former CEO Jay Flatley.""}, {""date"": ""2023-03-29"", ""headline"": ""What's The Similiarity Between Disney And Illumina? Billionaire Activist Investor Wanted Retired CEO To Come Back"", ""summary"": ""After launching a proxy battle against Illumina Inc (NASDAQ: ILMN), activist investor Carl Icahn has clarified that he wants management change with former CEO Jay Flatley to come back and Grail divested. \u201cThey should bring Flatley back as CEO immediately,\u201d Mr. Icahn said in an interview, without specifying whether he has contacted the former CEO about the idea. \u201cHe obviously knows the company and did a good job with it.\u201d Mr. Flatley, who served as CEO between 1999 and 2016, is credited with tran""}, {""date"": ""2023-03-29"", ""headline"": ""Illumina (ILMN) to Enable Tertiary Analysis With New Launch"", ""summary"": ""Illumina's (ILMN) Connected Software is an end-to-end software system that standardizes analysis tools and connects data across the genomics workflow.""}, {""date"": ""2023-03-29"", ""headline"": ""Carl Icahn wants to bring back Illumina's ex-CEO -WSJ"", ""summary"": ""In an interview with the WSJ, Icahn signaled that Illumina \""should bring Flatley back as CEO immediately\"".  Icahn, who owns 1.4% of Illumina, is pushing for Illumina to unwind its buyout of cancer detection test maker Grail and is seeking three board seats after weeks of private discussions failed to yield results.""}, {""date"": ""2023-03-29"", ""headline"": ""UPDATE 1-Carl Icahn wants to bring back Illumina's ex-CEO -WSJ"", ""summary"": ""Carl Icahn wants former Illumina CEO Jay Flatley back at the U.S. life sciences firm, the Wall Street Journal reported on Wednesday, as the activist investor intensifies his proxy fight that was launched earlier this month.  In an interview with the WSJ, Icahn signaled that Illumina \""should bring Flatley back as CEO immediately\"".  Icahn, who owns 1.4% of Illumina, is pushing for Illumina to unwind its buyout of cancer detection test maker Grail and is seeking three board seats after weeks of private discussions failed to yield results.""}, {""date"": ""2023-03-29"", ""headline"": ""DNA Data Storage Alliance Announces Board Appointments"", ""summary"": ""SAN DIEGO, March 29, 2023--The DNA Data Storage Alliance, a SNIA Technology Affiliate, formed in 2020 by Illumina, Inc. (NASDAQ: ILMN), Microsoft (Nasdaq: MSFT), Twist Bioscience Corporation (NASDAQ: TWST) and Western Digital (NASDAQ: WDC) to create and promote an interoperable storage ecosystem based on DNA as a data storage medium, today announced the appointments of CATALOG Technologies and Quantum Corporation to the governing board of the Alliance. David Turek will represent CATALOG and Don""}, {""date"": ""2023-03-29"", ""headline"": ""Carl Icahn plans to bring back Illumina's old CEO - WSJ"", ""summary"": ""Carl Icahn is planning to bring back former Illumina CEO Jay Flatley at the helm of the gene-sequencing machine maker, with whom the activist investor is engaged in a proxy fight, the Wall Street Journal reported on Wednesday. (Reporting by Leroy Leo in Bengaluru; Editing...""}, {""date"": ""2023-03-29"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-29"", ""headline"": ""Carl Icahn wants to bring back Illumina's ex-CEO 'immediately' as proxy fight intensifies "", ""summary"": ""Icahn said Illumina should bring back former CEO Jay Flatley, saying current management is making the mistake of holding onto the $7.1 billion Grail deal.  ""}, {""date"": ""2023-03-29"", ""headline"": ""Carl Icahn tells WSJ he wants old CEO back at Illumina"", ""summary"": ""Illumina Inc. activist shareholder and billionaire Carl Icahn told The Wall Street Journal he\u2019d like to see the return of ex-CEO Jay Flatley to replace the...""}, {""date"": ""2023-03-29"", ""headline"": ""Carl Icahn seeks to bring Illumina`s former CEO back \ufffd\ufffd\ufffd WSJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-29"", ""headline"": ""Icahn seeks to bring back Illumina`s former CEO, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""Carl Icahn and Illumina Proxy Fight Heats Up"", ""summary"": ""Biotech firm Illumina (ILMN) told shareholders not to vote for the board nominees put forward by billionaire activist investor Carl Icahn.""}, {""date"": ""2023-03-30"", ""headline"": ""Icahn, Illumina privately discussed settlement before public fight - filing"", ""summary"": ""Activist investor Carl Icahn and Illumina Inc had weeks-long private negotiations before he started a proxy fight to push the U.S. life sciences firm to unwind its 2021 buyout of Grail, a regulatory filing showed on Thursday.""}, {""date"": ""2023-03-30"", ""headline"": ""UPDATE 1-Icahn, Illumina privately discussed settlement before public fight - filing"", ""summary"": ""Activist investor Carl Icahn and Illumina Inc had weeks-long private negotiations before he started a proxy fight to push the U.S. life sciences firm to unwind its 2021 buyout of Grail, a regulatory filing showed on Thursday.  The billionaire proposed a negotiated settlement on March 8 that included two board seats for his nominees and one for a mutually agreed candidate, according to the filing from Illumina.  He also suggested a joint statement supporting the divestiture of cancer detection test maker Grail if Illumina's appeal to European regulators, which had ordered it to sell Grail, was not successful.""}, {""date"": ""2023-03-30"", ""headline"": ""Illumina, Icahn Fight Intensifies After Negotiation Failed"", ""summary"": ""(Bloomberg) -- Illumina Inc. and activist investor Carl Icahn tried but failed to reach a compromise that would have avoided the public battle over seats on its board, according to a preliminary proxy statement filed by the DNA-sequencing company.Most Read from BloombergTrump Faces Fingerprints, Mug Shots After Historic Indictment$335,000 Pay for \u2018AI Whisperer\u2019 Jobs Appears in Red-Hot Market$52 Billion Chipmaking Plan Is Racing Toward FailureNew Yorkers Are Moving to These Three Florida CitiesA""}, {""date"": ""2023-03-30"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. advanced 1.45% to $225.26 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-03-30"", ""headline"": ""Icahn, Illumina discussed settlement before proxy fight - filing"", ""summary"": ""Activist investor Carl Icahn and U.S. life sciences firm Illumina failed to reach a settlement during weeks-long private negotiations before he began a proxy fight earlier this month, a regulatory filing showed on Thursday.  Icahn, who owns 1.4% of Illumina, has been pushing for the company to unwind its buyout of cancer detection test maker Grail and is seeking three board seats.  In a preliminary proxy filing, Illumina disclosed that the billionaire had proposed a negotiated settlement on March 8.""}, {""date"": ""2023-03-30"", ""headline"": ""Illumina chief\u2019s pay nearly doubles ahead of clash with Carl Icahn"", ""summary"": ""Francis deSouza was awarded $26.7mn in total pay last year despite drop in genome sequencer\u2019s market value""}, {""date"": ""2023-03-30"", ""headline"": ""Illumina Files Preliminary Proxy, Urging Shareholders to Vote for Its Director Nominees and Withhold for Each Icahn Group Nominee"", ""summary"": ""Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today filed its preliminary proxy statement with the Securities and Exchange Commission, which contains important information for shareholders.""}, {""date"": ""2023-03-30"", ""headline"": ""Illumina urges shareholders to reject Carl Icahn's board nominees as proxy fight heats up "", ""summary"": ""Illumina told shareholders that Carl Icahn's board nominees would \""threaten the progress\"" of the biotech company's core business. ""}, {""date"": ""2023-03-30"", ""headline"": ""Illumina Urges Shareholders to Reject Carl Icahn's Board Nominees"", ""summary"": ""By Dean Seal Illumina Inc. is urging shareholders to vote in favor of its proposed board of directors at the next annual meeting and to withhold votes for...""}, {""date"": ""2023-03-30"", ""headline"": ""Illumina urges shareholders to withhold votes for Icahn Group director nominees"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""Illumina (NASDAQ:ILMN): Bringing Back Old CEOs Is the Latest Fad"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""Carl Icahn, Illumina fight continues with dueling statements"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-31"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. rose 3.24% to $232.55 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-31"", ""headline"": ""7 Stocks Gearing Up for a Major Breakout"", ""summary"": ""The entire stock market is gearing up for a major breakout as investors are becoming convinced that the banking sector has stabilized and that the Federal Reserve is, at the very least, almost done hiking interest rates. Meanwhile, two critical sectors \u2013housing and computer chips \u2014 are showing signs of recovery. Many investors are starting to focus on the economy\u2019s strong fundamentals instead of quaking in fear about interest rate hikes. In this environment, there are many potential breakout sto""}, {""date"": ""2023-03-31"", ""headline"": ""Carl Icahn blasts Illumina for nearly doubling CEO\u2019s pay despite steep drop in market value "", ""summary"": ""Activist investor Carl Icahn ramped up his proxy fight against Illumina with a blistering statement. ""}]",{}
12,2023-04-02,232.5500030517578,2023-04-09,229.99000549316406,-0.011008374650607888,D2,"[{""date"": ""2023-04-02"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""FTC Orders Illumina (NASDAQ:ILMN) to Unwind $7B Grail Acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""FTC Overturns Approval of $7 Billion Illumina-Grail Deal"", ""summary"": ""It's probably too late to put the champagne back in the bottle. Some six months after biotech giant Illumina gained regulatory approval for its...""}, {""date"": ""2023-04-03"", ""headline"": ""Regulators Tell Illumina to Unwind GRAIL Deal"", ""summary"": ""Shares of Ilumina (ILMN) dropped as the Federal Trade Commission (FTC) ordered the biotech firm to unwind its purchase of cancer test provider GRAIL.""}, {""date"": ""2023-04-03"", ""headline"": ""FTC Rejects Illumina\u2019s $7 Billion Deal for Cancer-Test Developer Grail"", ""summary"": ""The agency said the combination would hurt competition for cancer-detection tests while raising prices.""}, {""date"": ""2023-04-03"", ""headline"": ""Icahn proxy fight is 'distraction' for Illumina outlook: RBC analyst"", ""summary"": ""Illumina is struggling with its latest acquisition, facing regulatory backlash from both the EU and the FTC, as well as a proxy fight with activist investor Carl Icahn.""}, {""date"": ""2023-04-03"", ""headline"": ""FTC Orders Biotech Illumina To Unwind Grail Deal Amid Icahn Battle"", ""summary"": ""The FTC ordered Monday that biotech firm Illumina must unwind its $8 billion purchase of the cancer-testing startup Grail. ILMN stock fell on the news.""}, {""date"": ""2023-04-03"", ""headline"": ""FTC Orders Illumina To Divest Grail, Mounts Pressure On Company Amid Proxy Fight With Icahn"", ""summary"": ""The Fed\u00ader\u00adal Trade Com\u00admis\u00adsion has or\u00addered Il\u00adlu\u00admi\u00adna Inc (NASDAQ: ILMN) to di\u00advest Grail Inc, saying that the deal would stifle competition and innovation in the U.S. market for cancer tests. Billionaire activist Carl Icahn is preparing a proxy fight at Illumina, saying the company went ahead with the controversial acquisition of Grail Inc despite opposition from regulators, costing shareholders $50 billion. The Commission found that the acquisition would diminish innovation in the U.S. mar""}, {""date"": ""2023-04-03"", ""headline"": ""FTC orders Illumina to unwind $7B deal for cancer test developer Grail"", ""summary"": ""The Federal Trade Commission has rejected Illumina's $7.1 billion acquisition of cancer detection test maker Grail, saying the deal would stifle competition.""}, {""date"": ""2023-04-03"", ""headline"": ""U.S. Orders Illumina to Divest Cancer Tester Grail"", ""summary"": ""Chief Executive Francis deSouza had championed the deal to get Illumina into the nascent market for blood tests that can detect early signs of cancers.""}, {""date"": ""2023-04-03"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Illumina Inc. shed 1.09% to $230.02 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-03"", ""headline"": ""NEW YORK MARKET CLOSE: Soaring oil price lifts Dow, holds back tech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""US antitrust regulator orders Illumina to unwind $8bn Grail deal"", ""summary"": ""The Federal Trade Commission has ordered Illumina to divest cancer screening company Grail, arguing the $8bn acquisition would damage competition in the US market for life-saving cancer tests.  The decision reverses an earlier ruling by an administrative law judge in favour of the deal and marks the latest setback to the San Diego-based company\u2019s efforts to diversify into the nascent market for multi-cancer early detection tests.  The US antitrust regulator issued an opinion and order on Monday, which found Illumina\u2019s decision to buy Grail, a company that it had initially spun out in 2016, would diminish innovation in the domestic market for the oncology tests while increasing prices and decreasing choice and quality of tests.""}, {""date"": ""2023-04-03"", ""headline"": ""US FTC orders Illumina to divest cancer detection test maker Grail"", ""summary"": ""The U.S. Federal Trade Commission (FTC) on Monday ordered Illumina to divest cancer diagnostic test maker Grail, finding that its ownership would stifle competition in the U.S. market for cancer tests.""}, {""date"": ""2023-04-03"", ""headline"": ""UPDATE 2-US FTC orders Illumina to divest cancer detection test maker Grail"", ""summary"": ""The U.S. Federal Trade Commission (FTC) on Monday ordered Illumina to divest cancer diagnostic test maker Grail, finding that its ownership would stifle competition in the U.S. market for cancer tests.  Illumina said it would appeal the decision, and will seek expedited consideration from an appeals court.  Judge Michael Chappell, an administrative law judge at the agency, ruled last year that the $7.1 billion acquisition of Grail would not hurt competition.""}, {""date"": ""2023-04-03"", ""headline"": ""Illumina Will Appeal FTC Decision in Federal Court, Will Seek US Resolution by Late 2023 or Early 2024"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN) today announced that it will appeal the Federal Trade Commission's (\""FTC\"") decision ordering the unwinding of Illumina's acquisition of GRAIL.""}, {""date"": ""2023-04-03"", ""headline"": ""Midday movers: Marathon Oil, McDonald's, Illumina and more"", ""summary"": ""By Liz Moyer""}, {""date"": ""2023-04-03"", ""headline"": ""FTC orders Illumina to divest cancer test maker Grail on competition grounds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""TOP NEWS: US regulator orders Illumina to divest newly-bought Grail"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail"", ""summary"": ""The decision reverses an administrative judge's ruling that dismissed the FTC's initial challenge of Illumina's $7.1 billion Grail deal. ""}, {""date"": ""2023-04-03"", ""headline"": ""Illumina prepared to divest GRAIL if FTC appeal fails"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""FTC orders Illumina to divest Grail; Illumina plans to appeal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""Illumina to move expeditiously to divest GRAIL if it does not prevail in appeal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""Illumina sees resolution by late 2023, early 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""Illumina to appeal FTC decision in federal court"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""Illumina ordered by FTC to divest GRAIL over competition concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""FTC orders Illumina to divest cancer detection test maker GRAIL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""Illumina ordered to divest cancer detection test maker GRAIL by FTC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""Illumina to Announce First Quarter 2023 Financial Results on Tuesday, April 25, 2023"", ""summary"": ""Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the first quarter 2023 following the close of market on Tuesday, April 25, 2023.""}, {""date"": ""2023-04-04"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. inched 0.09% higher to $230.22 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""2023-04-04"", ""headline"": ""25 Greatest Impacts in 25 Years: Illumina and the Evolution of Genomics"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / April 4, 2023 / Illumina Originally published on Illumina News Center This month, Illumina celebrates a quarter century of innovation, research, and passion. As a genomics pioneer founded in San Diego in 1998, we ...""}, {""date"": ""2023-04-04"", ""headline"": ""Illumina's revolutionary NovaSeq X exceeds 200th order milestone in first quarter 2023"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has already exceeded more than 200 orders for its revolutionary NovaSeq X sequencing system in the first quarter of 2023. The orders represent a diverse customer base spanning research and clinical customer segments in nearly 30 countries, across five continents, all seeking to add NovaSeq X \u2013 our fastest, most powerful, most sustainable high-throughput sequencer available.""}, {""date"": ""2023-04-04"", ""headline"": ""OPEC Makes the Fed\u2019s Job Harder. That May End Up Hurting Investors."", ""summary"": ""OPEC production cuts put wind under major oil stocks, AMC common stock falls after \u2018APE\u2019 share settlement, Disney CEO Iger Calls Gov. DeSantis\u2019s Actions \u2018Anti-Florida,\u2019 and other news to start your day.""}, {""date"": ""2023-04-04"", ""headline"": ""The FTC ordered Illumina to unravel its $7 billion Grail purchase"", ""summary"": ""The US Federal Trade Commission (FTC) ordered Illumina, a leading DNA-sequencing firm, to unravel its $7 billion acquisition of Grail, a developer of cancer-screening tests, stating the deal would hurt innovation and competition in the market.""}, {""date"": ""2023-04-04"", ""headline"": ""Providence and GRAIL Expand Partnership to Increase Access to Galleri\u00ae Multi-Cancer Early Detection Screening"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""Illumina gets Street support after probable GRAIL divestment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""Illumina`s NovaSeq X exceeds 200th order milestone in Q1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""Virgin Orbit, AMC Entertainment and Ncino fall premarket; Etsy rises"", ""summary"": ""By Peter Nurse""}, {""date"": ""2023-04-04"", ""headline"": ""5 things to know before the stock market opens Tuesday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""2023-04-04"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (ILMN) and Travere Therapeutics (TVTX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""Carl Icahn Writes Another Letter to Illumina Shareholders"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""PRESS DIGEST- New York Times business news - April 4"", ""summary"": ""The following are the top stories on the New York Times business pages.  - The U.S. Federal Trade Commission on Monday ordered Illumina, the leading maker of gene-sequencing machines, to divest Grail, a cancer-test developer.  - Two workers were killed at Kennedy International Airport in New York City on Monday when they were buried under construction rubble inside a trench while moving utility lines as part of a broader overhaul at the airport.""}, {""date"": ""2023-04-04"", ""headline"": ""Grail alumni say Illumina battle threatens cancer breakthrough"", ""summary"": ""Two of Grail\u2019s founding directors have warned Illumina\u2019s battles with antitrust regulators and activist investor Carl Icahn over its ownership of the cancer screening company threaten to hamper access to potentially life-saving oncology tests.  Jeff Huber, former founding chief executive of Grail, and Meredith Halks-Miller, an Illumina scientist whose discovery led to development of its blood test that detects 50 types of cancer, said political wrangling was causing delays and funding concerns.  \u201cOne of the disappointing aspects of the European Union and Federal Trade Commission regulatory issues and now the Icahn proxy battle is that Grail is moving more slowly than it should,\u201d Huber told the Financial Times.""}, {""date"": ""2023-04-05"", ""headline"": ""Illumina Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Illumina Inc. inched 0.30% higher to $230.92 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-04-05"", ""headline"": ""Carl Icahn says Illumina\u2019s appeal of FTC order to divest Grail is \u2018an almost impossible battle\u2019"", ""summary"": ""Carl Icahn shares common ground with the FTC, which argued that Illumina's acquisition of cancer test developer Grail would stifle competition and innovation.\u00a0""}, {""date"": ""2023-04-05"", ""headline"": ""Illumina's (ILMN) NovaSeq X Exceeds 200 Order Milestone"", ""summary"": ""Illumina's (ILMN) NovaSeq X records the strongest pre-launch demand ever witnessed for any instrument.""}, {""date"": ""2023-04-05"", ""headline"": ""Illumina celebrates 25 years of innovation"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today begins a monthlong celebration of its 25th anniversary.""}, {""date"": ""2023-04-05"", ""headline"": ""ACEGID and Illumina to Increase Africa\u2019s Genomics Capacity through Establishment of a Joint Training Academy"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / April 5, 2023 / Illumina Originally published on LinkedIn The African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, announced that it will collaborate with Illumina, a ...""}, {""date"": ""2023-04-05"", ""headline"": ""ACEGID and Illumina to Increase Africa`s Genomics Capacity through Establishment of a Joint Training Academy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Carl Icahn calls for removal of Illumina CEO Francis deSouza"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Icahn issues new letter to Illumina holders, calls for deSouza to be dismissed"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Carl Ican Issues Another Letter to Illumina Shareholders"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-06"", ""headline"": ""The 3 Best Millionaire-Maker Stocks to Buy for April 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-06"", ""headline"": ""Illumina Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Illumina Inc. slipped 0.40% to $229.99 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-06"", ""headline"": ""Illumina (ILMN) to Expand Genomics Capacity With New Pact"", ""summary"": ""Illumina's (ILMN) recent collaboration is built on the shared goal of the organizations to expand sequencing capabilities and capacity for all people in Africa.""}, {""date"": ""2023-04-06"", ""headline"": ""Illumina Rings the Bell at Nasdaq"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / April 6, 2023 / Illumina Originally published on Illumina News Center The Nasdaq closing bell in New York City signifies the end of a full day of trading on the stock market, a day of transactions made to benefit ...""}, {""date"": ""2023-04-06"", ""headline"": ""5 things to know before the stock market opens Thursday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""2023-04-07"", ""headline"": ""Oil Prices Are Surging, but Futures Are Falling. Why That\u2019s a Bullish Sign."", ""summary"": ""The trading pattern, known as backwardation, looks bearish but is often bullish. The reason: Traders buy cheaper oil and producers balance the market by...""}, {""date"": ""2023-04-07"", ""headline"": ""The Old CEO\u2019s Back, but It Doesn\u2019t Mean Things Will Get Better"", ""summary"": ""Carl Icahn wants Illumina\u2019s former CEO back in the saddle at the life-sciences firm. A returning CEO usually can\u2019t pull off a Steve Jobs, however.""}, {""date"": ""2023-04-08"", ""headline"": ""Is There Any Hope for Illumina Stock?"", ""summary"": ""With shares of Illumina (NASDAQ: ILMN) down 37% over the last 12 months and underperforming the market over the last five years, shareholders have had a rough time.  As of April 3, regulators in the U.S. were rebuffing its acquisition of Grail, a cancer-testing company that it originally founded and spun off.  While some competitors make devices that do the same thing as Illumina's products, there's certainly no rising star anywhere in sight that could take its place.""}]","{""assetTurnoverTTM"": 0.3504, ""bookValue"": 6693, ""cashRatio"": 0.6699551569506726, ""currentRatio"": 1.4224, ""ebitPerShare"": -0.4051, ""eps"": 0.019, ""ev"": 37092.527, ""fcfPerShareTTM"": -1.443, ""grossMargin"": 0.6026, ""inventoryTurnoverTTM"": 3.1132, ""longtermDebtTotalAsset"": 0.1259, ""longtermDebtTotalCapital"": 0.1665, ""longtermDebtTotalEquity"": 0.2222, ""netDebtToTotalCapital"": 0.0831, ""netDebtToTotalEquity"": 0.1109, ""netMargin"": 0.0028, ""operatingMargin"": -0.0589, ""pb"": 5.4311, ""pretaxMargin"": -0.0718, ""psTTM"": 8.1742, ""ptbv"": 10.5181, ""quickRatio"": 0.9865, ""receivablesTurnoverTTM"": 6.779, ""roaTTM"": -0.3535, ""roeTTM"": -0.5891, ""roicTTM"": -0.4612, ""rotcTTM"": -0.455, ""salesPerShare"": 6.8797, ""sgaToSale"": 0.3974, ""tangibleBookValue"": 3456, ""totalDebtToEquity"": 0.3341, ""totalDebtToTotalAsset"": 0.1893, ""totalDebtToTotalCapital"": 0.2504, ""totalRatio"": 2.3077, ""period"": ""2023-04-02""}"
13,2023-04-09,229.99000549316406,2023-04-16,228.00999450683594,-0.008609117522661136,D1,"[{""date"": ""2023-04-10"", ""headline"": ""Illumina Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slumped 0.12% to $229.71 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-10"", ""headline"": ""Is It Time To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?"", ""summary"": ""Illumina, Inc. ( NASDAQ:ILMN ) saw a double-digit share price rise of over 10% in the past couple of months on the...""}, {""date"": ""2023-04-11"", ""headline"": ""Why Healthcare Stocks Are A Prescription For Investors In Q2 2023"", ""summary"": ""The recent drop in biopharma stocks presents a buying opportunity for investors. Find out why XLV seems like the best fit.""}, {""date"": ""2023-04-11"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. sank 0.85% to $227.76 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-04-11"", ""headline"": ""Local Teachers Spread Passion for STEM with SD2/Illumina Corporate Foundation STEM Educators Award"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / April 11, 2023 / Illumina Originally published on SD2 By Allison Harden The 2022 SD2 and Illumina Corporate Foundation STEM Educator Awards have been awarded to local San Diego educators Hannah Nakamoto, a chemistry ...""}, {""date"": ""2023-04-11"", ""headline"": ""GRAIL Showcases Methylation Platform Performance Across Cancer Continuum With New Data at American Association for Cancer Research (AACR) Annual Meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""S&P 500 Q1 2023 Earnings Preview: Entering An Earnings Recession"", ""summary"": ""Q1 is expected to mark the second consecutive quarter of negative y/y earnings growth, which meets the criteria of an earnings recession.""}, {""date"": ""2023-04-11"", ""headline"": ""Illumina and Henry Ford Health team up to study impact of comprehensive genomic testing for cardiovascular patients"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Henry Ford Health, a not-for-profit health care organization in the Detroit metro area, today announced the launch of a partnership to assess the impact of comprehensive genomic testing in cardiovascular disease. The first study under this new partnership, CardioSeq, launches today and will include 1500 patients receiving care from the Division of Cardiovascular Medicine at Henry Ford.""}, {""date"": ""2023-04-11"", ""headline"": ""Illumina, Henry Ford Health partner to study impact of genomic testing in heart disease"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Illumina partners with Henry Ford Health on genomic testing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""Illumina Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Illumina Inc. slid 0.39% to $226.88 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-04-12"", ""headline"": ""Illumina's cloud-based informatics programs recognized for robust, international data privacy protections"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has received the international privacy certification of six of its cloud-based informatics programs. The certification, ISO/IEC 27701, recognizes that Illumina implements, and complies with, robust, international data privacy requirements.""}, {""date"": ""2023-04-12"", ""headline"": ""Illumina (ILMN) Partners With Henry Ford Health for NGS Test"", ""summary"": ""Illumina (ILMN) collaborates with Henry Ford Health to conduct a series of studies that is likely to focus on the genetic drivers of cardiovascular disease.""}, {""date"": ""2023-04-13"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. advanced 2.55% to $232.67 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-13"", ""headline"": ""June 2nd Options Now Available For Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-14"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 2.00% to $228.01 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-04-14"", ""headline"": ""Here's Why You Shouldn't Buy the Dip With Illumina Stock"", ""summary"": ""For example, over the last five years, Illumina's (NASDAQ: ILMN) stock is down nearly 5%.  For those who aren't familiar, Illumina is the undisputed king of the gene sequencer hardware market, to where many accept it as a quasi-monopoly.  When healthcare systems or research laboratories need to analyze genetic material, the company's devices are the industry's standard, and it has a product in every segment of the market.""}, {""date"": ""2023-04-14"", ""headline"": ""RBC Capital Remains a Buy on Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""Cleveland-Cliffs: A Steel Producer To Target In This Resilient Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3504, ""bookValue"": 6693, ""cashRatio"": 0.6699551569506726, ""currentRatio"": 1.4224, ""ebitPerShare"": -0.4051, ""eps"": 0.019, ""ev"": 37092.527, ""fcfPerShareTTM"": -1.443, ""grossMargin"": 0.6026, ""inventoryTurnoverTTM"": 3.1132, ""longtermDebtTotalAsset"": 0.1259, ""longtermDebtTotalCapital"": 0.1665, ""longtermDebtTotalEquity"": 0.2222, ""netDebtToTotalCapital"": 0.0831, ""netDebtToTotalEquity"": 0.1109, ""netMargin"": 0.0028, ""operatingMargin"": -0.0589, ""pb"": 5.4311, ""pretaxMargin"": -0.0718, ""psTTM"": 8.1742, ""ptbv"": 10.5181, ""quickRatio"": 0.9865, ""receivablesTurnoverTTM"": 6.779, ""roaTTM"": -0.3535, ""roeTTM"": -0.5891, ""roicTTM"": -0.4612, ""rotcTTM"": -0.455, ""salesPerShare"": 6.8797, ""sgaToSale"": 0.3974, ""tangibleBookValue"": 3456, ""totalDebtToEquity"": 0.3341, ""totalDebtToTotalAsset"": 0.1893, ""totalDebtToTotalCapital"": 0.2504, ""totalRatio"": 2.3077, ""period"": ""2023-04-02""}"
14,2023-04-16,228.00999450683594,2023-04-23,227.67999267578125,-0.0014473130082234276,D1,"[{""date"": ""2023-04-16"", ""headline"": ""Cleveland-Cliffs: A Steel Producer To Target In This Resilient Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Illumina Singapore continues to climb in Best Employers Award Reaching 7th Overall"", ""summary"": ""Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) was honoured today to be ranked 7th overall from 250 companies and 1st in Healthcare Equipment & Services, in Singapore's Best Employers Award.""}, {""date"": ""2023-04-17"", ""headline"": ""Illumina Inc. stock underperforms Monday when compared to competitors despite daily gains"", ""summary"": ""Shares of Illumina Inc. inched 0.86% higher to $229.97 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-04-17"", ""headline"": ""Ravgen settles patent fight with Illumina over genetic testing"", ""summary"": ""Gene-sequencing giant Illumina Inc has settled a patent lawsuit brought by Maryland biotech company Ravgen Inc, which accused Illumina's genetic tests of infringing its patents.""}, {""date"": ""2023-04-17"", ""headline"": ""GRAIL Presents New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment at American Association for Cancer Research (AACR) Annual Meeting 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""The African Continent Ramps Up Efforts To Crack the Code on Outbreaks"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / April 17, 2023 / Illumina Samuel Oyola, senior scientist and head of genomics at Nairobi's International Livestock Research Institute, near a vat used for long-term storage of specimen samples. Photo by: Sara Jerving ...""}, {""date"": ""2023-04-17"", ""headline"": ""Profit from the Artificial Intelligence Boom with These 7 AI ETFs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Illumina (ILMN) Receives a Buy from HSBC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Beware: The Singularity Is Almost Here"", ""summary"": """"}, {""date"": ""2023-04-18"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. sank 0.73% to $228.28 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-04-18"", ""headline"": ""Illumina Celebrates \""Save the Smile of the Yangtze River\"" Charity Walk in China"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / April 18, 2023 / Illumina: From March 23rd to March 29th, a total of 206 Illumina colleagues in Greater China walked to support the recovery of the endangered species, finless porpoise population, and the healthy development ...""}, {""date"": ""2023-04-18"", ""headline"": ""Tarsus Pharmaceuticals, Inc. (TARS) Soars 8.6%: Is Further Upside Left in the Stock?"", ""summary"": ""Tarsus Pharmaceuticals, Inc. (TARS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.""}, {""date"": ""2023-04-18"", ""headline"": ""FirstHealth of the Carolinas to Offer GRAIL\u2019s Galleri\u00ae, a Multi-Cancer Early Detection Blood Test"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Chinese genetics company targets US despite political tensions"", ""summary"": ""MGI Tech insists it can succeed even though parts of its former parent BGI Group have been blacklisted""}, {""date"": ""2023-04-19"", ""headline"": ""Singapore\u2019s Best Employers 2023: Illumina Singapore Illustrates a \u2018Culture of Care\u2019"", ""summary"": ""SINGAPORE / ACCESSWIRE / April 19, 2023 / Illumina: Originally published on The Straits Times By Cheow Sue-Ann, Business Correspondent Flexible time off, critical care leave, mentorship programmes and a week-long company-wide shutdown are just ...""}, {""date"": ""2023-04-19"", ""headline"": ""Illumina wins fast-track appeal of FTC order to offload Grail"", ""summary"": ""A U.S. appeals court on Tuesday said it will accelerate reviewing Illumina Inc's challenge to a federal agency order requiring the biotechnology company to divest cancer diagnostic test maker Grail LLC.""}, {""date"": ""2023-04-19"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. rose 1.46% to $231.61 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-04-19"", ""headline"": ""GRAIL Presents Positive Analytical Validation Data on its Methylation-Based Post-Diagnostic Cancer Research Solution at American Association for Cancer Research (AACR) Annual Meeting 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-19"", ""headline"": ""Singapore`s Best Employers 2023: Illumina Singapore Illustrates a \ufffd\ufffd\ufffdCulture of Care`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""Illumina Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Illumina Inc. shed 2.62% to $225.55 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-20"", ""headline"": ""Illumina Urges Shareholders to Vote the WHITE Proxy Card FOR all Nine of Illumina's Nominees"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today urged shareholders to vote in favor of Illumina's slate of highly qualified director nominees. It also announced that its Annual Meeting will be held virtually on May 25, 2023, at 10:00 am Pacific Time (1:00 pm Eastern Time).""}, {""date"": ""2023-04-20"", ""headline"": ""Illumina issues letter to shareholders regarding board nomination vote"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-21"", ""headline"": ""Illumina Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.94% higher to $227.68 Friday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-04-21"", ""headline"": ""Illumina Is Poised to Make an Upside Breakout"", ""summary"": ""The charts of biotech firm Illumina  have been basing for months and now look ready and able to make an upside breakout.  In this daily bar chart of ILMN, below, I can see a large ascending triangle formation playing out from June.  An ascending triangle has roughly equal highs with rising lows.""}, {""date"": ""2023-04-21"", ""headline"": ""Carl Icahn further accuses Illumina board of `obfuscation`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-21"", ""headline"": ""Piper Sandler Sticks to Their Buy Rating for Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3504, ""bookValue"": 6693, ""cashRatio"": 0.6699551569506726, ""currentRatio"": 1.4224, ""ebitPerShare"": -0.4051, ""eps"": 0.019, ""ev"": 37092.527, ""fcfPerShareTTM"": -1.443, ""grossMargin"": 0.6026, ""inventoryTurnoverTTM"": 3.1132, ""longtermDebtTotalAsset"": 0.1259, ""longtermDebtTotalCapital"": 0.1665, ""longtermDebtTotalEquity"": 0.2222, ""netDebtToTotalCapital"": 0.0831, ""netDebtToTotalEquity"": 0.1109, ""netMargin"": 0.0028, ""operatingMargin"": -0.0589, ""pb"": 5.4311, ""pretaxMargin"": -0.0718, ""psTTM"": 8.1742, ""ptbv"": 10.5181, ""quickRatio"": 0.9865, ""receivablesTurnoverTTM"": 6.779, ""roaTTM"": -0.3535, ""roeTTM"": -0.5891, ""roicTTM"": -0.4612, ""rotcTTM"": -0.455, ""salesPerShare"": 6.8797, ""sgaToSale"": 0.3974, ""tangibleBookValue"": 3456, ""totalDebtToEquity"": 0.3341, ""totalDebtToTotalAsset"": 0.1893, ""totalDebtToTotalCapital"": 0.2504, ""totalRatio"": 2.3077, ""period"": ""2023-04-02""}"
15,2023-04-23,227.67999267578125,2023-04-30,205.55999755859375,-0.09715388189021334,D5+,"[{""date"": ""2023-04-24"", ""headline"": ""Illumina reports Q1 non-GAAP EPS 8c, consensus 2c"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Illumina Non-GAAP EPS of $0.08 beats by $0.05, revenue of $1.09B beats by $20M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Illumina sees FY23 non GAAP EPS $1.25-$1.50, consensus $1.41"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Illumina reports Q1 EPS 2c, consensus 2c"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Illumina options imply 5.4% move in share price post-earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""2,800 Singapore Students to Benefit from new STEM Partnership"", ""summary"": ""Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) today announced an inaugural partnership with the Science Centre Board to inspire 2,800 students through the power of genomics.""}, {""date"": ""2023-04-24"", ""headline"": ""Sequencing at Sea - Unlocking the Power of the Genome With eDNA and NextSeq(TM) 2000"", ""summary"": ""In 2022, Illumina and Minderoo Foundation announced a $40M AUD partnership to leverage the power of genomics to accelerate scientific understanding of marine systems and help marine conservationists make informed decisions.""}, {""date"": ""2023-04-24"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. inched 0.61% higher to $229.07 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-04-24"", ""headline"": ""Illumina under the spotlight as Q1 earnings approach"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Icahn issues letter to Illumina, accuses of `attempt to disenfranchise` holders"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Notable earnings after Tuesday`s close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""Barclays Remains a Sell on Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""Illumina (ILMN) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates"", ""summary"": ""While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.""}, {""date"": ""2023-04-25"", ""headline"": ""Illumina (ILMN) Beats Q1 Earnings and Revenue Estimates"", ""summary"": ""Illumina (ILMN) delivered earnings and revenue surprises of 300% and 2.42%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""2023-04-25"", ""headline"": ""Illumina Narrowly Squeaks Out First-Quarter Beat As Grail Battle Continues"", ""summary"": ""Illumina narrowly topped first-quarter forecasts Tuesday as its fight to retain its Grail subsidiary continues. ILMN stock dipped.""}, {""date"": ""2023-04-25"", ""headline"": ""Illumina, Inc. (ILMN) Q1 2023 Earnings Call Transcript"", ""summary"": ""Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Q1 2023 Earnings Conference Call April 25, 2023 5:00 PM ETCompany ParticipantsSalli Schwartz - Vice President of Investor RelationsFrancis deSouza -...""}, {""date"": ""2023-04-25"", ""headline"": ""Illumina Reports Financial Results for First Quarter of Fiscal Year 2023; Announces Commitment to Accelerate Margin Growth"", ""summary"": ""Illumina, Inc. (Nasdaq: ILMN) (\""Illumina\"" or the \""company\"") today announced its financial results for the first quarter of fiscal year 2023, which include the consolidated financial results for GRAIL.""}, {""date"": ""2023-04-25"", ""headline"": ""Illumina, Inc. 2023 Q1 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Illumina, Inc.""}, {""date"": ""2023-04-25"", ""headline"": ""Illumina unveils plans to cut costs as it faces shrinking margins"", ""summary"": ""The plans aim to reduce Illumina's annualized run rate expenses by more than $100 million starting later this year.""}, {""date"": ""2023-04-25"", ""headline"": ""Illumina Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Illumina Inc. slipped 4.53% to $218.69 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-25"", ""headline"": ""Illumina Now Expects to Post Per-Share Loss in FY23"", ""summary"": ""By Dean Seal Illumina Inc. now expects to post a per-share loss this year after previously guiding for a profit. The maker of gene-sequencing machines said...""}, {""date"": ""2023-04-25"", ""headline"": ""Illumina first quarter profit, revenue fall; expects full year growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""Illumina 1Q Profit, Revenue Drops"", ""summary"": ""By Dean Seal Illumina Inc. reported an expected drop in earnings and revenue for the first quarter as its costs rose and margins tightened. The maker of...""}, {""date"": ""2023-04-25"", ""headline"": ""Illumina: Q1 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""EXEL or ILMN: Which Is the Better Value Stock Right Now?"", ""summary"": ""EXEL vs. ILMN: Which Stock Is the Better Value Option?""}, {""date"": ""2023-04-25"", ""headline"": ""Notable companies reporting after market close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""Carl Icahn Writes Another Open Letter to Illumina Shareholders"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""Fly Intel: After-Hours Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""Illumina unveils $100M annual cost cutting plan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""Illumina Stock Tumbles As Sales, Profits Decline \u2014 Why The First-Quarter Beat Has 'Mixed Implications'"", ""summary"": ""DNA-sequencing leader Illumina eked out a first-quarter beat, but ILMN stock toppled Wednesday on its cloudy future.""}, {""date"": ""2023-04-26"", ""headline"": ""Illumina Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slipped 3.53% to $210.96 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-26"", ""headline"": ""Illumina CEO touts Grail\u2019s 100% revenue growth amid proxy fight with Icahn "", ""summary"": ""CEO Francis deSouza said San Diego-based Illumina can significantly expand the market for Grail's early cancer screening test. ""}, {""date"": ""2023-04-26"", ""headline"": ""Baird Maintains Illumina (ILMN) Neutral Recommendation"", ""summary"": """"}, {""date"": ""2023-04-26"", ""headline"": ""RBC Capital Maintains Illumina (ILMN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""2023-04-26"", ""headline"": ""Stifel Maintains Illumina (ILMN) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-04-26"", ""headline"": ""Illumina (ILMN) Q1 Earnings Beat Estimates, Margins Contract"", ""summary"": ""Illumina's (ILMN) Q1 revenues decline year over year, reflecting the impact of Covid-19 monitoring headwinds and the transition of its high-throughput customers to NovaSeq X.""}, {""date"": ""2023-04-26"", ""headline"": ""Illumina's Q1 Revenue Drop, Dwindling Margins: Outlines Cost Cutting Plans With $100M Savings"", ""summary"": ""In its Q1 earnings release, Illumina Inc (NASDAQ: ILMN) unveiled plans to accelerate margin improvement and create flexibility for further investment in high-growth areas. The company aims to reduce its annualized run rate expenses by more than $100 million starting later this year. Q1 Revenue of $1.09 billion was down 11% Y/Y (down 9% on a constant currency basis), beating the consensus of $1.07 billion. Adjusted EPS of $0.08 declined from $1.07 a year ago, beating the consensus of $0.02. Also""}, {""date"": ""2023-04-26"", ""headline"": ""Illumina (ILMN) Shares Cross Below 200 DMA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""Illumina price target raised to $265 from $235 at Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""Analysts Conflicted on These Healthcare Names: GlaxoSmithKline (GSK), Illumina (ILMN) and USANA Health (USNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""Illumina price target raised to $229 from $224 at Baird"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""Bank of America Securities Sticks to Its Hold Rating for Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""Icahn says board nominees to help keep Illumina from `sinking further`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""Lightning Round: Illumina's core business has some problems"", ""summary"": ""\""Mad Money\"" host Jim Cramer weighs in on stocks, including New Fortress, Illumina, Vontier and Peakstone Realty Trust.""}, {""date"": ""2023-04-27"", ""headline"": ""GE Healthcare Technologies: The Dip Offers A Renewed Buying Opportunity"", ""summary"": ""GE Healthcare faced some pressure despite posting attractive financial results for the latest quarter. Read why I'm keeping GEHC stock rated strong buy for now.""}, {""date"": ""2023-04-27"", ""headline"": ""Breeding Better Sugar With Genomics"", ""summary"": ""Folk wisdom says that putting sugar in someone's gas tank will ruin their car.""}, {""date"": ""2023-04-27"", ""headline"": ""June 9th Options Now Available For Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""SVB Securities Keeps Their Buy Rating on Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Humana (HUM) and Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""Illumina Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.57% higher to $205.56 Friday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-04-28"", ""headline"": ""Microsoft Strikes Nware Deal to Woo European Officials Over Activision Acquisition, Lyft Lay-offs Over 1K Employees, Big Oil Earnings: Top Stories For Today"", ""summary"": ""Benzinga Playing the Regulator Game: Microsoft Strikes Nware Deal to Woo Skeptical European Officials Over Activision Acquisition Microsoft Corp (NASDAQ: MSFT) President Brad Smith tweeted that European cloud gaming platform Nware inked a 10-year agreement to stream PC games built by Xbox on Nware's platform. After the acquisition closes, the deal also includes rights to stream Activision Blizzard, Inc's (NASDAQ: ATVI) titles on Nware's platform. Earlier, Microsoft forged similar deals with Nvid""}, {""date"": ""2023-04-28"", ""headline"": ""Carl Icahn calls Illumina Q1 results \u2018very disappointing,\u2019 slams cost-cutting plan"", ""summary"": ""Activist investor Carl Icahn accused Illumina CEO Francis deSouza of trying to downplay the company's \""decidedly mediocre\"" Q1 2023 results this week. ""}, {""date"": ""2023-04-28"", ""headline"": ""FDA Warns Cybersecurity Vulnerability For Illumina Sequencers"", ""summary"": ""The FDA issued a letter noting that nearly the entire Illumina Inc's (NASDAQ: ILMN) sequencer lineup carries a cybersecurity vulnerability that could impact genomic data results or even result in a data breach. The agency said that the Universal Copy Service software in the Illumina NovaSeq 6000, NextSeq 500, NextSeq 550, NextSeq 550Dx NextSeq 1000/2000, iSeq 100, MiniSeq, MiSeq, and MiSeqDx sequencing instruments could be exploited to let an unauthorized user remotely control, or aAlter setting""}, {""date"": ""2023-04-28"", ""headline"": ""Baron Partners Fund Q4 2022 Quarterly Letter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""Illumina DNA sequencing devices could be vulnerable to hackers - FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""3 Telemedicine Stocks to Watch as Healthcare Goes Digital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
16,2023-04-30,205.55999755859375,2023-05-07,199.66000366210938,-0.02870205276589677,D3,"[{""date"": ""2023-04-30"", ""headline"": ""Illumina: Icahn`s nominees \ufffd\ufffd\ufffdunqualified`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-30"", ""headline"": ""Illumina says Icahn`s campaign `spreading false information`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-01"", ""headline"": ""Illumina Issues Shareholder Letter and Requests Shareholders Vote for the Illumina Director Nominees on the WHITE Proxy Card"", ""summary"": ""Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued a shareholder letter providing additional information regarding its plans to create long-term shareholder value, and requesting shareholders to vote for the Illumina director nominees on the WHITE proxy card.""}, {""date"": ""2023-05-01"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 1.58% to $202.31 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-01"", ""headline"": ""Illumina: Icahn\u2019s nominees \u2018unqualified\u2019"", ""summary"": ""Illumina Inc. said Monday that activist investor Carl Icahn\u2019s board nominees are \u201cunqualified,\u201d urging shareholders to reject all three of Icahn\u2019s nominees...""}, {""date"": ""2023-05-01"", ""headline"": ""Illumina criticises investor Carl Icahn's nominees for directors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-02"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. shed 3.53% to $195.16 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-02"", ""headline"": ""Illumina increases equitable access to STEM education, reaching over 1 million learners"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced outcomes from its annual The Future Is Bright campaign, a monthlong global genomic literacy initiative, in which Illumina employees connect with students by hosting career panels, implementing genomics curricula, and leading hands-on experiments.""}, {""date"": ""2023-05-02"", ""headline"": ""Icahn Writes Another Open Letter to Illumina Shareholders"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-02"", ""headline"": ""Illumina, Inc. (NASDAQ:ILMN) Q1 2023 Earnings Call Transcript"", ""summary"": ""Illumina, Inc. (NASDAQ:ILMN) Q1 2023 Earnings Call Transcript April 25, 2023 Illumina, Inc. beats earnings expectations. Reported EPS is $0.08, expectations were $0.03. Operator: Good day, ladies and gentlemen, and welcome to the First Quarter 2023 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers\u2019 presentation, there [\u2026]""}, {""date"": ""2023-05-03"", ""headline"": ""7 Stocks Poised for a Major Breakout in May 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Tracking Baillie Gifford's 13F Portfolio - Q1 2023 Update"", ""summary"": ""Baillie Gifford\u00e2\u0080\u0099s 13F portfolio value increased from ~$96B to ~$111B this quarter. Click here to see an update on the portfolio for Q1 2023.""}, {""date"": ""2023-05-04"", ""headline"": ""Carl Icahn urges Illumina to divest GRAIL as soon as possible"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Tracking Baillie Gifford`s 13F Portfolio - Q1 2023 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Carl Icahn sends open letter to Illumina shareholders"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Illumina Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-05"", ""headline"": ""Illumina Inc. stock rises Friday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-06"", ""headline"": ""Is Illumina, Inc. (NASDAQ:ILMN) Worth US$200 Based On Its Intrinsic Value?"", ""summary"": ""Key Insights Illumina's estimated fair value is US$164 based on 2 Stage Free Cash Flow to Equity Illumina is estimated...""}, {""date"": ""2023-05-06"", ""headline"": ""Better Gene Sequencing Stock: Illumina vs. Bionano Genomics"", ""summary"": ""Illumina (NASDAQ: ILMN) and Bionano Genomics (NASDAQ: BNGO) might both make gene sequencing devices, but as investments the two couldn't be more different.  Whereas Bionano is a new entrant to the market and still has a lot to prove to its investors as well as the scientific community, Illumina is the top dog that's fighting to maintain its position.  Bulls argue that Illumina is the better gene sequencing stock because in some sequencing markets, it's basically the only option in town, particularly in the all-important market for next generation sequencers (NGS).""}, {""date"": ""2023-05-06"", ""headline"": ""Why Illumina Fell 11.6% in April"", ""summary"": ""The gene-sequencing company reported weaker results while the Federal Trade Commission has ordered it to divest its Grail acquisition.""}]",{}
17,2023-05-07,199.66000366210938,2023-05-14,208.60000610351562,0.04477613080953202,U5,"[{""date"": ""2023-05-08"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slipped 1.98% to $195.70 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-08"", ""headline"": ""Illumina Sends Letter to Shareholders Highlighting Board Strength, Weakness of Icahn's \""Plan\"""", ""summary"": ""Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued a shareholder letter highlighting the strength of its Board and noting that Carl Icahn's \""plan\"" for Illumina is sloppy and uninformed.""}, {""date"": ""2023-05-08"", ""headline"": ""Illumina defends \""deeply experienced\"" board amid Carl Icahn attacks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-08"", ""headline"": ""Illumina urges shareholders to vote the WHITE proxy card"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""IEP Stock Alert: Regulators Request Information From Icahn Enterprises"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slumped 0.74% to $194.26 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-10"", ""headline"": ""Glass Lewis backs Carl Icahn\u2019s push to oust Illumina\u2019s chief and chair"", ""summary"": ""Influential proxy adviser Glass Lewis has urged investors to vote against the reappointment of the chief executive and chair of Illumina, the world\u2019s largest gene sequencing company, saying the pair have failed to take responsibility for the \u201cvalue crimping\u201d acquisition of cancer-screening group Grail.  The recommendation that shareholders withdraw their support for chief executive Francis deSouza and chair John Thompson is a boost for activist investor Carl Icahn, who has launched a proxy battle against Illumina\u2019s board over what he describes as its \u201creckless\u201d purchase of Grail.""}, {""date"": ""2023-05-10"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. rallied 7.84% to $209.49 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-10"", ""headline"": ""Glass Lewis backs two of Icahn's nominees for Illumina"", ""summary"": ""Proxy adviser Glass Lewis said on Wednesday Illumina Inc shareholders should vote for two of Carl Icahn's nominees to the firm's board, as representatives who can challenge the current board would be beneficial to the company.""}, {""date"": ""2023-05-10"", ""headline"": ""UPDATE 2-Glass Lewis backs two of Icahn's nominees for Illumina"", ""summary"": ""Proxy adviser Glass Lewis said on Wednesday Illumina Inc shareholders should vote for two of Carl Icahn's nominees to the firm's board, as representatives who can challenge the current board would be beneficial to the company.  Glass Lewis added shareholders should vote against the re-election of the current chief Francis deSouza and chair John Thompson, saying they had enough reasons to advocate for a new chair.  The recommendations come ahead of the company's annual shareholder meeting on May 25, which could bring to an end the two-month long proxy battle between Illumina and billionaire investor Carl Icahn.""}, {""date"": ""2023-05-10"", ""headline"": ""Glass Lewis backs Icahn's nominees for Illumina "", ""summary"": ""Proxy adviser Glass Lewis on Wednesday recommended Illumina Inc shareholders support two of Carl Icahn's nominees to the U.S. life sciences firm's board and vote against re-election of the current chief Francis deSouza and chair John Thompson.""}, {""date"": ""2023-05-10"", ""headline"": ""PacBio equal weight at Barclays on tough macro environment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-10"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-10"", ""headline"": ""Carl Icahn's company stock falls as much as 20% after prosecutors seek financial information"", ""summary"": ""Federal investigators contacted Icahn Enterprises last Wednesday seeking information about corporate governance and other materials.""}, {""date"": ""2023-05-10"", ""headline"": ""Glass Lewis backs Carl Icahn attempt to replace Illumina CEO and chair"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-10"", ""headline"": ""Early notable gainers among liquid option names on May 10th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-10"", ""headline"": ""Glass Lewis backs Icahn`s effort to oust Illumina CEO, chair, FT reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-11"", ""headline"": ""Illumina Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 0.61% to $208.21 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-11"", ""headline"": ""BRIEF-Icahn Says Agree With Many Of Glass Lewis Points, Most Importantly That Shareholders Vote Against Illumina CEO, Chair "", ""summary"": ""* CARL C. ICAHN ISSUES OPEN LETTER TO SHAREHOLDERS OF ILLUMINA, INC.""}, {""date"": ""2023-05-11"", ""headline"": ""Illumina (NASDAQ:ILMN) shareholders are up 6.6% this past week, but still in the red over the last three years"", ""summary"": ""As an investor its worth striving to ensure your overall portfolio beats the market average. But if you try your hand...""}, {""date"": ""2023-05-11"", ""headline"": ""Carl Icahn sends open letter to Illumina shareholders"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-11"", ""headline"": ""June 30th Options Now Available For Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-12"", ""headline"": ""Illumina wins partial victory in Icahn battle as proxy firm ISS backs CEO DeSouza"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-12"", ""headline"": ""Leading Proxy Advisory Firm ISS Recommends Illumina Shareholders Vote \""FOR\"" Eight of Illumina's Highly Qualified Director Nominees"", ""summary"": ""Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that Institutional Shareholder Services (\""ISS\""), a leading independent proxy voting and corporate governance advisory firm, recommends Illumina shareholders vote FOR Illumina CEO Francis deSouza and Board member Robert Epstein. Illumina's Annual Meeting is scheduled to be held on May 25, 2023, at 10:00 am Pacific Time (1:00 pm Eastern Time).""}, {""date"": ""2023-05-12"", ""headline"": ""Proxy adviser ISS backs one of Icahn's nominees for Illumina board"", ""summary"": ""Proxy advisory firm Institutional Shareholder Services (ISS) on Friday backed only one of Carl Icahn's three nominees to Illumina Inc's board, saying that the activist investor's push to remove the company's CEO was too disruptive.""}, {""date"": ""2023-05-12"", ""headline"": ""UPDATE 2-Proxy adviser ISS backs one of Icahn's nominees for Illumina board"", ""summary"": ""Proxy advisory firm Institutional Shareholder Services (ISS) on Friday backed only one of Carl Icahn's three nominees to Illumina Inc's board, saying that the activist investor's push to remove the company's CEO was too disruptive.  ISS backed Icahn's candidate Andrew Teno and said he could be an adequate replacement for Illumina Chairman John Thompson, but did not support any other Icahn nominee.""}, {""date"": ""2023-05-12"", ""headline"": ""Illumina Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.19% higher to $208.60 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-12"", ""headline"": ""Q1 2023 Somalogic Inc Earnings Call"", ""summary"": ""Q1 2023 Somalogic Inc Earnings Call""}, {""date"": ""2023-05-12"", ""headline"": ""GSIT, TLS, MHUA and ILMN among after hour movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-12"", ""headline"": ""GSIT, TLS, MHUA and ILMN are among after hour movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
18,2023-05-14,208.60000610351562,2023-05-21,204.86000061035156,-0.01792907662384302,D2,"[{""date"": ""2023-05-14"", ""headline"": ""Icahn bought Illumina in Q1, sold shares of Herc and Newell"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-14"", ""headline"": ""Icahn says Illumina shareholders `clearly want more change`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-15"", ""headline"": ""Illumina Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 1.80% to $204.85 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-15"", ""headline"": ""What Is Illumina, Inc.'s (NASDAQ:ILMN) Share Price Doing?"", ""summary"": ""Let's talk about the popular Illumina, Inc. ( NASDAQ:ILMN ). The company's shares received a lot of attention from a...""}, {""date"": ""2023-05-15"", ""headline"": ""Illumina sends letter to shareholders detailing why Illumina's nominees far outmatch Icahn's slate in skills and experience"", ""summary"": ""Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued a shareholder letter outlining the purpose-built mix of skills Illumina's nominees bring to the Board compared to Carl Icahn's unqualified associates, each of whom lack relevant experience and independence.""}, {""date"": ""2023-05-15"", ""headline"": ""Illumina board tells shareholders to ignore Carl Icahn`s `unfit associates`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-15"", ""headline"": ""RBC Capital Sticks to Its Buy Rating for Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-15"", ""headline"": ""Illumina board urges shareholders to vote the WHITE proxy card"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-15"", ""headline"": ""Carl Icahn adds Illumina in Q1, cuts stakes in Herc, Newell Brands"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-16"", ""headline"": ""Illumina Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Illumina Inc. slid 1.43% to $201.92 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-16"", ""headline"": ""Illumina's genomic technologies enable better pathogen preparedness and response"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today recognized the progress and impact of genomic technologies on pathogen preparedness and response. Following the boost in sequencing infrastructure and capabilities driven by the COVID-19 pandemic, today genomic technologies are enabling public health agencies and health care systems to better prepare for, and respond to, pathogenic threats.""}, {""date"": ""2023-05-16"", ""headline"": ""FTC sues to block Amgen acquisition of Horizon Therapeutics"", ""summary"": ""Amgen wants to buy Horizon Therapeutics to bolster is drug portfolio as it faces patent expirations. The FTC fears the deal could entrench monopoly positions.""}, {""date"": ""2023-05-17"", ""headline"": ""Illumina Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 2.20% to $197.48 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-17"", ""headline"": ""Video: S&P 500 Movers: ILMN, CMA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-17"", ""headline"": ""Quick blood tests to spot cancer: will they help or harm patients?"", ""summary"": ""Investors are pouring billions into companies claiming they can analyse DNA to find the disease early. But some scientists question if they really work""}, {""date"": ""2023-05-18"", ""headline"": ""Illumina call volume above normal and directionally bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-18"", ""headline"": ""Illumina Board Chair issues letter to shareholders and urges shareholders to vote the WHITE proxy card FOR all nine of Illumina's nominees"", ""summary"": ""Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued a shareholder letter from Board Chair John Thompson.""}, {""date"": ""2023-05-18"", ""headline"": ""Illumina (ILMN) Progresses in Pathogen Genomic Technologies"", ""summary"": ""Illumina's (ILMN) genomic surveillance solutions enable better pathogen preparedness and response.""}, {""date"": ""2023-05-18"", ""headline"": ""Illumina board chair issues letter, urges shareholders to vote for all nominees"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-18"", ""headline"": ""Carl Icahn and Illumina Square Off Soon. The Stakes Are High."", ""summary"": ""Icahn, who's also juggling an attack from a short seller and questions from prosecutors, is going after the CEO of the gene sequencing leader.""}, {""date"": ""2023-05-19"", ""headline"": ""A Wounded Carl Icahn Makes His Play at a Struggling Illumina"", ""summary"": ""The legendary activist, whose own company is under attack, has launched a proxy contest for three seats on the gene-sequencing giant\u2019s board, which is mired in a messy acquisition. The stakes are high for both.""}, {""date"": ""2023-05-19"", ""headline"": ""Carl Icahn Dives Into Activist Investment Illumina"", ""summary"": ""The guru has launched a proxy battle against the company""}, {""date"": ""2023-05-19"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. rallied 1.77% to $204.86 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-19"", ""headline"": ""15 Best Stocks to Buy and Hold According to Billionaire Carl Icahn"", ""summary"": ""In this article, we discuss 15 best stocks to buy and hold according to billionaire Carl Icahn. If you want to see more stocks in this selection, check out 5 Best Stocks to Buy and Hold According to Billionaire Carl Icahn. Carl Icahn, recognized for his expertise in the financial market, faced another blow on [\u2026]""}, {""date"": ""2023-05-19"", ""headline"": ""Does Illumina (NASDAQ:ILMN) Have A Healthy Balance Sheet?"", ""summary"": ""Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...""}, {""date"": ""2023-05-19"", ""headline"": ""TD Cowen life science/diagnostic analyst holds analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-19"", ""headline"": ""Carl Icahn\u2019s activist play plays into the hands of Lina Khan and EU regulators"", ""summary"": ""Every company with acquisition plans in the U.S. and Europe should be concerned about the FTC partnering with EU regulators to sink the Illumina-Grail deal.""}, {""date"": ""2023-05-20"", ""headline"": ""Icahn Is No Saint, but Illumina Can Still Use a Flawed Savior"", ""summary"": ""Despite a short seller\u2019s accusations that his company has inflated its asset prices, Carl Icahn\u2019s effort to shake up Illumina\u2019s board is still very much in the interest of shareholders.""}]",{}
19,2023-05-21,204.86000061035156,2023-05-28,195.88999938964844,-0.043786006023519786,D5,"[{""date"": ""2023-05-22"", ""headline"": ""$100 Invested In This Stock 15 Years Ago Would Be Worth $500 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-22"", ""headline"": ""GRAIL to Present New Multi-Cancer Early Detection Data at the 2023 ASCO Annual Meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""ILMN Makes Bullish Cross Above Critical Moving Average"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""Illumina call volume above normal and directionally bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""Illumina Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slipped 2.15% to $204.37 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-23"", ""headline"": ""Here\u2019s Why Baron Partners Fund Exited Illumina (ILMN)"", ""summary"": ""Baron Funds, an investment management company, released its \u201cBaron Partners Fund\u201d first quarter 2023 investor letter. A copy of the same can be downloaded here. Despite the market volatility, the fund performed well and returned 23.41% in the first quarter, which exceeds the Russell Midcap Growth Index\u2019s 9.14% return and the S&P 500 Index\u2019s 7.50% return [\u2026]""}, {""date"": ""2023-05-24"", ""headline"": ""Icahn's Teno says activism 'alive and well' after Illumina elects him to board"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Illumina stock declines as shareholder voting results overdone - Evercore"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Illumina confirms Icahn Capital's Andrew Teno elected to board"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Exclusive-Icahn poised to win at least one seat on Illumina's board -sources"", ""summary"": ""Activist investor Carl Icahn is set to win enough Illumina Inc shareholder support to install at least one of his three nominees to the gene sequencing machine maker's board, two people familiar with the matter said on Wednesday.""}, {""date"": ""2023-05-24"", ""headline"": ""Icahn poised to win at least one seat on Illumina's board - sources"", ""summary"": ""NEW YORK (Reuters) -Activist investor Carl Icahn is set to win enough Illumina Inc shareholder support to install at least one of his three nominees to the gene sequencing machine maker's board, two people familiar with the matter said on Wednesday.""}, {""date"": ""2023-05-24"", ""headline"": ""EXCLUSIVE-Icahn poised to win at least one seat on Illumina\u2019s board -sources"", ""summary"": ""Activist investor Carl Icahn is set to win enough Illumina Inc shareholder support to install at least one of his three nominees to the gene sequencing machine maker\u2019s board, two people familiar with the matter said on Wednesday.""}, {""date"": ""2023-05-24"", ""headline"": ""Pluton Biosciences Raises $16.5M Series A led by Illumina Ventures and RA Capital to discover and deploy microbes that will fight climate change"", ""summary"": ""Pluton Biosciences, a startup leveraging the power of microbes to create cost-effective innovative solutions that address sustainability challenges facing agriculture, announces the close of a $16.5 M Series A funding round. The round was co-led by Illumina Ventures and RA Capital, with participation from existing investors Fall Line Capital, The Grantham Foundation, and First In Ventures, as well as new investors Wollemi, Radicle Growth (first investment from their second fund), and iSelect.""}, {""date"": ""2023-05-24"", ""headline"": ""Alejandro Pliego\u2019s Journey Into STEM"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / May 24, 2023 / Illumina: Originally published on Illumina News Center Alejandro Pliego is attending Princeton, class of 2027. He is smart and poised, but Princeton was hardly a foregone conclusion. The child of immigrants ...""}, {""date"": ""2023-05-24"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Illumina director says company prepared if CEO, chairman tossed out - FT"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Icahn nominee gets enough support to win Illumina board seat, Reuters says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Illumina director says company strong enough to survive loss of CEO, FT reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Illumina can survive loss of chair and CEO, says board director"", ""summary"": ""Illumina is strong enough to survive the loss of its chair John Thompson and chief executive Francis deSouza if shareholders vote them down at an annual meeting on Thursday, a director of the company has said.  Gary Guthart told the Financial Times there is depth on the board and management of the world\u2019s biggest gene sequencing company beyond the two executives, who have been targeted in a proxy battle waged by activist investor Carl Icahn.""}, {""date"": ""2023-05-25"", ""headline"": ""Baillie Gifford Dumps Salesforce, Loads Up on AMD"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Icahn scores partial Illumina win amid pressure to defend investment acumen"", ""summary"": ""Carl Icahn secured a seat on Thursday for one of his three nominees to the board of gene sequencing machine maker Illumina Inc, a partial victory for the activist investor who is struggling to burnish his credentials following a shortseller attack on his company.""}, {""date"": ""2023-05-25"", ""headline"": ""U.S. Equities End Mixed on Nvidia News, Debt Ceiling Worries"", ""summary"": ""U.S. equities were mixed on Thursday, May 25, 2023 as Nvidia's results and outlook helped send the Nasdaq and S&P 500 higher, while the Dow fell on growing concerns about a possible government default.""}, {""date"": ""2023-05-25"", ""headline"": ""UPDATE 2-Icahn scores partial Illumina win amid pressure to defend investment acumen"", ""summary"": ""Carl Icahn secured a seat on Thursday for one of his three nominees to the board of gene sequencing machine maker Illumina Inc, a partial victory for the activist investor who is struggling to burnish his credentials following a shortseller attack on his company.  Illumina said Icahn nominee Andrew Teno won enough shareholder votes for election, confirming an earlier Reuters report.  Illumina's market value of $30 billion made the fight this year's largest proxy contest to go to a shareholder vote.""}, {""date"": ""2023-05-25"", ""headline"": ""Icahn vs. Illumina Is a Split Decision: CEO Survives, Chairman Is Out"", ""summary"": ""Activist investor Carl  Icahn  failed to topple the CEO of gene-sequencing giant  Illumina  in a proxy battle that culminated on Thursday afternoon, but succeeded in getting one of his three nominees onto the company\u2019s board, and knocking out its chairman.  The mixed decision represents a rebuke of Illumina (ticker: ILMN) CEO Francis deSouza, though not as severe a punishment as shareholders could have handed him.  Icahn sought to replace deSouza as CEO, and one influential proxy advisor recommended that investors vote against his board nomination.""}, {""date"": ""2023-05-25"", ""headline"": ""Illumina chair ousted in proxy battle with Carl Icahn"", ""summary"": ""Vote to remove John Thompson is the culmination of one of the largest shareholder activism campaigns in years""}, {""date"": ""2023-05-25"", ""headline"": ""Illumina announces preliminary results of annual meeting"", ""summary"": ""Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that based on the preliminary results of its 2023 Annual Meeting, Illumina shareholders have voted to elect eight of nine Illumina director nominees \u2013 Francis deSouza, Robert Epstein, MD, Frances Arnold, PhD, Caroline Dorsa, Scott Gottlieb, MD, Gary Guthart, PhD, Philip Schiller, and Sue Siegel, as well as Andrew Teno, to the Board of Directors. The Board thanks John Thompson for his board te""}, {""date"": ""2023-05-25"", ""headline"": ""Icahn Nominee Elected to Illumina\u2019s Board"", ""summary"": ""Shareholders selected one of the activist investor\u2019s picks, who will replace on the board a director who had served as Illumina\u2019s chairman.""}, {""date"": ""2023-05-25"", ""headline"": ""Icahn Wins One Board Seat in Illumina Proxy Fight"", ""summary"": ""(Bloomberg) -- Illumina Inc. shareholders voted to elect a board member nominated by activist shareholder Carl Icahn, a much-needed partial victory for the billionaire as his investment firm grapples with an attack by short-seller Hindenburg Research. Andrew Teno, a portfolio manager at Icahn Capital, will join Illumina\u2019s nine-person board as a director, the company said in a statement Thursday. Teno, one of Icahn\u2019s three nominees, replaces Chairman John Thompson, who had been on Illumina\u2019s boar""}, {""date"": ""2023-05-25"", ""headline"": ""Carl Icahn's Power Play at Illumina: Potential Board Changes and Management Overhaul"", ""summary"": ""According to undisclosed sources, activist investor Carl Icahn is poised to secure enough shareholder support to place Andrew Teno, an Icahn nominee, to join the board of Illumina Inc (NASDAQ: ILMN). However, it should be noted that the tally has not yet been finalized, and shareholders still have the opportunity to modify their votes before the commencement of the company's annual shareholder meeting on Thursday, Reuters reported. Also Read: Carl Icahn Admits Making A Mistake On Bearish Bet, Sa""}, {""date"": ""2023-05-25"", ""headline"": ""Illumina shareholders vote to elect one of Carl Icahn\u2019s candidates to its board after proxy fight"", ""summary"": ""Illumina Inc. shareholders voted Thursday to elect one of activist investor Carl Icahn\u2019s nominees to its board, and voted against the re-election of company...""}, {""date"": ""2023-05-25"", ""headline"": ""Illumina shareholders oust board chair in Carl Icahn proxy battle"", ""summary"": ""Carl Icahn has accused Illumina's management and board of poor oversight, particularly with regard to the company's acquisition of cancer test maker Grail. ""}, {""date"": ""2023-05-25"", ""headline"": ""Midday movers: Nvidia, Illumina, American Eagle Outfitters and more"", ""summary"": ""Investing.com -- Stocks are mixed on Thursday as tech gets a boost from Nvidia's strong outlook while Dow stocks are weaker on a lack of resolution in the debt ceiling negotiations. Here are the market movers for May 25.""}, {""date"": ""2023-05-25"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Check Out What Whales Are Doing With ILMN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Illumina investors elect Icahn nominee Andrew Teno to board, Bloomberg reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Icahn holdings Illumina, CVR Energy drop amid Icahn Enterprises' weakness"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Icahn holdings Illumina, CVR Energy drop amid Icahn Enterprises weakness"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""July 7th Options Now Available For Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Carl Icahn set to win at least one Illumina board seat - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Icahn vs. Illumina: The CEO\u2019s Job\u2014and Icahn\u2019s Reputation\u2014Are on the Line"", ""summary"": ""Activist investor Carl Icahn is seeking to unseat Illumina\u2019s chairman and its CEO, and put three of his own people on the company\u2019s board.""}, {""date"": ""2023-05-25"", ""headline"": ""Illumina\u2019s Fight With the FTC Over Blood Testing Could Reshape U.S. Merger Policy"", ""summary"": ""The biotech is fighting U.S.and European regulators to save its deal for cancer screener Grail. The Supreme Court may have the last word.""}, {""date"": ""2023-05-25"", ""headline"": ""Illumina Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""The Olive Oil Crisis Spreads as Prices Soar. What\u2019s to Blame. "", ""summary"": ""A record heat wave hit Spain last summer, the world\u2019s largest producer of olive oil, reducing production by half. The culprit may be climate change, which is...""}, {""date"": ""2023-05-26"", ""headline"": ""Illumina (NASDAQ:ILMN): A Major Victory for Carl Icahn\u2019s Activism"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""12% Of This Illumina Insider's Holdings Were Sold \\"", ""summary"": ""Insiders were net sellers of Illumina, Inc.'s ( NASDAQ:ILMN ) stock during the past year. That is, insiders sold more...""}, {""date"": ""2023-05-26"", ""headline"": ""Debt Deal Optimism, AI Rally Can\u2019t Mask Market Fears Ahead of the Weekend"", ""summary"": ""High hopes for Memorial Day travel, Illumina CEO survives in split decision for Carl Icahn, and other news to start your day.""}, {""date"": ""2023-05-26"", ""headline"": ""Illumina chair fails to survive board vote amid Carl Icahn proxy fight"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""Illumina Inc. stock rises Friday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""Analysts Are Neutral on These Healthcare Stocks: Illumina (ILMN), Pfizer (PFE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""Why Vice\u2019s bankruptcy is a warning on private equity investment"", ""summary"": ""Plus, the battle heats up between Icahn and Illumina and Cayman Islands defends itself as a go-to for the super-rich""}, {""date"": ""2023-05-27"", ""headline"": ""Illumina accused by Brussels of \u2018delay tactics\u2019 on Grail divestiture"", ""summary"": ""Brussels has accused Illumina of using \u201cdelay tactics\u201d to prevent a speedy ruling on whether the world\u2019s biggest gene sequencing company should be forced to divest cancer test developer Grail.  It follows repeated claims by Illumina that it is moving as \u201cexpeditiously as possible\u201d to resolve litigation linked to its $8bn acquisition of Grail, which is the focus of a bruising proxy battle waged by Carl Icahn, the veteran activist investor.  US antitrust regulators also ordered Grail\u2019s divestiture in April, a decision Illumina is appealing against.""}]",{}
20,2023-05-28,195.88999938964844,2023-06-04,207.30999755859375,0.05829801523573219,U5+,"[{""date"": ""2023-05-29"", ""headline"": ""Illumina fight with FTC could reshape U.S. merger policy, Barron's says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-29"", ""headline"": ""Fly Intel: Top five weekend stock stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""First Week of ILMN December 15th Options Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""Illumina CEO survived Icahn's challenge by more than 2-to-1 margin"", ""summary"": ""Illumina Inc CEO Francis deSouza survived a challenge to his board seat from activist investor Carl Icahn last week by securing more than twice the shareholder votes than the number his challenger received, the company said in a filing on Tuesday.""}, {""date"": ""2023-05-30"", ""headline"": ""CORRECTED-Illumina CEO survived Icahn's challenge by more than 2-to-1 margin"", ""summary"": ""Illumina Inc CEO Francis deSouza survived a challenge to his board seat from activist investor Carl Icahn last week by securing more than twice the shareholder votes than the number his challenger received, the company said in a filing on Tuesday.  It gives deSouza legitimacy to carry on after Icahn mustered enough shareholder support to oust Illumina's board chair John Thompson and install one of his board nominees, Andrew Teno.""}, {""date"": ""2023-05-30"", ""headline"": ""Illumina Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. shed 0.70% to $194.51 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-30"", ""headline"": ""Real-world study data reveals better outcomes for cancer patients who receive comprehensive genomic testing"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced some of the latest data on the impact of comprehensive genomic profiling (CGP) for oncology patients, which will be presented at the American Society of Clinical Oncology's Annual Meeting June 2\u20136 in Chicago. In addition to the real-world study data, Illumina, along with study collaborators, will also present on findings that expose gaps in current standard-of-care and unmet needs for ca""}, {""date"": ""2023-05-30"", ""headline"": ""Carl Icahn Buys Activist Target Illumina, Adds to Southwest Gas Stake"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-31"", ""headline"": ""Illumina launches AI software to predict disease-causing genetic mutations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-31"", ""headline"": ""Illumina announces AI algorithm that predicts disease-causing genetic mutations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-31"", ""headline"": ""Illumina to Host Third Annual Virtual ESG Investor Event on Monday, June 12, 2023"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN) announced today that it will host its third annual virtual Environment, Social and Corporate Governance (ESG) focused investor event at 9:00 am Pacific Time (12:00 pm Eastern Time), Monday, June 12, 2023.""}, {""date"": ""2023-05-31"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. rallied 1.10% to $196.65 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-31"", ""headline"": ""Illumina (ILMN) to Present Real-World CGP Data at ASCO Meet '23"", ""summary"": ""At the ASCO meeting, Illumina (ILMN) is set to showcase data that highlights better outcomes for cancer patients who receive comprehensive genomic testing.""}, {""date"": ""2023-06-01"", ""headline"": ""Illumina unit Grail in hot water over erroneous cancer results \u2013 FT"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""Over 400 Grail patients falsely told they may have cancer, FT reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""GRAIL and University of Oxford to Present Results From First Prospective Study of Multi-Cancer Early Detection in a Symptomatic Patient Population at 2023 ASCO Annual Meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""\u2018Primate AI algorithm\u2019 predicts genetic health risks"", ""summary"": ""Scientists apply deep learning to expanded DNA database to help identify disease-causing mutations in humans""}, {""date"": ""2023-06-01"", ""headline"": ""Illumina unveils AI software to predict disease-causing genetic mutations in patients"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the new PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts with unprecedented accuracy disease-causing genetic mutations in patients. The results are published in two papers in the June 2 issue of Science (issue 6648), detailing the training of the algorithm and its application to half a million genomes in the UK Biobank cohort. Two accompanying papers on the primate e""}, {""date"": ""2023-06-01"", ""headline"": ""Why Is Repligen (RGEN) Up 2.7% Since Last Earnings Report?"", ""summary"": ""Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""2023-06-01"", ""headline"": ""IN BRIEF: Illumina unveils AI software to predict patient mutations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""Interesting ILMN Put And Call Options For July 14th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""Illumina's GRAIL present on first study of multi-cancer early detection at ASCO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""The Market Continues To Underprice Illumina's Stock And Its Genomics Leadership"", ""summary"": ""Illumina is undervalued by 23% according to a discounted cash flow analysis, with a fair value of $253.94. Read why ILMN stock is a Buy.""}, {""date"": ""2023-06-02"", ""headline"": ""Grail says about 400 patients incorrectly informed they may have cancer"", ""summary"": ""Cancer test maker Grail Inc said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer.""}, {""date"": ""2023-06-02"", ""headline"": ""UPDATE 1-Grail says about 400 patients incorrectly informed they may have cancer"", ""summary"": ""Cancer test maker Grail Inc said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer.  Grail's flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear.  The company, owned by Illumina Inc, said the letters were mistakenly sent by PWNHealth due to a software issue and that it \""was in no way related to or caused by an incorrect Galleri test result\"".""}, {""date"": ""2023-06-02"", ""headline"": ""Grail says over 400 patients incorrectly informed they may have cancer"", ""summary"": ""About 400 patients who signed up to take cancer diagnostic test maker Grail's pioneering oncology detection test received erroneous letters suggesting they may have developed cancer, the company said on Friday.  Grail's flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear.  The company, owned by Illumina Inc, said the letters were mistakenly sent by its telemedicine provider PWNHealth due to a software issue and that it \""was in no way related to or caused by an incorrect Galleri test result\"".""}, {""date"": ""2023-06-02"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. advanced 4.13% to $207.31 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-02"", ""headline"": ""Illumina's (ILMN) New AI Tool to Predict Genomics Disease"", ""summary"": ""Illumina's (ILMN) PrimateAI-3D will be made broadly available to the genomics community integrated across Illumina Connected Software.""}, {""date"": ""2023-06-02"", ""headline"": ""Illumina expands board after fight with Icahn"", ""summary"": ""Illumina Inc on Friday said it had expanded its board, adding two C-suite executives a week after shareholders voted to replace the gene sequencing company's chairman with activist investor Carl Icahn's nominee.""}, {""date"": ""2023-06-02"", ""headline"": ""Why Is Horizon Therapeutics (HZNP) Down 9% Since Last Earnings Report?"", ""summary"": ""Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""2023-06-02"", ""headline"": ""Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients. PrimateAI-3D utilizes deep neural network architectures similar to ChatGPT and AlphaFold, but is trained on genome sequences rather than human language. After applying the algorithm to half a million genomes in the U.K. Biobank cohort detailing the training, the results showed unprecedented accuracy. The result is a deep neural network that h""}, {""date"": ""2023-06-02"", ""headline"": ""Stock Buying Ideas After The Non-Farm Payroll Report"", ""summary"": ""The U.S. saw strong job growth in the service super sector, government and healthcare. Read more on investment ideas after the release of the May jobs report.""}, {""date"": ""2023-06-02"", ""headline"": ""UPDATE 2-Illumina expands board after fight with Icahn"", ""summary"": ""Illumina Inc on Friday said it had expanded its board, adding two C-suite executives a week after shareholders voted to replace the gene sequencing company's chairman with activist investor Carl Icahn's nominee.  On Friday it named Stephen MacMillan, CEO of diagnostics products company Hologic Inc, and Scott Ullem, CFO of heart valve systems maker Edwards Lifesciences Corp, as new directors.""}, {""date"": ""2023-06-02"", ""headline"": ""Illumina board appoints Hologic CEO as non-exec chairman"", ""summary"": ""Illumina Inc said on Friday it has elected two new independent board members, including Hologic Inc CEO Stephen MacMillan as the non-executive chairperson, with immediate effect. (Reporting by Leroy Leo in Bengaluru; Editing by Savio D'Souza)""}, {""date"": ""2023-06-02"", ""headline"": ""Illumina's Board of Directors elects two experienced Independent Directors to Board"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of governance changes consistent with the goal of enhancing long-term shareholder value.""}, {""date"": ""2023-06-02"", ""headline"": ""Illumina names Hologic CEO as chair, elects Edwards CFO to board"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-02"", ""headline"": ""Elon Musk Praises Quality of Made in China Teslas, Exxon Eyes Double Output With New Fracking Tech, Netflix Shareholders Vote Against Fat Exec. Pay: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-02"", ""headline"": ""Elon Musk Calls China-Made Tesla's Highest Quality, Exxon Eyes Double Output With New Fracking Tech, Netflix Shareholders Vote Against Fat Exec. Pay: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-02"", ""headline"": ""Illumina elects Hologic chair and chief executive to board as chair"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-03"", ""headline"": ""Blood-Test Customers Mistakenly Told They May Have Cancer"", ""summary"": ""Grail said its telemedicine vendor sent the inaccurate forms to 400 people because of a software glitch.""}, {""date"": ""2023-06-03"", ""headline"": ""New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-03"", ""headline"": ""GRAIL Presents Real-World Experience With The Galleri\u00ae Multi-Cancer Early Detection Test At 2023 ASCO Annual Meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
21,2023-06-04,207.30999755859375,2023-06-11,200.52999877929688,-0.03270463971415849,D4,"[{""date"": ""2023-06-05"", ""headline"": ""UPDATE 2-Illumina appeals FTC order to divest cancer test maker Grail"", ""summary"": ""Illumina on Monday filed an appeal against a Federal Trade Commission (FTC) order, demanding that it divest cancer diagnostic test maker Grail over competition concerns in the U.S. market for cancer tests.  San Diego-based Illumina is arguing that the FTC \""violated due process by depriving Illumina and Grail of a fair proceeding before an impartial tribunal,\"" according to the filing in the U.S. Fifth Circuit Court of Appeals.  The FTC in April ruled for a second time that Illumina's 2021 acquisition of its formerly part-owned subsidiary should be undone.""}, {""date"": ""2023-06-05"", ""headline"": ""Illumina asks appeals court to undo FTC ruling that it must sell subsidiary"", ""summary"": ""Illumina Inc filed an appeal late on Monday against an order by the U.S. Federal Trade Commission, which is demanding that the company divest cancer diagnostic test maker Grail Inc because of concern that its ownership would stifle competition in the U.S. market for cancer...""}, {""date"": ""2023-06-05"", ""headline"": ""Tuesday Sector Laggards: Healthcare, Consumer Products"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. advanced 1.57% to $210.56 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-05"", ""headline"": ""Software Configuration Error at Grail Causes Cancer Misdiagnosis Scare; Could It Impact Illumina's Acquisition Plans?"", ""summary"": ""Illumina Inc's (NASDAQ: ILMN) Grail Inc acquisition is reportedly in more hot water when Grail mistakenly sent form letters to 400 patients, suggesting they may have developed cancer. Galleri, the company's primary blood test for cancer diagnosis, is designed to detect more than 50 different malignancies even before symptoms appear. Related: FTC Orders Illumina To Divest Grail, Mounts Pressure On Company Amid Proxy Fight With Icahn. Grail sells Galleri at about $950 per test and markets it to in""}, {""date"": ""2023-06-05"", ""headline"": ""Illumina releases 2022 Corporate Social Responsibility Report"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today published its annual Corporate Social Responsibility (CSR) Report, highlighting the company's commitment to human health, and the progress made by its environmental, social, and governance (ESG) program in 2022.""}, {""date"": ""2023-06-05"", ""headline"": ""Early notable gainers among liquid option names on June 5th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""Illumina releases 2022 CSR report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""Tracking Carl Icahn's Portfolio - Q1 2023 Update"", ""summary"": ""Carl Icahn's 13F portfolio value increased from $21.75B to $22.03B, with the number of holdings rising from 16 to 17. Click here for a detailed discussion.""}, {""date"": ""2023-06-06"", ""headline"": ""Rocky history of Illumina's Grail deal"", ""summary"": ""Gene-sequencing machine maker Illumina Inc has filed an appeal against an order from the U.S. Federal Trade Commission (FTC) that demands it divest cancer diagnostic test maker Grail Inc on competition concerns.""}, {""date"": ""2023-06-06"", ""headline"": ""TIMELINE-Rocky history of Illumina's Grail deal"", ""summary"": ""Gene-sequencing machine maker Illumina Inc has filed an appeal against an order from the U.S. Federal Trade Commission (FTC) that demands it divest cancer diagnostic test maker Grail Inc due to competition concerns.  Illumina spun off Grail in 2016 but retained a 12% stake.""}, {""date"": ""2023-06-06"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 3.56% to $203.07 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-06-06"", ""headline"": ""Stock market today: Dow cuts losses to eke out win as regional banks flex muscles"", ""summary"": ""Investing.com -- The Dow ended the day above the flatline Tuesday after cutting gains into the close as renewed investor appetite for regional banking stocks and a climb in tech helped offset losses in health care stocks.""}, {""date"": ""2023-06-06"", ""headline"": ""LGND or ILMN: Which Is the Better Value Stock Right Now?"", ""summary"": ""LGND vs. ILMN: Which Stock Is the Better Value Option?""}, {""date"": ""2023-06-06"", ""headline"": ""S&P 500 struggles for direction as regional banks rebound, but health care weighs"", ""summary"": ""Investing.com -- The S&P 500 slipped between gains and losses Tuesday as investors digested a slip in health care stocks and renewed investor appetite for regional banking stocks.""}, {""date"": ""2023-06-06"", ""headline"": ""$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-06"", ""headline"": ""Illumina appeals FTC order to divest cancer test maker Grail"", ""summary"": ""Illumina on Monday filed an appeal against a Federal Trade Commission (FTC) order, demanding that it divest cancer diagnostic test maker Grail over competition concerns in the U.S. market for cancer tests.""}, {""date"": ""2023-06-07"", ""headline"": ""Illumina Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Illumina Inc. shed 0.36% to $202.33 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-06-07"", ""headline"": ""SVB Securities Sticks to Its Buy Rating for Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-08"", ""headline"": ""Illumina Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.19% higher to $202.72 Thursday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-06-08"", ""headline"": ""US House Republicans press FTC about fight against Illumina's Grail buy"", ""summary"": ""The chair of the House Judiciary Committee, Jim Jordan, and two other Republicans wrote to the U.S. Federal Trade Commission on Thursday to demand information about the agency's battle to oppose Illumina's purchase of former subsidiary Grail.  Jordan, along with Representatives Darrell Issa and Thomas Massie, expressed concern that the agency inappropriately worked with European regulators to get the $7.1 billion deal scrapped.  Massie is chair of the panel's antitrust subcommittee.""}, {""date"": ""2023-06-08"", ""headline"": ""House Republicans seek information from FTC over Illumina's Grail deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-08"", ""headline"": ""House Republicans seek information from FTC over Illumina's Grail takeover"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-09"", ""headline"": ""Illumina Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Illumina Inc. slid 1.08% to $200.53 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-09"", ""headline"": ""Illumina (ILMN) Sequencing Arm Grows, Margin Woes Linger"", ""summary"": ""Illumina's (ILMN) total sequencing activity on connected high- and mid-throughput instruments are growing strongly.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO deSouza resigns after battle with Icahn"", ""summary"": ""Illumina CEO Francis deSouza stepped down on Sunday, the gene-sequencing machine maker said in a statement, ending a battle with activist investor Carl Icahn in which the company's chairman left the company earlier this year.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO resigns amid pressure from activist investor Carl Icahn"", ""summary"": ""Gene sequencing test maker Illumina Inc. said Sunday that its board has accepted the resignation of its CEO and director, Francis deSouza, effective immediately.  Charles Dadswell, senior vice president and general counsel, has been named interim CEO, while the board conducts a search for a new CEO.  Illumina said deSouza, who has been with the company since 2013 and was named CEO three years later, will stay on in an advisory capacity until July 31.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO Steps Down"", ""summary"": ""The gene sequencing company has been in a battle with regulators over its $7 billion deal for cancer test maker Grail.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO Francis DeSouza resigns after battle with Icahn"", ""summary"": ""Illumina Chief Executive Officer Francis DeSouza stepped down on Sunday, the gene-sequencing machine maker said in a statement, ending a battle with activist investor Carl Icahn in which the company's chairman left the company earlier this year.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO Francis deSouza Resigns"", ""summary"": ""Head of gene-sequencing test maker steps aside after regulators challenged deal for a cancer test-developer.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO DeSouza Resigns Following Pressure From Icahn"", ""summary"": ""(Bloomberg) -- Illumina Inc.\u2019s board accepted the resignation of Chief Executive Officer Francis deSouza, handing a victory to activist investor Carl Icahn who had been seeking his removal.Most Read from BloombergOil Traders Are Daring to Defy Market Kingpin Saudi ArabiaUBS Completes Credit Suisse Takeover to Create Bank TitanAs Fed Signals Rate Pause, Powell Will Have to Placate HawksGoldman\u2019s Low US Recession Odds Get It Wrong, Bond Investors SayJeff Bezos Has Gained $10 on Mystery Purchase of""}, {""date"": ""2023-06-11"", ""headline"": ""UPDATE 1-Illumina CEO Francis DeSouza resigns"", ""summary"": ""The CEO of gene-sequencing machine maker Illumina Francis DeSouza has resigned from the group, it said on Sunday, weeks after he survived a challenge to his board seat from activist investor Carl Icahn.  In May Icahn secured a seat for one of his three nominees to Illumina's board, marking a partial victory for him and his months-long proxy battle to remove DeSouza.  The company said on Sunday senior vice president and General Counsel Charles Dadswell will take over as interim CEO while a replacement for DeSouza is found.""}, {""date"": ""2023-06-11"", ""headline"": ""Francis deSouza resigns as Illumina boss after proxy battle with Carl Icahn"", ""summary"": ""Illumina chief executive Francis deSouza has resigned following a bruising proxy battle with activist investor Carl Icahn over the future of the world\u2019s biggest gene sequencing company.  Illumina said on Sunday that the company\u2019s board of directors had accepted deSouza\u2019s immediate resignation and begun a search for a replacement.  DeSouza will stay on in an advisory capacity at Illumina until July 31, said the company.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina appoints Dadswell as interim CEO"", ""summary"": ""Illumina said on Sunday that it had appointed Charles Dadswell as interim chief executive officer while the board conducts a search for a new CEO. (Reporting by Lavanya Ahire in Bengaluru; editing by Jason Neely)""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina announces CEO transition plan"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has accepted the resignation of Francis deSouza as Illumina's Chief Executive Officer and as a Director, effective Sunday, June 11. Charles Dadswell, Senior Vice President and General Counsel, has been named interim CEO while the Board of Directors conducts a search for a new CEO. Mr. deSouza will stay on in an advisory capacity until July 31, 2023.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO Francis deSouza leaving, Charles Dadswell named interim CEO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO is said to have resigned"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
22,2023-06-11,200.52999877929688,2023-06-18,205.8699951171875,0.02662941390513751,U3,"[{""date"": ""2023-06-11"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO deSouza resigns after proxy battle with Icahn"", ""summary"": ""Illumina CEO Francis deSouza stepped down on Sunday, marking a victory for activist investor Carl Icahn and heightening expectations that it could unwind its controversial $7.1 billion acquisition of Grail.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO Francis deSouza resigns amid proxy battle with Carl Icahn"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-11"", ""headline"": ""Tech Sector Powers S&P 500 To 10-Month High While Oil Stocks Struggle: What's Driving Markets Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-11"", ""headline"": ""PRESS DIGEST-Financial Times - June 12"", ""summary"": ""Andreessen Horowitz has chosen London for its first office outside the U.S., betting that the UK government will create a more hospitable climate for blockchain start-ups amid a crypto crackdown by the American financial regulator.  - The European Union has offered Tunisia more than 1 billion euros ($1.07 billion) in a bid to help the North African nation overcome a deepening economic crisis that has prompted thousands of migrants to cross the Mediterranean Sea to Italy.  - Illumina CEO Francis deSouza has resigned following a bruising proxy battle with activist investor Carl Icahn over the future of the world's biggest gene-sequencing machine maker.""}, {""date"": ""2023-06-11"", ""headline"": ""Tech Sector Powers S&P 500 To 10-Month High, While Oil Stocks Struggle: What's Driving Markets Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO deSouza resigns after battle with Icahn"", ""summary"": ""Illumina CEO Francis deSouza stepped down on Sunday, the gene-sequencing machine maker said in a statement, ending a battle with activist investor Carl Icahn in which the company's chairman left the company earlier this year.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO resigns amid pressure from activist investor Carl Icahn"", ""summary"": ""Gene sequencing test maker Illumina Inc. said Sunday that its board has accepted the resignation of its CEO and director, Francis deSouza, effective immediately.  Charles Dadswell, senior vice president and general counsel, has been named interim CEO, while the board conducts a search for a new CEO.  Illumina said deSouza, who has been with the company since 2013 and was named CEO three years later, will stay on in an advisory capacity until July 31.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO Steps Down"", ""summary"": ""The gene sequencing company has been in a battle with regulators over its $7 billion deal for cancer test maker Grail.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO Francis DeSouza resigns after battle with Icahn"", ""summary"": ""Illumina Chief Executive Officer Francis DeSouza stepped down on Sunday, the gene-sequencing machine maker said in a statement, ending a battle with activist investor Carl Icahn in which the company's chairman left the company earlier this year.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO Francis deSouza Resigns"", ""summary"": ""Head of gene-sequencing test maker steps aside after regulators challenged deal for a cancer test-developer.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO DeSouza Resigns Following Pressure From Icahn"", ""summary"": ""(Bloomberg) -- Illumina Inc.\u2019s board accepted the resignation of Chief Executive Officer Francis deSouza, handing a victory to activist investor Carl Icahn who had been seeking his removal.Most Read from BloombergOil Traders Are Daring to Defy Market Kingpin Saudi ArabiaUBS Completes Credit Suisse Takeover to Create Bank TitanAs Fed Signals Rate Pause, Powell Will Have to Placate HawksGoldman\u2019s Low US Recession Odds Get It Wrong, Bond Investors SayJeff Bezos Has Gained $10 on Mystery Purchase of""}, {""date"": ""2023-06-11"", ""headline"": ""UPDATE 1-Illumina CEO Francis DeSouza resigns"", ""summary"": ""The CEO of gene-sequencing machine maker Illumina Francis DeSouza has resigned from the group, it said on Sunday, weeks after he survived a challenge to his board seat from activist investor Carl Icahn.  In May Icahn secured a seat for one of his three nominees to Illumina's board, marking a partial victory for him and his months-long proxy battle to remove DeSouza.  The company said on Sunday senior vice president and General Counsel Charles Dadswell will take over as interim CEO while a replacement for DeSouza is found.""}, {""date"": ""2023-06-11"", ""headline"": ""Francis deSouza resigns as Illumina boss after proxy battle with Carl Icahn"", ""summary"": ""Illumina chief executive Francis deSouza has resigned following a bruising proxy battle with activist investor Carl Icahn over the future of the world\u2019s biggest gene sequencing company.  Illumina said on Sunday that the company\u2019s board of directors had accepted deSouza\u2019s immediate resignation and begun a search for a replacement.  DeSouza will stay on in an advisory capacity at Illumina until July 31, said the company.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina appoints Dadswell as interim CEO"", ""summary"": ""Illumina said on Sunday that it had appointed Charles Dadswell as interim chief executive officer while the board conducts a search for a new CEO. (Reporting by Lavanya Ahire in Bengaluru; editing by Jason Neely)""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina announces CEO transition plan"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has accepted the resignation of Francis deSouza as Illumina's Chief Executive Officer and as a Director, effective Sunday, June 11. Charles Dadswell, Senior Vice President and General Counsel, has been named interim CEO while the Board of Directors conducts a search for a new CEO. Mr. deSouza will stay on in an advisory capacity until July 31, 2023.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO Francis deSouza leaving, Charles Dadswell named interim CEO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-11"", ""headline"": ""Illumina CEO is said to have resigned"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Tesla charging wins, Illumina CEO steps down, Nasdaq-Adenza deal: Trending stocks"", ""summary"": ""Tesla's charging plug is being used by more EV charging companies, the Nasdaq is acquiring Adenza in $10.5 billion deal, and Illumina shares rise as CEO steps down. Yahoo Finance Live breaks down some of the trending stories of the day.""}, {""date"": ""2023-06-12"", ""headline"": ""Canaccord Genuity Reiterates Illumina (ILMN) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-06-12"", ""headline"": ""Illumina CEO\u2019s Resignation May Restore Stock\u2019s Popularity"", ""summary"": ""The gene-sequencing firm's shares were up 3% mid-Monday, to $206, as traders digested the news of Francis deSouza's resignation.""}, {""date"": ""2023-06-12"", ""headline"": ""After Illumina CEO\u2019s Fall, Other Executives Are Expected to Take Hard Look at Deals"", ""summary"": ""Francis deSouza resigned from gene-sequencing maker after regulators challenged $7.1 billion deal, triggering proxy battle with Carl Icahn.""}, {""date"": ""2023-06-12"", ""headline"": ""These Stocks Are Moving the Most Today: Tesla, Carnival, Nasdaq, SoFi, and More"", ""summary"": ""Tesla is rising for a 12th consecutive day, Carnival trades higher after Wall Street upgrades the stock, and Nasdaq falls after agreeing to acquire software company Adenza for $10.5 billion in cash and shares.""}, {""date"": ""2023-06-12"", ""headline"": ""Illumina Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Illumina Inc. rallied 3.79% to $208.14 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-12"", ""headline"": ""Illumina, Inc. (ILMN) Special Call (2023 ESG Investor Event) Transcript"", ""summary"": ""Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Special Call (2023 ESG Investor Event) Transcript June 12, 2023 12:00 PM ETCompany ParticipantsSalli Schwartz - Vice President of Investor...""}, {""date"": ""2023-06-12"", ""headline"": ""Broadcom Might Receive European Approval For $61B VMware Deal, UBS Closes Credit Suisse Takeover, Illumina CEO Steps Down Amid Activist Investor Carl Icahn's Pressure: Today's Top Stories"", ""summary"": ""Reuters Broadcom Most Likely To Receive EU Approval For $61B VMware Merger In early May, U.S. chipmaker Broadcom Inc's (NASDAQ: AVGO) CEO Hock Tan proposed a pitch to EU antitrust enforcers regarding the pro-competitiveness of the proposed $61 billion bid for cloud computing firm VMware Inc (NASDAQ: VMW). Broadcom is set to gain conditional EU antitrust approval for its proposed acquisition of VMware. The European Commission's approval is linked to Broadcom's interoperability remedies to rivals""}, {""date"": ""2023-06-12"", ""headline"": ""llumina CEO deSouza resigns after proxy battle with Carl Icahn"", ""summary"": ""Illumina CEO Francis deSouza has stepped down after a lengthy proxy battle with activist investor Carl Icahn. Yahoo Finance health care reporter Anjalee Khemlani breaks down the timeline of events, while also commenting on Novartis' $3.5 billion acquisition deal with Chinook Therapeutics.""}, {""date"": ""2023-06-12"", ""headline"": ""Pharma: M&A strategy gets dose of bitter medicine"", ""summary"": ""Medicines price gouger Martin Shkreli was one of a kind.  Illumina bought cancer test developer Grail for $8bn in 2021, even though US and EU authorities complained the US gene sequencer could deny crucial inputs to Grail\u2019s rivals.  On Monday, its boss Francis deSouza resigned after a proxy fight with activist investor Carl Icahn over Illumina\u2019s decision to proceed.""}, {""date"": ""2023-06-12"", ""headline"": ""Oracle earnings, Illumina CEO steps down, Nasdaq-Adenza deal: Trending stocks"", ""summary"": ""Oracle is set to report Q4 earnings after the bell. Illumina CEO steps down. Nasdaq Inc. is acquiring Adenza in $10.5 billion deal. Yahoo Finance Live breaks down some of the trending stocks this morning.""}, {""date"": ""2023-06-12"", ""headline"": ""Executive Shakeup at Illumina: CEO Francis deSouza Steps Down Amid Activist Investor Carl Icahn's Pressure"", ""summary"": ""Illumina Inc (NASDAQ. ILMN) announced that its Board of Directors accepted the resignation of Francis deSouza as Illumina\u2019s Chief Executive Officer and Director, effective June 11. Charles Dadswell, Senior Vice President and General Counsel, has been named interim CEO while the Board of Directors searches for a new CEO. Mr. deSouza has been with Illumina since 2013 and served as chief executive since 2016. Mr. deSouza will remain in an advisory capacity until July 31, 2023. The resignation comes""}, {""date"": ""2023-06-12"", ""headline"": ""Stocks making the biggest moves midday: Carnival, Nasdaq, Oracle, KeyCorp and more"", ""summary"": ""These are the stocks posting the largest moves midday.""}, {""date"": ""2023-06-12"", ""headline"": ""Midday movers: Oracle, Carnival Corp., Illumina and more"", ""summary"": ""Investing.com -- Stocks are rising as investors await Tuesday's inflation report and the start of the Federal Reserve's two-day meeting. Here are the market movers for June 12.""}, {""date"": ""2023-06-12"", ""headline"": ""Stocks to Watch Monday: Biogen, Illumina, Oracle"", ""summary"": ""**\u2197\ufe0f** [**Biogen (BIIB)**](https://www.wsj.com/market-data/quotes/BIIB): The biotech company's shares rose 1.3% after an advisory committee [recommended the Food and Drug Administration approve Leqembi](https://investors.""}, {""date"": ""2023-06-12"", ""headline"": ""Is CEO Resignation a Sign That Carl Icahn Can Save Illumina (ILMN) Stock?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Expert Ratings for Illumina"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""A Skip and Pause Aren\u2019t the Same. What\u2019s Next for Fed\u2019s Inflation Fight."", ""summary"": ""Glencore bids for Teck\u2019s coal assets, new CEO at Illumina amid Grail battle, and other news to start your day.""}, {""date"": ""2023-06-12"", ""headline"": ""Illumina shares rise after CEO deSouza steps down"", ""summary"": ""Investing.com -- Shares in Illumina Inc (NASDAQ:ILMN) rose in premarket U.S. trading on Monday after the gene-sequencing machine maker's Chief Executive Francis deSouza stepped down over the weekend.""}, {""date"": ""2023-06-12"", ""headline"": ""Illumina shares rise after CEO resignation"", ""summary"": ""Illumina Inc. stock gained 4.7% premarket on Monday after the company announced Sunday that its board had accepted the resignation of Francis deSouza as CEO,...""}, {""date"": ""2023-06-12"", ""headline"": ""Illumina rises as Carl Icahn sees positives in CEO transition (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Illumina shares likely to trend up again, says Piper Sandler"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Stocks making the biggest moves before the bell: Nasdaq, Illumina, Oracle, Carnival & more"", ""summary"": ""These are the stocks posting the largest moves in premarket trading. ""}, {""date"": ""2023-06-12"", ""headline"": ""Analysts\u2019 Top Healthcare Picks: Keros Therapeutics (KROS), Biogen (BIIB)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Canaccord Genuity Reaffirms Their Buy Rating on Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Goldman pushes back against bearish Morgan Stanley's Mike Wilson with new 4,500 S&P 500 target"", ""summary"": ""Resilient economic growth and softening inflation will keep stocks supported, says Goldman Sachs, which has a new bullish S&P 500 target.""}, {""date"": ""2023-06-12"", ""headline"": ""Illumina rises as Carl Icahn sees positives in CEO transition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Illumina gains as Carl Icahn sees positives in CEO transition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Nasdaq, S&P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Illumina (NASDAQ:ILMN) CEO Vacates Office;  Path to Victory for Activist Investor Carl Icahn"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Goldman pushes back against bearish Morgan Stanley\u2019s Mike Wilson with new 4,500 S&P 500 target"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Biogen, Carnival and Oracle post solid gains, while Nasdaq and KeyCorp slump"", ""summary"": ""Here are some of the biggest movers on Monday.""}, {""date"": ""2023-06-12"", ""headline"": ""Illumina CEO change likely to be viewed positively, says Citi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-13"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. dropped 0.62% to $206.84 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-13"", ""headline"": ""Illumina acquisition of Grail wins support from GOP lawmakers, state AGs as FTC tries to block it"", ""summary"": ""The groups argued in the briefs that the FTC overstepped its authority in trying to unwind Illumina's $7.1 billion acquisition of Grail. ""}, {""date"": ""2023-06-14"", ""headline"": ""Illumina Breaks Above 200-Day Moving Average - Bullish for ILMN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-14"", ""headline"": ""Illumina's Grail Acquisition Gains Support from GOP Lawmakers and Advocacy Groups Despite FTC Resistance"", ""summary"": ""Republican lawmakers, state attorneys general, and several advocacy groups have expressed their support for Illumina Inc's (NASDAQ: ILMN) acquisition of Grail Inc, even as the Federal Trade Commission (FTC) continues challenging the deal. On Monday, these groups filed 14 amicus briefs urging the U.S. 5th Circuit Court of Appeals to reverse the FTC's order, which sought to undo the Grail deal due to concerns about competition suppression. Illumina appealed the agency's ruling last week, CNBC repo""}, {""date"": ""2023-06-14"", ""headline"": ""Illumina Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. dropped 0.97% to $204.84 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-14"", ""headline"": ""10 DNA Stocks Billionaires Are Loading Up On"", ""summary"": ""In this article, we discuss 10 DNA stocks that billionaires love. If you want to skip our detailed analysis of the DNA market, head over to 5 DNA Stocks Billionaires Are Loading Up On. Genomics is the study of a complete set of DNA within an organism. The global genomics market was worth $28.39 billion [\u2026]""}, {""date"": ""2023-06-14"", ""headline"": ""Here's Why You Should Retain Illumina (ILMN) Stock for Now"", ""summary"": ""Investors are optimistic about Illumina (ILMN) on solid long-term growth potential in the oncology space.""}, {""date"": ""2023-06-14"", ""headline"": ""GOP lawmakers, state AGs voice support for Illumina's Grail acquisition"", ""summary"": ""CNBC's Becky Quick reports on the latest news.""}, {""date"": ""2023-06-15"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. rallied 2.49% to $209.94 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-15"", ""headline"": ""Ominous Death Cross Forms On Illumina's Chart"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-16"", ""headline"": ""Illumina CEO Steps Down; Grail Soap Opera Continues"", ""summary"": ""In this podcast, Motley Fool senior analyst Jason Moser and host Deidre Woollard discuss:  Whether the departure of Illumina's CEO will impact the company's efforts to keep its Grail acquisition. Carl Icahn's history of activist investing.""}, {""date"": ""2023-06-16"", ""headline"": ""A Schwab Wealth Survey Reveals a Paradox"", ""summary"": ""Nearly half of the respondents averaging $560,000 in net worth said they were wealthy, when including nonfinancial factors like health and family. But when...""}, {""date"": ""2023-06-16"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 1.94% to $205.87 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-06-17"", ""headline"": ""3 Gene Testing Stocks to Buy Before They Take Off"", ""summary"": ""Genes are the foundation of human life. They are the code that gives every instruction to our bodies about how to move, digest and think. So understanding those genes can be critical to understanding our own health. It\u2019s no wonder that the clinical sequencing market is expected to have a compound annual growth rate (CAGR) of 14.6% through 2032. With such growth comes profits, and some of the best biotech stocks to buy right now are already building the future of gene testing. Ever since the huma""}, {""date"": ""2023-06-18"", ""headline"": ""How to Retire Rich: Biotech Stocks Edition"", ""summary"": ""Among the most difficult endeavors when it comes to deciphering the best retirement planning stocks is to identify companies that will remain relevant for years, if not decades to come. While no guarantees exist for anything, those who focus on investing in biotech own a clear advantage. Almost surely, the underlying sector \u2013 which falls under the broad healthcare industry \u2013 is permanently relevant. Further, I submitted a query on ChatGPT to extract key reasons why biotech stocks for retirement""}]",{}
23,2023-06-18,205.8699951171875,2023-06-25,201.6699981689453,-0.02040120973360604,D3,"[{""date"": ""2023-06-18"", ""headline"": ""How to Retire Rich: Biotech Stocks Edition"", ""summary"": ""Among the most difficult endeavors when it comes to deciphering the best retirement planning stocks is to identify companies that will remain relevant for years, if not decades to come. While no guarantees exist for anything, those who focus on investing in biotech own a clear advantage. Almost surely, the underlying sector \u2013 which falls under the broad healthcare industry \u2013 is permanently relevant. Further, I submitted a query on ChatGPT to extract key reasons why biotech stocks for retirement""}, {""date"": ""2023-06-19"", ""headline"": ""PBE: Healthcare Dashboard For June"", ""summary"": ""Pharma/biotechnology and healthcare providers are slightly undervalued relative to 11-year averages. Click here for the June edition of the Healthcare Dashboard.""}, {""date"": ""2023-06-20"", ""headline"": ""The Lancet Oncology Publishes Results from SYMPLIFY, The First Prospective Study of a Multi-Cancer Early Detection Test in a Symptomatic Patient Population"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-20"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 1.82% to $202.13 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-20"", ""headline"": ""Illumina's CEO Was Just Ousted: Should Investors Buy In Now or Steer Clear?"", ""summary"": ""On June 11, the gene sequencing giant Illumina (NASDAQ: ILMN) announced that its CEO, Francis deSouza, resigned after a tenure of roughly 10 years and that the company would start looking for a replacement.  In the past five years, its quarterly revenue only rose by 30.9%, reaching nearly $1.1 billion.""}, {""date"": ""2023-06-20"", ""headline"": ""Illumina Ventures to Launch Illumina\u00ae Ventures Labs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-21"", ""headline"": ""Red-Hot Quality Opportunities in Genomics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-21"", ""headline"": ""Illumina Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 1.12% to $199.87 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-06-22"", ""headline"": ""Illumina Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Illumina Inc. rallied 1.14% to $202.15 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-22"", ""headline"": ""Life Sciences Has Lagged; Morningstar Likes These Biotech Stocks"", ""summary"": ""Life-science stocks have struggled this year, with the iShares Biotechnology ETF suffering a negative return of 0.64%. The stocks' struggles have put them on average at a discount to Morningstar's fair-value estimate for the first time in five years.""}, {""date"": ""2023-06-22"", ""headline"": ""ILMN August 4th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""If You Invested $1000 In This Stock 20 Years Ago, You Would Have $140 Thousand Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-23"", ""headline"": ""UPDATE 1-US House panel critical of Twitter probe to question FTC chair at July 13 hearing"", ""summary"": ""U.S. Federal Trade Commission Chair Lina Khan is set to testify on July 13 before the House Judiciary Committee led by Republicans who have sharply criticized her leadership of the antitrust enforcement agency, the committee and commission confirmed on Friday.  This will be her first appearance before the committee since Republicans assumed control.  Republicans have been especially critical of the FTC's privacy investigation into Twitter since it was purchased by billionaire Tesla CEO Elon Musk.""}, {""date"": ""2023-06-23"", ""headline"": ""Illumina Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Illumina Inc. slumped 0.24% to $201.67 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-23"", ""headline"": ""LGND vs. ILMN: Which Stock Is the Better Value Option?"", ""summary"": ""LGND vs. ILMN: Which Stock Is the Better Value Option?""}, {""date"": ""2023-06-23"", ""headline"": ""Goldman adds 25 new stocks with growth potential to its ROE basket"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-24"", ""headline"": ""10 Personalized Medicine Stocks Billionaires Are Loading Up On"", ""summary"": ""In this article, we will take a look at the 10 personalized medicine stocks billionaires are purchasing. If you want to skip our detailed analysis of the industry and its growth prospects, go to the 5 Personalized Medicine Stocks Billionaires Are Loading Up On. According to Allied Market Research, the global personalized medicine industry is set [\u2026]""}, {""date"": ""2023-06-25"", ""headline"": ""CEO Shuffle: 7 Stocks That Could Gain Momentum From New Leadership"", ""summary"": ""New CEOs can breathe new life into a company by launching new initiatives, hiring more effective managers, and/or entering new markets. One great example is General Electric. (NYSE:GE). When Larry Culp took the helm of that storied firm in 2018, it was losing billions of dollars. However, after cutting GE\u2019s costs and making it far more customer-focused, he was to turn the sinking ship around. Here are seven stocks to gain momentum from leadership changes. Amazon (AMZN) Source: Tada Images / Shut""}]",{}
24,2023-06-25,201.6699981689453,2023-07-02,187.49000549316406,-0.070312851710854,D5+,"[{""date"": ""2023-06-25"", ""headline"": ""CEO Shuffle: 7 Stocks That Could Gain Momentum From New Leadership"", ""summary"": ""New CEOs can breathe new life into a company by launching new initiatives, hiring more effective managers, and/or entering new markets. One great example is General Electric. (NYSE:GE). When Larry Culp took the helm of that storied firm in 2018, it was losing billions of dollars. However, after cutting GE\u2019s costs and making it far more customer-focused, he was to turn the sinking ship around. Here are seven stocks to gain momentum from leadership changes. Amazon (AMZN) Source: Tada Images / Shut""}, {""date"": ""2023-06-26"", ""headline"": ""Tuesday Sector Laggards: Healthcare, Utilities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""UPDATE 2-Illumina starts job cuts, plans office exit to rein in costs"", ""summary"": ""Illumina Inc has commenced job cuts, the genetic sequencing equipment maker said on Monday, as it looks to cushion the impact of sticky inflation and a strong dollar on its business.  Illumina has begun to lay off 10% of its research and development team, health news website STAT reported on Monday, citing internal emails.  Illumina, which had engaged in a proxy battle with activist investor Carl Icahn, earlier this month said CEO Francis deSouza had stepped down.""}, {""date"": ""2023-06-26"", ""headline"": ""Illumina starts job cuts, plans office exit to rein in costs"", ""summary"": ""The company also intends to further cut workforce in the third quarter and reducing its real estate footprint in California as part of a plan to reduce annualized run rate expenses by more than $100 million in 2023.  Illumina has begun to lay off 10% of its research and development team, health news website STAT reported on Monday, citing internal emails.  Illumina, which had engaged in a proxy battle with activist investor Carl Icahn, earlier this month said CEO Francis deSouza had stepped down.""}, {""date"": ""2023-06-26"", ""headline"": ""Illumina to lay off workers as part of cost cuts amid Icahn fight"", ""summary"": ""Illumina Inc. disclosed Monday that it has begun laying off workers, as the DNA-sequencing company looks to cut costs amid a withering fight with activist...""}, {""date"": ""2023-06-26"", ""headline"": ""Illumina to Reduce Head Count, Exit Real Estate Amid Cost- Cutting Efforts"", ""summary"": ""By Denny Jacob Illumina on Monday disclosed it plans to reduce its head count further as part of a broader effort to cut its operating expenses. The maker of...""}, {""date"": ""2023-06-26"", ""headline"": ""Illumina Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 4.85% to $191.88 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-26"", ""headline"": ""Illumina eyes USD100 million worth of annual cost cuts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Video: Nasdaq 100 Movers: ILMN, LCID"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Illumina Announces Job Layoffs After CEO Resignation, Icahn's Board Chess Game: What's Next?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Illumina Announces Job Layoffs After CEO Resignation: What's Next?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Illumina announces job cuts, to exit San Diego i3 campus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Illumina to reduce global real estate footprint, exit i3 campus in San Diego"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Illumina sees charges of $25M-$35M in connection with job cuts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Illumina commenced headcount reduction, sees further job cuts in Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-27"", ""headline"": ""Illumina Unusual Options Activity For June 28"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-27"", ""headline"": ""Illumina Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 4.40% to $183.43 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-27"", ""headline"": ""Stocks Rebound, Tech Rallies As Dip Buyers Return: What's Driving Markets Tuesday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-27"", ""headline"": ""Delta Air Lines, Generac stocks rally, Walgreens and Lordstown Motors shares tumble, and other stocks on the move"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-27"", ""headline"": ""Illumina (NASDAQ:ILMN) Downsizes Workforce, Exits Office Space"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-27"", ""headline"": ""Tesla shares bounce higher after Monday\u2019s decline, Lordstown stock plunges on bankruptcy filing, and other stocks on the move"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-28"", ""headline"": ""Looking Into Illumina's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-28"", ""headline"": ""Illumina Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.59% higher to $184.51 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-28"", ""headline"": ""SVB Securities Remains a Buy on Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-28"", ""headline"": ""Citi screens for most crowded short stocks with new model"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-28"", ""headline"": ""How a big biotech\u2019s start-up gamble went wrong"", ""summary"": ""Gene sequencer Illumina took a bet on start-up Grail during the height of the biotech boom. What happened next was not part of the plan""}, {""date"": ""2023-06-29"", ""headline"": ""PacBio initiated with a Buy at Goldman Sachs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-29"", ""headline"": ""What Does Illumina's Debt Look Like?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-29"", ""headline"": ""Illumina Inc. stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of Illumina Inc. inched 0.53% higher to $185.49 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-06-30"", ""headline"": ""Illumina Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Illumina Inc. advanced 1.08% to $187.49 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-30"", ""headline"": ""Nvidia upgraded, Apple initiated: Wall Street's top analyst calls"", ""summary"": ""Nvidia upgraded, Apple initiated: Wall Street's top analyst calls""}, {""date"": ""2023-06-30"", ""headline"": ""PacBio initiated at buy at Goldman on sequencing system"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-01"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.""}]",{}
25,2023-07-02,187.49000549316406,2023-07-09,183.32000732421875,-0.022241175778819566,D3,"[{""date"": ""2023-07-04"", ""headline"": ""Illumina assumed with a Neutral at JPMorgan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-04"", ""headline"": ""Illumina faces record European Union fine over Grail deal  next week - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-04"", ""headline"": ""Illumina faces record fine over purchase of Grail without EU approval"", ""summary"": ""World\u2019s biggest gene sequencing group closed deal with cancer screening start-up despite ongoing investigation""}, {""date"": ""2023-07-05"", ""headline"": ""Analyst Expectations for Illumina's Future"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Illumina Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. sank 0.58% to $187.03 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-07-05"", ""headline"": ""Illumina Stock (NASDAQ:ILMN): Regulators Come Knocking on the Door"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""FTC Vs. Microsoft: FTC Wins"", ""summary"": ""Microsoft Corporation has already won in its acquisition of Activision Blizzard, Inc. See what\u00e2\u0080\u0099s next in the process for MSFT and ATVI and my strategy.""}, {""date"": ""2023-07-05"", ""headline"": ""Wall Street Breakfast Podcast: Instagram's Threads"", ""summary"": ""Instagram puts Threads on App Store with launch imminent. Illumina faces record European Union fine over Grail deal next week-report. GTCR in advanced talks to buy Worldpay stake.""}, {""date"": ""2023-07-05"", ""headline"": ""Inside a media mogul\u2019s 60th birthday bash"", ""summary"": ""Plus, the FT digs into Nigel Farage\u2019s bank blacklisting claims and Illumina faces a record fine for jumping the EU antitrust gun""}, {""date"": ""2023-07-06"", ""headline"": ""Illumina Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slipped 2.43% to $182.48 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-07-06"", ""headline"": ""Canaccord Genuity Reiterates Illumina (ILMN) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-07-06"", ""headline"": ""August 25th Options Now Available For Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-07"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. inched 0.46% higher to $183.32 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-07-09"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3789, ""bookValue"": 6555, ""cashRatio"": 0.6743378202344767, ""currentRatio"": 1.3995, ""ebitPerShare"": -0.557, ""eps"": -1.481, ""ev"": 30426.771, ""fcfMargin"": 0.0493, ""fcfPerShareTTM"": -1.4177, ""grossMargin"": 0.6224, ""inventoryTurnoverTTM"": 2.9692, ""longtermDebtTotalAsset"": 0.1264, ""longtermDebtTotalCapital"": 0.1692, ""longtermDebtTotalEquity"": 0.227, ""netDebtToTotalCapital"": 0.0779, ""netDebtToTotalEquity"": 0.1045, ""netMargin"": -0.199, ""operatingMargin"": -0.0748, ""pb"": 4.5373, ""pfcfTTM"": 254.2032, ""pretaxMargin"": -0.0757, ""psTTM"": 6.6671, ""ptbv"": 8.8333, ""quickRatio"": 1.0061, ""receivablesTurnoverTTM"": 6.292, ""roaTTM"": -0.3556, ""roeTTM"": -0.63, ""roicTTM"": -0.4713, ""rotcTTM"": -0.4431, ""salesPerShare"": 7.443, ""sgaToSale"": 0.3776, ""tangibleBookValue"": 3367, ""totalDebtToEquity"": 0.3414, ""totalDebtToTotalAsset"": 0.1901, ""totalDebtToTotalCapital"": 0.2545, ""totalRatio"": 2.256, ""period"": ""2023-07-02""}"
26,2023-07-09,183.32000732421875,2023-07-16,187.14999389648438,0.02089235445802662,U3,"[{""date"": ""2023-07-09"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. inched 0.34% higher to $183.94 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-07-10"", ""headline"": ""Illumina Or Pacific Biosciences? The Upstart Vs. The 800-Pound Gorilla"", ""summary"": ""Illumina and Pacific Biosciences are two of the best-known next-generation DNA sequencing companies. Read what stock is a better short-term buy and the other is a good long-term investment.""}, {""date"": ""2023-07-10"", ""headline"": ""RBC Capital Reaffirms Their Buy Rating on Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""Did Carl Icahn Just Save IEP Stock?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""Citi opens 'negative catalyst watch' on Illumina into earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-11"", ""headline"": ""UPDATE 2-Illumina to face record EU antitrust fine for Grail deal, source says"", ""summary"": ""U.S. genetic testing company Illumina will face a record EU antitrust fine on Wednesday for closing its takeover of Grail before it secured approval from EU regulators, a person familiar with the matter said on Tuesday.  Reuters reported in January that the European Commission is set to hand out a fine of up to 10% of Illumina's global revenue, the maximum allowed under EU merger rules.  Illumina has set aside $458 million, representing 10% of its consolidated annual revenue for fiscal year 2022, as of Jan. 1 for a potential fine, according to a regulatory filing.""}, {""date"": ""2023-07-11"", ""headline"": ""Illumina Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.48% higher to $184.82 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-07-11"", ""headline"": ""LGND or ILMN: Which Is the Better Value Stock Right Now?"", ""summary"": ""LGND vs. ILMN: Which Stock Is the Better Value Option?""}, {""date"": ""2023-07-11"", ""headline"": ""Illumina to face record EU antitrust fine on Wednesday for Grail deal, source says"", ""summary"": ""U.S. life sciences company\nIllumina will face a record EU antitrust fine on\nWednesday for closing its takeover of Grail before it\nsecured EU antitrust approval, a person familiar with the matter\nsaid...""}, {""date"": ""2023-07-11"", ""headline"": ""Illumina DRAGEN\u2122 4.2 delivers most accurate and comprehensive coverage of the genome, powering greater applications and discovery"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of the latest version of DRAGEN\u2122 software for analysis of next-generation sequencing data. DRAGEN 4.2 expands award-winning accuracy combined with its renowned flexibility and scalability to enable efficient workflows and extract meaningful insights from genomic data.""}, {""date"": ""2023-07-11"", ""headline"": ""Illumina DRAGEN&trade; 4.2 delivers most accurate and comprehensive coverage of the genome, powering greater applications and discovery"", ""summary"": ""2023 marks five years of industry-leading DRAGEN software offered by Illumina\nSAN DIEGO, July 11, 2023 /PRNewswire/ -- Illumina Inc. , a global leader in DNA sequencing and array-based technologies,...""}, {""date"": ""2023-07-11"", ""headline"": ""Illumina to receive record EU fine related to Grail Inc. merger, Bloomberg says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-12"", ""headline"": ""Illumina Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Illumina Inc. rose 3.86% to $191.95 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-07-12"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks up, dollar down as CPI hits two-year low"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-12"", ""headline"": ""Illumina's (ILMN) Latest Launch to Boost Genomics Analysis"", ""summary"": ""Illumina's (ILMN) DRAGEN v4.2 is expected to improve the identification of genetic disease causes, drug discovery and population genomics.""}, {""date"": ""2023-07-12"", ""headline"": ""Nvidia, Microsoft, Netflix and Domino's rise premarket; Illumina falls"", ""summary"": ""Investing.com -- U.S. futures traded lower, with investors cautious ahead of the release of Federal Reserve meeting minutes from the June policy gathering.""}, {""date"": ""2023-07-12"", ""headline"": ""EU Fines Illumina Record $476 Million for Closing Grail Deal Without Approval"", ""summary"": ""The European Commission fined biotech firm Illumina 432 million euros ($476 million) for closing its acquisition of Grail without the commission's approval, in the Commission's largest merger regulation fine yet.\ufeff\ufeff""}, {""date"": ""2023-07-12"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-12"", ""headline"": ""Illumina to Appeal $476 Million EU Fine for Closing Grail Acquisition Early"", ""summary"": ""The European Commission says the gene-sequencing company completed its acquisition of Grail, a cancer test developer, before receiving the appropriate approvals.""}, {""date"": ""2023-07-12"", ""headline"": ""Illumina hit with record \u20ac432mn fine for ignoring EU concerns over Grail deal"", ""summary"": ""US gene sequencing company proceeded with acquisition of cancer test developer even as regulators were probing deal""}, {""date"": ""2023-07-12"", ""headline"": ""Illumina Fined More Than $400 Million in Europe for Closing Grail Deal Early"", ""summary"": ""The European Union\u2019s antitrust watchdog called the move to wrap up the acquisition during an in-depth probe an unprecedented infringement. Illumina said it would appeal the fine.""}, {""date"": ""2023-07-12"", ""headline"": ""UPDATE 2-Illumina fined a record $476 mln by EU over Grail deal"", ""summary"": ""U.S. genetic testing company Illumina was fined a record 432-million-euro ($476 million) by the EU on Wednesday for closing its takeover of cancer test maker Grail before securing EU antitrust approval.  Illumina has been fighting the EU competition watchdog on several fronts since it was forced to seek its approval in 2021 despite the deal falling short of the EU turnover threshold for scrutiny.  The deal was eventually blocked last September, with regulators concerned that Illumina, once it had acquired Grail, would have an incentive to cut off Grail's rivals from accessing its technology to develop blood-based early cancer detection tests to compete with Grail.""}, {""date"": ""2023-07-12"", ""headline"": ""Illumina fined a record $476 million by EU over Grail deal"", ""summary"": ""BRUSSELS (Reuters) -U.S. genetic testing company Illumina was fined a record 432-million-euro ($476 million) by the EU on Wednesday for closing its takeover of cancer test maker Grail before securing EU antitrust approval.  Illumina has been fighting the EU competition watchdog on several fronts since it was forced to seek its approval in 2021 despite the deal falling short of the EU turnover threshold for scrutiny.  The deal was eventually blocked last September, with regulators concerned that Illumina, once it had acquired Grail, would have an incentive to cut off Grail's rivals from accessing its technology to develop blood-based early cancer detection tests to compete with Grail.""}, {""date"": ""2023-07-12"", ""headline"": ""EU fines US firm Illumina $475 million for jumping gun on buying cancer-screening company Grail"", ""summary"": ""The European Union on Wednesday slapped a $475 million fine on U.S. biotech giant Illumina for buying cancer-screening company Grail without regulators' approval, the latest setback for the deal.  Illumina announced an $7.1 billion acquisition of Grail in 2020, but the European Commission, the EU's executive arm and top antitrust enforcer, said the company broke EU merger rules by completing the deal without its consent.""}, {""date"": ""2023-07-12"", ""headline"": ""EU regulators fine Illumina $476 mln for closing Grail deal without green light"", ""summary"": ""EU antitrust regualators on Wednesday fined Illumina a record 432 million euros ($476.19 million) for closing its takeover of Grail before securing EU antitrust approval.  \""This is a very serious infringement, which requires the imposition of a proportionate fine, with the aim of deterring such conduct,\"" the European Commission said.  The fine, 10% of Illumina's global turnover, was the maximum allowed under EU merger rules for such infringements.""}, {""date"": ""2023-07-12"", ""headline"": ""Disney Considers Different Strategies For Star India, Broadcom Wins Conditional European Approval For VMware Deal, Google Deprioritizes Gen Z Chatbot App: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-12"", ""headline"": ""EU regulator fines Illumina EUR432 million for breach of merger rules"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-12"", ""headline"": ""Illumina DRAGEN 4.2 delivers most accurate and comprehensive coverage of the genome, powering greater applications and discovery"", ""summary"": ""SAN DIEGO - Illumina Inc. , a global leader in DNA sequencing and array-based technologies, today announced the launch of the latest version of DRAGEN software for analysis of next-generation...""}, {""date"": ""2023-07-12"", ""headline"": ""Illumina Fined $475 Million in Europe Over Grail Acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-12"", ""headline"": ""Illumina Slapped With \u20ac400M In Fines: European Commission Penalizes Company For Hasty Grail Deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-12"", ""headline"": ""5 things to know before the stock market opens Wednesday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""2023-07-12"", ""headline"": ""Illumina Fined $475M in Europe Over Grail Acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-12"", ""headline"": ""Illumina hit with record $476 million fine for closing Grail deal without EU approval "", ""summary"": ""The European Commission last year blocked Illumina's $7.1 billion acquisition of Grail over concerns it would stifle innovation and consumer choice. ""}, {""date"": ""2023-07-12"", ""headline"": ""Illumina fined $475M in EU for closing GRAIL acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-12"", ""headline"": ""Illumina, GRAIL fined by EU for implementing deal without approval"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-13"", ""headline"": ""Grail sued by three female ex-employees over \u2018toxic work culture\u2019"", ""summary"": ""Illumina-owned cancer testing group allegedly failed to deal with accusations of inappropriate behaviour and racism""}, {""date"": ""2023-07-13"", ""headline"": ""Illumina Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slipped 1.63% to $188.83 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-07-14"", ""headline"": ""Illumina Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 0.89% to $187.15 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-07-14"", ""headline"": ""Mettler-Toledo International: Shares Still Expensive Heading Into Q2 Earnings"", ""summary"": ""Mettler-Toledo International Inc. stock was hit hard despite MTD's improvement in revenue, profits, and cash flows. Click for our MTD Q2 earnings preview.""}, {""date"": ""2023-07-14"", ""headline"": ""SVB Securities Sticks to Its Buy Rating for Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-14"", ""headline"": ""Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3789, ""bookValue"": 6555, ""cashRatio"": 0.6743378202344767, ""currentRatio"": 1.3995, ""ebitPerShare"": -0.557, ""eps"": -1.481, ""ev"": 30426.771, ""fcfMargin"": 0.0493, ""fcfPerShareTTM"": -1.4177, ""grossMargin"": 0.6224, ""inventoryTurnoverTTM"": 2.9692, ""longtermDebtTotalAsset"": 0.1264, ""longtermDebtTotalCapital"": 0.1692, ""longtermDebtTotalEquity"": 0.227, ""netDebtToTotalCapital"": 0.0779, ""netDebtToTotalEquity"": 0.1045, ""netMargin"": -0.199, ""operatingMargin"": -0.0748, ""pb"": 4.5373, ""pfcfTTM"": 254.2032, ""pretaxMargin"": -0.0757, ""psTTM"": 6.6671, ""ptbv"": 8.8333, ""quickRatio"": 1.0061, ""receivablesTurnoverTTM"": 6.292, ""roaTTM"": -0.3556, ""roeTTM"": -0.63, ""roicTTM"": -0.4713, ""rotcTTM"": -0.4431, ""salesPerShare"": 7.443, ""sgaToSale"": 0.3776, ""tangibleBookValue"": 3367, ""totalDebtToEquity"": 0.3414, ""totalDebtToTotalAsset"": 0.1901, ""totalDebtToTotalCapital"": 0.2545, ""totalRatio"": 2.256, ""period"": ""2023-07-02""}"
27,2023-07-16,187.14999389648438,2023-07-23,190.49000549316406,0.01784670962119872,U2,"[{""date"": ""2023-07-16"", ""headline"": ""Looking Into Illumina's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""Shady Business: 3 Well-Known Stocks That Deserve to Be on Your Blacklist"", ""summary"": ""Bank of America (NYSE:BAC) is one of the country\u2019s largest banks. It\u2019s also one of America\u2019s most well-known stocks thanks to Warren Buffett\u2019s 13% ownership stake. While the bank has found itself in a bit of hot water recently, I\u2019ve learned over the years that the Oracle of Omaha isn\u2019t afraid to own controversial stocks that get into trouble with regulators and consumers. One that comes to mind is Wells Fargo (NYSE:WFC). Berkshire Hathaway (NYSE:BRK-B) held on to shares for several years after i""}, {""date"": ""2023-07-17"", ""headline"": ""Illumina Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""Illumina to Announce Second Quarter 2023 Financial Results on Wednesday, August 9, 2023"", ""summary"": ""Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the second quarter 2023 following the close of market on Wednesday, August 9, 2023.""}, {""date"": ""2023-07-18"", ""headline"": ""Bridging the Diagnosis Gap for Canada\u2019s Indigenous Children"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / July 18, 2023 / Illumina Originally published on Illumina News Center The United Nations Declaration on the Rights of Indigenous Peoples asserts \""the right to access, without any discrimination, to all social and ...""}, {""date"": ""2023-07-18"", ""headline"": ""The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced the five founding members of the Alliance for Genomic Discovery (AGD). The multiyear agreement aims to accelerate development of therapeutics through large-scale genomics and the establishment of a preeminent clinical ge""}, {""date"": ""2023-07-18"", ""headline"": ""Illumina put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""The Alliance for Genomic Discovery announces founding biopharma members : AbbVie, Amgen, AstraZeneca, Bayer, and Merck"", ""summary"": ""Alliance aims to accelerate therapeutic development and expand the diversity of genomic data through inclusion of more samples from currently underrepresented ancestries \nSAN DIEGO, July 18, 2023...""}, {""date"": ""2023-07-18"", ""headline"": ""RBC Capital Reaffirms Their Buy Rating on Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-19"", ""headline"": ""Illumina, Inc.: Collapsing Margins, Rising Debt, Legal Setbacks, And Downward Momentum"", ""summary"": ""Illumina\u00e2\u0080\u0099s financials are deteriorating; its customers are tightening up purchases due to persistent macro headwinds. Find out why I'm bearish on ILMN stock.""}, {""date"": ""2023-07-19"", ""headline"": ""Illumina Inc. - The Alliance for Genomic Discovery announces founding biopharma members, AbbVie, Amgen, AstraZeneca, Bayer, and Merck"", ""summary"": ""SAN DIEGO - Illumina Inc. , a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC, a leading clinical and genomic data company and wholly...""}, {""date"": ""2023-07-19"", ""headline"": ""Illumina Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Polen Focus Growth Q2 2023 Portfolio Manager Commentary"", ""summary"": ""The Focus Growth Composite Portfolio returned 10.51% gross fees and 10.36% net fees in the second quarter of 2023. Click here to read the full fund letter.""}, {""date"": ""2023-07-20"", ""headline"": ""Lightning Round: It's time to buy KeyCorp, says Jim Cramer"", ""summary"": ""'Mad Money' host Jim Cramer weighs in on stocks including: Illumina, Compass Pathways, KeyCorp, Eaton, Verve Theraputics, Informatica and ASML.""}, {""date"": ""2023-07-20"", ""headline"": ""Cramer's Lightning Round: KeyCorp is a buy"", ""summary"": ""\""Mad Money\"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.""}, {""date"": ""2023-07-20"", ""headline"": ""Illumina Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-21"", ""headline"": ""FTC and DOJ reveal new merger guidelines"", ""summary"": ""The Federal Trade Commission and the Department of Justice have released new draft guidelines for how they will evaluate mergers. There is a public will have until September 18 to comment on the proposals. Jonathan Kanter, Assistant Attorney General for the Justice Department's Antitrust Division, tells Yahoo Finance Live that the \""guidelines help provide transparency\"" about how the law is applied. Addressing criticism that the guidelines may impact some industries more than others, Kanter says the guidelines \""are business-model agnostic, they don't focus on any specific companies or any specific businesses. It simply says we want to protect and preserve competition.\""""}, {""date"": ""2023-07-21"", ""headline"": ""Is Illumina Inc (ILMN) a Value Trap? An In-depth Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-21"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-22"", ""headline"": ""20 Countries With Highest Rate Of Down Syndrome"", ""summary"": ""In this detailed article, we\u2019ll talk about 20 countries with the highest rate of down syndrome. You can skip our analysis on progress in corporate healthcare sector on this front and go to 8 Countries With Highest Rate Of Down Syndrome. Each year, around 6,000 babies are born with Down syndrome across the globe, which [\u2026]""}, {""date"": ""2023-07-22"", ""headline"": ""Is It Too Late To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?"", ""summary"": ""Today we're going to take a look at the well-established Illumina, Inc. ( NASDAQ:ILMN ). The company's stock received a...""}, {""date"": ""2023-07-22"", ""headline"": ""Ensemble Capital Second Quarter 2023 Investor Letter"", ""summary"": ""On a year-to-date basis, Ensemble Fund is now up 11.61% vs the S&P 500 up 16.89%. Click here to read the full fund letter.""}, {""date"": ""2023-07-22"", ""headline"": ""Assessing the GF Value of Illumina Inc (ILMN): A Potential Value Trap?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-23"", ""headline"": ""Is Illumina Inc (ILMN) a Value Trap? An In-depth Look at the GF Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3789, ""bookValue"": 6555, ""cashRatio"": 0.6743378202344767, ""currentRatio"": 1.3995, ""ebitPerShare"": -0.557, ""eps"": -1.481, ""ev"": 30426.771, ""fcfMargin"": 0.0493, ""fcfPerShareTTM"": -1.4177, ""grossMargin"": 0.6224, ""inventoryTurnoverTTM"": 2.9692, ""longtermDebtTotalAsset"": 0.1264, ""longtermDebtTotalCapital"": 0.1692, ""longtermDebtTotalEquity"": 0.227, ""netDebtToTotalCapital"": 0.0779, ""netDebtToTotalEquity"": 0.1045, ""netMargin"": -0.199, ""operatingMargin"": -0.0748, ""pb"": 4.5373, ""pfcfTTM"": 254.2032, ""pretaxMargin"": -0.0757, ""psTTM"": 6.6671, ""ptbv"": 8.8333, ""quickRatio"": 1.0061, ""receivablesTurnoverTTM"": 6.292, ""roaTTM"": -0.3556, ""roeTTM"": -0.63, ""roicTTM"": -0.4713, ""rotcTTM"": -0.4431, ""salesPerShare"": 7.443, ""sgaToSale"": 0.3776, ""tangibleBookValue"": 3367, ""totalDebtToEquity"": 0.3414, ""totalDebtToTotalAsset"": 0.1901, ""totalDebtToTotalCapital"": 0.2545, ""totalRatio"": 2.256, ""period"": ""2023-07-02""}"
28,2023-07-23,190.49000549316406,2023-07-30,192.44000244140625,0.010236741519292769,U2,"[{""date"": ""2023-07-23"", ""headline"": ""Is Illumina Inc (ILMN) a Value Trap? An In-depth Look at the GF Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slipped 1.27% to $188.07 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-07-24"", ""headline"": ""Illumina (ILMN) Soars 3.4%: Is Further Upside Left in the Stock?"", ""summary"": ""Illumina (ILMN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.""}, {""date"": ""2023-07-25"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Illumina Inc. inched 0.68% higher to $189.35 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-07-25"", ""headline"": ""Illumina and Pillar Biosciences partner to improve access to personalized cancer treatment options"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences Inc., the pioneers of Decision Medicine\u2122, today announced a strategic partnership to make Pillar's suite of oncology assays commercially available globally as part of the Illumina portfolio of oncology products. The agreement will result in an unprecedented offering of complementary next-generation sequencing solutions that will enhance the efficiency, accuracy, and cost-effective""}, {""date"": ""2023-07-25"", ""headline"": ""Illumina, Pillar Biosciences announce partnership"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-26"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. inched 0.97% higher to $191.19 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-07-26"", ""headline"": ""New Research Shows CGP Is Most Effective as a Standalone Test"", ""summary"": ""Comprehensive genomic profiling (CGP) assesses hundreds of tumor genes to find actionable mutations and is becoming the standard of care for many cancers.""}, {""date"": ""2023-07-26"", ""headline"": ""Yourgene Health inks five-year, Illumina contract extension"", ""summary"": ""Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Signs five-year contract extension with Illumina Inc. The contract is a restated licence and supply agreement for...""}, {""date"": ""2023-07-26"", ""headline"": ""IN BRIEF: Yourgene Health inks five-year, Illumina contract extension"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Inside Illumina\u2019s $8 billion deal that spurred a proxy fight with Carl Icahn and the ouster of 2 prominent Black Silicon Valley executives"", ""summary"": ""Illumina\u2019s contentious acquisition of cancer test maker Grail brought billionaire Carl Icahn to the company\u2019s doorstep.""}, {""date"": ""2023-07-27"", ""headline"": ""Illumina Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Illumina Inc. slid 0.78% to $189.70 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-07-27"", ""headline"": ""Budi Hermawan\u2019s Long Fight Against Tuberculosis"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / July 27, 2023 / Illumina: Originally published on Illumina News Center Nothing about Budi Hermawan's experience with tuberculosis (TB) has been easy. In 2003, he had a cough. He didn't think much of it, but as his ...""}, {""date"": ""2023-07-27"", ""headline"": ""September 8th Options Now Available For Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. rose 1.44% to $192.44 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-07-28"", ""headline"": ""Here\u2019s Why Illumina (ILMN) Declined -19.4% in Q2"", ""summary"": ""Ensemble Capital Management, an investment management company, released its second quarter 2023 investor letter. A copy of the same can be downloaded here. During the quarter, the strategy slightly outperformed with a gain of 8.76% compared to the S&P 500\u2019s 8.74% gain. The strategy\u2019s performance in the quarter was driven by big gains generated by small [\u2026]""}, {""date"": ""2023-07-29"", ""headline"": ""Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil"", ""summary"": ""As biotech stock prices have fallen, Wall Street and biotech boards have grown increasingly unfriendly. Amid the turmoil, key biotech stocks have become the targets of activist investors demanding new executives, new boards and new strategies. The specifics of each case vary, but the biotech stocks in sharpest focus have been those whose earnings and revenue have disappointed investors. Of course, it\u2019s no accident this happens. Investors want to protect their investments. And if the company isn\u2019""}, {""date"": ""2023-07-29"", ""headline"": ""Week In Review: Pyrotech Closes $97 Million Series A Round For Immunomodulator Drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""This Illumina Insider Reduced Their Stake By 12%"", ""summary"": ""Insiders were net sellers of Illumina, Inc.'s ( NASDAQ:ILMN ) stock during the past year. That is, insiders sold more...""}, {""date"": ""2023-07-30"", ""headline"": ""Baron Opportunity Fund Q2 2023 Shareholder Letter"", ""summary"": ""During Q2 2023, Baron Opportunity Fund\u00c2\u00ae climbed 16.31% (Institutional Shares), outperforming the broader market. Click here to read the full fund letter.""}]",{}
29,2023-07-30,192.44000244140625,2023-08-06,187.6699981689453,-0.024786968467812698,D3,"[{""date"": ""2023-07-30"", ""headline"": ""This Illumina Insider Reduced Their Stake By 12%"", ""summary"": ""Insiders were net sellers of Illumina, Inc.'s ( NASDAQ:ILMN ) stock during the past year. That is, insiders sold more...""}, {""date"": ""2023-07-30"", ""headline"": ""Baron Opportunity Fund Q2 2023 Shareholder Letter"", ""summary"": ""During Q2 2023, Baron Opportunity Fund\u00c2\u00ae climbed 16.31% (Institutional Shares), outperforming the broader market. Click here to read the full fund letter.""}, {""date"": ""2023-07-31"", ""headline"": ""Guardant Health resolves pending litigation with Illumina"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""Tracking Baillie Gifford's 13F Portfolio - Q2 2023 Update"", ""summary"": ""Baillie Gifford's 13F portfolio value increased from ~$111B to ~$118B this quarter. Top three holdings make up ~17% of the portfolio. Click here to read more.""}, {""date"": ""2023-07-31"", ""headline"": ""Illumina and Pillar Biosciences Partner To Improve Access to Personalized Cancer Treatment Options"", ""summary"": ""SAN DIEGO -- Illumina Inc. , a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences Inc., the pioneers of Decision Medicine, announced a strategic partnership to make...""}, {""date"": ""2023-07-31"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""Hologic CEO Steve MacMillan says he's not leaving after taking on Illumina chair role"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""Guardant resolves lllumina litigation, will share cancer research specimens"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Illumina Inc. stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""Icahn Enterprises\u2019 bonds see buying after bond-friendly halving of distribution"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""Carl Icahn\u2019s company stock drops 30% after IEP slashes quarterly dividend in half"", ""summary"": ""Carl Icahn's conglomerate Icahn Enterprises slashed quarterly dividend in half amid notable short seller Hindenburg Research's campaign.""}, {""date"": ""2023-08-04"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-05"", ""headline"": ""2023 shaping up to be biggest year for biopharma M&A since pandemic"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-06"", ""headline"": ""Earnings week ahead: Disney, Palantir, Plug Power, Roblox, Rivian and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
30,2023-08-06,187.6699981689453,2023-08-13,180.47999572753906,-0.038311943899171474,D4,"[{""date"": ""2023-08-05"", ""headline"": ""2023 shaping up to be biggest year for biopharma M&A since pandemic"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-06"", ""headline"": ""Earnings week ahead: Disney, Palantir, Plug Power, Roblox, Rivian and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-07"", ""headline"": ""BNGO Stock Alert: Bionano Just Reverse Split Its Stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-07"", ""headline"": ""Illumina Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""Illumina cuts full year top and bottom line guidance, shares fall nearly 6% after hours"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""Illumina names Dr. Steven Barnard as Chief Technology Officer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""Illumina sees customers 'more cautious in their purchasing' in 2H23"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""Illumina Non-GAAP EPS of $0.32 beats by $0.30, revenue of $1.18B beats by $20M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""Illumina cuts FY23 adjusted EPS view to 75c-90c from  $1.25-$1.50"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""Illumina reports Q2 adjusted EPS 32c, consensus 2c"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""GLOBAL BRIEFING: China slips into deflation as domestic spending slows"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""The Final Peak Week For Q2 Starts As Earnings Hit Their Stride"", ""summary"": ""S&P 500 EPS growth for Q2 2023 is set to come in at -5.2%, the lowest rate in nearly 3 years and the third consecutive quarter of negative earnings growth.""}, {""date"": ""2023-08-08"", ""headline"": ""Acquisition of Grail Pressured Illumina (ILMN)\u2019s Stock Price"", ""summary"": ""Polen Capital, an investment management company, released its \u201cPolen Focus Growth Strategy\u201d second-quarter 2023 investor letter. A copy of the same can be downloaded here. The fund returned 10.51% gross of fees and 10.36% net of fees in the second quarter compared to a 12.81% return for the Russell 1000 Growth Index and an 8.74% return [\u2026]""}, {""date"": ""2023-08-08"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""What You Missed On Wall Street On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Disney, Alibaba And 3 Stocks To Watch Heading Into Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Iovance Biotherapeutics (IOVA), Insulet (PODD) and Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina, Inc. 2023 Q2 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Illumina, Inc.""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina, Inc. (ILMN) Q2 2023 Earnings Call Transcript"", ""summary"": ""Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Q2 2023 Results Earnings Conference Call August 9, 2023 5:00 PM ETCompany ParticipantsSalli Schwartz - Vice President of Investor RelationsCharles...""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina (ILMN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates"", ""summary"": ""While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina (ILMN) Tops Q2 Earnings and Revenue Estimates"", ""summary"": ""Illumina (ILMN) delivered earnings and revenue surprises of 1,500% and 1.11%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""2023-08-09"", ""headline"": ""UPDATE 1-Illumina cuts annual profit forecast as biotech funding woes linger"", ""summary"": ""Illumina Inc cut annual profit forecast, in a sign that a funding crunch among its biotech and pharmaceutical clients is expected to weigh on sales for its genetic testing tools and diagnostics products.  The funding crunch has been exacerbated by the collapse of U.S. lender Silicon Valley Bank, a key investment banker in the biotech sector.  Higher-than-estimated demand for the production-scale sequencer, NovaSeq X, however, helped the U.S. genetic testing company surpass Wall Street estimates for second-quarter profit.""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina Stock Crumbles As Earnings Outlook Completely Misses Forecasts"", ""summary"": ""Illumina's earnings outlook completely missed Wall Street's expectations late Wednesday, causing ILMN stock to dive in late action.""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina Slides After Slashing Full-Year Forecast"", ""summary"": ""(Bloomberg) -- Shares of Illumina Inc. dropped as much as 7% in late trading after the company cut its sales and profit outlook and said a pair of top executives are departing.Most Read from BloombergFirst American City to Tame Inflation Owes Its Success to Affordable HousingEveryone Wants to Work at UPS After Teamsters DealRetirees Face $17,400 Cut to Social Security Benefits in 2033Stock Traders Shun Risk in Run-Up to Key CPI Test: Markets WrapTycoon Who Gave Away $750 Million Sees Profit in L""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina cuts annual profit forecast as biotech funding woes linger"", ""summary"": ""The funding crunch has been exacerbated by the collapse of U.S. lender Silicon Valley Bank, a key investment banker in the biotech sector.  \""We expect our second-half revenue to be negatively impacted by customers remaining more cautious in their purchasing, a more protracted recovery in China, and a larger-than-expected temporary decline in high throughput consumables as customers transition to NovaSeq X,\"" said Interim CEO Charles Dadswell.  Higher-than-estimated demand for the production-scale sequencer, NovaSeq X, however, helped the U.S. genetic testing company surpass Wall Street estimates for second-quarter profit.""}, {""date"": ""2023-08-09"", ""headline"": ""Dr. Steven Barnard Appointed Chief Technology Officer"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Dr. Steven Barnard, Illumina's Vice President and Head of Global Advanced Science, will serve as its next Chief Technology Officer (CTO), effective immediately. Dr. Alex Aravanis, who held the position of CTO, will be departing Illumina to pursue another opportunity outside of the company.""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina stock falls, as \u2018cautious consumer backdrop\u2019 tempers outlook"", ""summary"": ""Shares of Illumina Inc. slid 6.6% after hours on Wednesday after the DNA-sequencing company tempered its full-year sales outlook, amid a cautious consumer...""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina Medical Chief Phil Febbo, Chief Technology Officer Aravanis Exit"", ""summary"": ""By Ben Glickman Illumina said Wednesday that Chief Medical Officer Phil Febbo had departed the company. The San Diego-based gene-sequencing company didn't...""}, {""date"": ""2023-08-09"", ""headline"": ""Stocks making the biggest moves after hours: Disney, Wynn Resorts, AppLovin and more"", ""summary"": ""See which stocks are posting big moves after the bell.""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina 2Q Loss Narrows on Higher Sales of NovaSeq X Instruments"", ""summary"": ""By Ben Glickman Illumina's loss narrowed in the second quarter as the gene-sequencing company posted higher-than-expected sales of its new NovaSeq X product....""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina Reduces Guidance On Cautious Consumers"", ""summary"": ""By Ben Glickman Illumina lowered its full-year revenue guidance, anticipating more cautious consumers. The San Diego-based gene-sequencing company now...""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina narrows quarter losses but expects tricky second half"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina : Q2 Earnings Snapshot"", ""summary"": ""SAN DIEGO  \u2014 SAN DIEGO  \u2014 Illumina Inc.  on Wednesday reported a loss of $234 million in its second quarter.\n  The San Diego-based company said it had a loss of $1.48 per share. Earnings,...""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina: Q2 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina cuts annual profit forecast"", ""summary"": ""Illumina Inc lowered annual\nprofit forecast on Wednesday, signaling weak demand for its\nsequencing and diagnostic services, sending the life sciences\nfirm's shares down 7.5% after the bell.\n          ...""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina Reports Financial Results for Second Quarter of Fiscal Year 2023"", ""summary"": ""$\nAmortization of acquired intangible assets\n1.23\nLegal contingency and settlement \n0.09\nAcquisition-related expenses \n0.30\nStrategic investment related loss, net \n0.10\nGain on Helix contingent value...""}, {""date"": ""2023-08-09"", ""headline"": ""How Genetic Technologies Can Empower More People With Information"", ""summary"": ""After earning a graduate degree in genetic counseling, Zo\u00eb Milgrom's first job immediately exposed her to the difficult reality of putting her education into practice.""}, {""date"": ""2023-08-09"", ""headline"": ""Stocks Retreat, Nasdaq Hits 4-Week Low, Energy Sector Rallies: What's Driving Markets Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Notable companies reporting after market close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""US Stocks Walk Inflation Tightrope As Futures Point To Cautious Recovery: Why This Analyst Downplays Fed Rate Worries"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Fly Intel: After-Hours Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Illumina Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Is Illumina Inc (ILMN) a Potential Value Trap? A Comprehensive Valuation Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""JP Morgan Maintains Illumina (ILMN) Neutral Recommendation"", ""summary"": """"}, {""date"": ""2023-08-10"", ""headline"": ""Stifel Maintains Illumina (ILMN) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-08-10"", ""headline"": ""Citigroup Maintains Illumina (ILMN) Sell Recommendation"", ""summary"": """"}, {""date"": ""2023-08-10"", ""headline"": ""Evercore ISI Group Maintains Illumina (ILMN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""2023-08-10"", ""headline"": ""Credit Suisse Maintains Illumina (ILMN) Neutral Recommendation"", ""summary"": """"}, {""date"": ""2023-08-10"", ""headline"": ""Is Illumina (ILMN) a Potential Value Trap? Think Twice Before Investing"", ""summary"": ""An in-depth analysis of Illumina Inc's intrinsic value, financial strength, profitability, and growth""}, {""date"": ""2023-08-10"", ""headline"": ""Q2 2023 Singular Genomics Systems Inc Earnings Call"", ""summary"": ""Q2 2023 Singular Genomics Systems Inc Earnings Call""}, {""date"": ""2023-08-10"", ""headline"": ""NEW YORK MARKET CLOSE: S&P gains evaporate despite inflation surprise"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Illumina (ILMN) Q2 Earnings Beat Estimates, Margins Contract"", ""summary"": ""Illumina (ILMN) shipped 109 NovaSeq X instruments in the second quarter, boosting its supply capacity to more than 390 instruments for fiscal 2023.""}, {""date"": ""2023-08-10"", ""headline"": ""Illumina Recovers After Torching Its 2023 Outlook; Announces A 'Huge Accomplishment'"", ""summary"": ""Illumina stock recovered Thursday after the company torched its guidance on continuing headwinds. ILMN stock retook its 50-day line.""}, {""date"": ""2023-08-10"", ""headline"": ""Illumina Slashes Guidance Amid \u2018Cautious\u2019 Consumer. What Wall Street Thinks."", ""summary"": ""Illumina  stock was rising Thursday, following an initial drop in the premarket session, after the\u00a0gene-sequencing company cut its full-year outlook as it faces a hesitant consumer and growing competition.  Illumina  (ticker: ILMN) said after the close of trading Wednesday that it now expects to report full-year earnings between 75 cents a share to 90 cents a share and revenue growth of about 1%.  \u201cMany of our customers are remaining more cautious in their purchasing behaviors,\u201d Interim Chief Executive Charles Dadswell said on the earnings conference call.""}, {""date"": ""2023-08-10"", ""headline"": ""Novo Nordisk reports earnings miss, sees profit and sales growth"", ""summary"": ""Novo Nordisk (NVO) earnings came in lower than expected while reporting profits rose by 43 percent and sales are up by as much as 30 percent. Novo Nordisk is lifting its full-year outlook in accordance with the overwhelming success of its weight-loss and diabetes drugs while reducing their supply of lower doses. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down Novo Nordisk's earnings, also turning her attention to biotech company Illumina's (ILMN) slashed annual profits and the latest COVID-19 variant, \""Eris\"", which the World Health Organization is calling a \""variant of interest.\""""}, {""date"": ""2023-08-10"", ""headline"": ""Illumina To Bear The Brunt Of Slowdown In Consumables Purchasing Amid Lower Demand In China: Analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Stocks Trim Gains Following Inflation Data, NVIDIA Faces Worst Week Of 2023: What's Driving Markets Thursday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Stocks Trim Gains On Inflation Data, NVIDIA Faces Worst Week Of 2023: What's Driving Markets Thursday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Illumina Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""AppLovin, Wynn Resorts rise; Tapestry, Plug Power fall, Thursday, 8/10/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Illumina Takes Over #260 Spot From Aptiv"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Piper Sandler Sticks to Their Buy Rating for Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Stocks making the biggest moves premarket: Capri, Tapestry, AppLovin, Disney and more"", ""summary"": ""These are the stocks posting the largest moves in early trading. ""}, {""date"": ""2023-08-10"", ""headline"": ""Illumina price target raised to $240 from $235 at Evercore ISI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Illumina price target lowered to $225 from $265 at Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Illumina price target lowered to $210 from $230 at BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Bank of America Securities Reaffirms Their Hold Rating on Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Nasdaq, S&P 500 Futures Rally Ahead Of Inflation Data; Why This Analyst Sounds Out Caution About Stock Valuations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Deciphera Pharmaceuticals (DCPH), Illumina (ILMN) and Ionis Pharmaceuticals (IONS)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Illumina price target lowered to $150 from $180 at Citi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Illumina price target lowered to $200 from $225 at Credit Suisse"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Illumina price target lowered to $180 from $229 at Baird"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-11"", ""headline"": ""Illumina To Webcast Upcoming Investor Conference"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN) today announced that its vice president of investor relations will be speaking at the following investor conference:""}, {""date"": ""2023-08-11"", ""headline"": ""Illumina, Inc. (NASDAQ:ILMN) Q2 2023 Earnings Call Transcript"", ""summary"": ""Illumina, Inc. (NASDAQ:ILMN) Q2 2023 Earnings Call Transcript August 10, 2023 Operator: Good day, ladies and gentlemen, and welcome to the Second Quarter 2023 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers\u2019 presentation, there will be a question-and-answer session. Please be advised that today\u2019s conference is [\u2026]""}, {""date"": ""2023-08-11"", ""headline"": ""UPDATE 1-US securities regulator probes Illumina over Grail deal"", ""summary"": ""The U.S. Securities and Exchange Commission (SEC) has begun an investigation into Illumina's $7.1 billion acquisition of cancer detection test maker Grail, the gene sequencing company said in a regulatory filing.  Shares of the California-based company fell 3.6% in afternoon trading on Friday.  Illumina said it is cooperating with the SEC.""}, {""date"": ""2023-08-11"", ""headline"": ""US securities regulator probes Illumina over Grail deal"", ""summary"": ""The regulator has requested documents and communications related to the acquisition along with certain statements and disclosures about the \""conduct and compensation\"" of certain members of the companies' management, according to Illumina.  Illumina said it is cooperating with the SEC.  An SEC spokesperson said the agency \""does not comment on the existence or nonexistence of a possible investigation\"".""}, {""date"": ""2023-08-11"", ""headline"": ""Company News for Aug 11, 2023"", ""summary"": ""Companies in The News Are: DDS,MFC,ILMN,G""}, {""date"": ""2023-08-11"", ""headline"": ""Icahn Enterprises LP: An Update On Its Ballooning Unit Count"", ""summary"": ""IEP continues to trade at a multiple of its underlying NAV, and even its newly announced lower distribution surely looks unsustainable. Click here to read more.""}, {""date"": ""2023-08-11"", ""headline"": ""Illumina Shares Fall After Disclosing SEC Investigation Into Grail Deal"", ""summary"": ""By Will Feuer Shares of Illumina slid more than 4% after the gene-sequencing company disclosed that the Securities and Exchange Commission is investigating the company's $7 billion takeover...""}, {""date"": ""2023-08-11"", ""headline"": ""SEC investigating Illumina over acquisition of cancer test developer Grail"", ""summary"": ""Illumina's acquisition of cancer test developer Grail has also faced heavy scrutiny from antitrust regulators in the U.S. and European Union. ""}, {""date"": ""2023-08-11"", ""headline"": ""Illumina under SEC investigation over GRAIL acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-11"", ""headline"": ""Illumina Inc. stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-12"", ""headline"": ""RBC Capital Sticks to Their Buy Rating for Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
31,2023-08-13,180.47999572753906,2023-08-20,167.22000122070312,-0.07347071598369181,D5+,"[{""date"": ""2023-08-13"", ""headline"": ""Illumina price target lowered to $235 from $270 at HSBC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""Is Illumina Inc. (ILMN) a Hidden Value Trap? An In-Depth Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""HSBC Maintains Illumina (ILMN) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-08-14"", ""headline"": ""Illumina to Webcast Upcoming Investor Conference"", ""summary"": ""SAN DIEGO - Illumina, Inc. today announced that its vice president of investor relations will be speaking at the following investor conference: UBS MedTech, Tools and Genomics Summit 2023 on August...""}, {""date"": ""2023-08-14"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Illumina (ILMN) and Tonix Pharma (TNXP)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""The Latest Analyst Ratings for Illumina"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""Wall Street Breakfast: AI Generation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""Illumina Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""Piper Sandler Maintains Illumina (ILMN) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-08-15"", ""headline"": ""Why Shares of SomaLogic Are Up Tuesday"", ""summary"": ""What happened Shares of SomaLogic (NASDAQ: SLGC) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock is down more than 9% this year.""}, {""date"": ""2023-08-15"", ""headline"": ""Illumina price target lowered to $275 from $290 at Piper Sandler"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""Elliott Wave Technical Analysis: Illumina Inc."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Canaccord Genuity Maintains Illumina (ILMN) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-08-16"", ""headline"": ""S&P 500 2023 Q2 Earnings Review: Revenues Miss Analyst Expectations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Baron Fifth Avenue Growth Fund Q2 2023 Quarterly Letter"", ""summary"": ""Baron Fifth Avenue Growth Fund gained 16.0% during Q2, which compares to gains of 12.8% for the Russell 1000 Growth Index (R1KG) and 8.7% for S&P 500 Index (SPX).""}, {""date"": ""2023-08-16"", ""headline"": ""Baron Global Advantage Fund Q2 2023 Shareholder Letter"", ""summary"": ""Baron Global Advantage Fund gained 6.4% (Institutional Shares) in the second quarter of 2023. Click here to read the full fund letter.""}, {""date"": ""2023-08-16"", ""headline"": ""Is Illumina Inc (ILMN) a Hidden Value Trap? A Comprehensive Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Illumina price target lowered to $285 from $300 at Canaccord"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Illumina Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Illumina, Inc. (ILMN) Management Presents at UBS MedTech, Tools and Genomics Summit 2023 Conference (Transcript)"", ""summary"": ""Illumina, Inc. (NASDAQ:NASDAQ:ILMN) UBS MedTech, Tools and Genomics Summit 2023 Conference Transcript August 17, 2023 12:00 PM ETExecutivesSalli Schwartz - Vice President, Investor...""}, {""date"": ""2023-08-17"", ""headline"": ""Illumina expands genomics capabilities in India with opening of Solutions Center"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the opening of a new office and state-of-the-art Illumina Solutions Center in Bengaluru, India.""}, {""date"": ""2023-08-17"", ""headline"": ""Down 15% in 2023, Should You Buy the Dip With Illumina Stock?"", ""summary"": ""Illumina's (NASDAQ: ILMN) stock is down by 15% this year so far, and it's no surprise why.  With the new disclosure of a Securities and Exchange Commission (SEC) investigation into its bedraggled acquisition of Grail, a genetic-testing company it originally founded, and\u00a0a $476 million fine from regulators in the E.U. just one month ago on account of the purchase in advance of regulatory permission, things look fraught.  The bull thesis for Illumina stock\u00a0has nothing at all to do with its most visible struggles resulting from the Grail acquisition.""}, {""date"": ""2023-08-17"", ""headline"": ""Illumina opens Solutions Center in India"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-18"", ""headline"": ""EXEL or ILMN: Which Is the Better Value Stock Right Now?"", ""summary"": ""EXEL vs. ILMN: Which Stock Is the Better Value Option?""}, {""date"": ""2023-08-18"", ""headline"": ""Here\u2019s Why Illumina (ILMN) Declined in Q2"", ""summary"": ""Baron Funds, an investment management company, released its \u201cBaron Fifth Avenue Growth Fund\u201d second quarter 2023 investor letter. A copy of the same can be downloaded here. The second quarter saw a continuation of the trends seen earlier in the year. The fund was up 16% (Institutional Shares) in the second quarter compared to a 12.8% [\u2026]""}, {""date"": ""2023-08-18"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
32,2023-08-20,167.22000122070312,2023-08-27,158.0800018310547,-0.054658529619223795,D5+,"[{""date"": ""2023-08-21"", ""headline"": ""Illumina Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.11% higher to $167.41 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""2023-08-21"", ""headline"": ""Wall Street Thinks Illumina Stock Will Rise 27% in 1 Year. Here's Why That Probably Won't Happen."", ""summary"": ""Wall Street analysts are upbeat on California-based biotech Illumina (NASDAQ: ILMN) these days, estimating on average that the stock could climb by up to 27% over the next year.  The most important reason why Illumina's shares are unlikely to rise that much in the near term is that nobody is anticipating an uptick in sales of the gene sequencers that Illumina makes -- or the consumable reagents that those sequencers need in perpetuity if they're to be usable by customers.  To make matters worse, its sales of consumables, which totaled $739 million in the second quarter, actually dropped by 1% year over year.""}, {""date"": ""2023-08-21"", ""headline"": ""Illumina (ILMN) Expands Presence in India With New Facility"", ""summary"": ""Illumina (ILMN) boosts genomic capabilities in India with a new state-of-the-art Solutions Center.""}, {""date"": ""2023-08-22"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. shed 2.67% to $162.94 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-08-22"", ""headline"": ""Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-23"", ""headline"": ""Illumina Inc. stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.61% higher to $163.94 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-08-24"", ""headline"": ""Illumina Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. shed 2.65% to $159.60 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-08-24"", ""headline"": ""Whitman-Walker Institute, Cancer Support Community and GRAIL Collaborate On Research Aimed at Advancing Health Equity in Cancer Screening and Care through Multi-Cancer Early Detection"", ""summary"": ""WASHINGTON - Whitman-Walker Institute, a leader in LGBTQ health, research, education and policy with special expertise in HIV care; Cancer Support Community , a global nonprofit that works to ease...""}, {""date"": ""2023-08-25"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 0.95% to $158.08 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-08-27"", ""headline"": ""18 Best 52-Week Low Stocks To Buy Now"", ""summary"": ""In this article, we will take a look at the 18 best 52-week low stocks to buy now. To see more such companies, go directly to 5 Best 52-Week Low Stocks To Buy Now. US stock markets are jittery after Fed Chair Jerome Powell made it clear that inflation is still high and needs further [\u2026]""}]",{}
33,2023-08-27,158.0800018310547,2023-09-03,168.4600067138672,0.0656629855932438,U5+,"[{""date"": ""2023-08-27"", ""headline"": ""18 Best 52-Week Low Stocks To Buy Now"", ""summary"": ""In this article, we will take a look at the 18 best 52-week low stocks to buy now. To see more such companies, go directly to 5 Best 52-Week Low Stocks To Buy Now. US stock markets are jittery after Fed Chair Jerome Powell made it clear that inflation is still high and needs further [\u2026]""}, {""date"": ""2023-08-28"", ""headline"": ""Illumina To Webcast Upcoming Investor Conference"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:""}, {""date"": ""2023-08-28"", ""headline"": ""Illumina Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.08% higher to $158.20 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-08-29"", ""headline"": ""Illumina Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Illumina Inc. rallied 2.36% to $161.93 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-08-29"", ""headline"": ""RBC Capital Remains a Buy on Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Unusual Put Option Trade in Illumina (ILMN)  Worth $4,743.00K"", ""summary"": """"}, {""date"": ""2023-08-31"", ""headline"": ""Illumina Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Illumina Inc. shed 0.51% to $165.22 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-08-31"", ""headline"": ""Interesting ILMN Put And Call Options For October 13th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-01"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. rose 1.96% to $168.46 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-01"", ""headline"": ""Is Illumina (ILMN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap"", ""summary"": ""Navigating the Thin Line Between Value and Trap in Illumina (ILMN) Stock""}, {""date"": ""2023-09-01"", ""headline"": ""Early notable gainers among liquid option names on September 1st"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-01"", ""headline"": ""At Illumina, new leadership could fuel turnaround, analysts say"", ""summary"": ""Illumina Inc. shares may be poised for a turnaround as the company hunts for a new CEO, Evercore ISI analysts wrote in a research note Friday. The analysts...""}, {""date"": ""2023-09-01"", ""headline"": ""Illumina added to Evercore\u2019s Tactical Outperform list on a potential CEO hire"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-01"", ""headline"": ""Illumina added to 'Tactical Outperform' list at Evercore ISI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-02"", ""headline"": ""Evercore ISI Group Reiterates Illumina (ILMN) Outperform Recommendation"", ""summary"": """"}]",{}
34,2023-09-03,168.4600067138672,2023-09-10,158.36000061035156,-0.05995491927452368,D5+,"[{""date"": ""2023-09-04"", ""headline"": ""Illumina: Genetic Plot Twist, Time To Unravel The Stock"", ""summary"": ""Illumina faces legal challenges over GRAIL acquisition and reduced guidance, causing short-term volatility. ILMN stock is rated a sell due to uncertainties, see more.""}, {""date"": ""2023-09-04"", ""headline"": ""AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""PRESS DIGEST- Financial Times - Sept. 6"", ""summary"": ""The European Commission has appointed Belgium's Didier Reynders as the EU's competition chief, while incumbent commissioner Margrethe Vestager takes a leave of absence to run for the top job at the European Investment Bank.  - Illumina has appointed Jacob Thaysen as its new chief executive, as the biotech group seeks to rebuild its leadership team following a bruising battle with activist investor Carl Icahn.""}, {""date"": ""2023-09-05"", ""headline"": ""Illumina Picks New CEO, but Shares Continue To Slide"", ""summary"": ""Illumina on Tuesday named Agilent Technologies' Jacob Thaysen its CEO after a proxy battle with activist investor Carl Icahn led former head Francis deSouza to resign.""}, {""date"": ""2023-09-05"", ""headline"": ""Stocks to Watch Tuesday: Blackstone, Airbnb, Trip.com, Novo Nordisk"", ""summary"": ""[**\u2197\ufe0f**](https://www.wsj.com/market-data/quotes/BX) [**Blackstone (BX)**](https://www.wsj.com/market-data/quotes/BX)**,** [**Airbnb (ABNB)**](https://www.wsj.com/market-data/quotes/ABNB): Shares in both companies rose premarket after S&P Dow Jones Indices said late Friday that they would join the S&P 500 on Sept.""}, {""date"": ""2023-09-05"", ""headline"": ""Markets Fall at Midday Amid Oil and Interest Rate Concerns"", ""summary"": ""U.S. equities declined at midday on Tuesday, Sept. 5, 2023 amid worries about higher oil prices and interest rates.""}, {""date"": ""2023-09-05"", ""headline"": ""EXEL vs. ILMN: Which Stock Is the Better Value Option?"", ""summary"": ""EXEL vs. ILMN: Which Stock Is the Better Value Option?""}, {""date"": ""2023-09-05"", ""headline"": ""Illumina appoints Agilent's Jacob Thaysen as chief executive officer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Is Illumina (ILMN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap"", ""summary"": ""Navigating the Thin Line Between Value and Trap with Illumina (ILMN)""}, {""date"": ""2023-09-05"", ""headline"": ""Illumina Names Jacob Thaysen as New CEO"", ""summary"": ""Jacob Thaysen was named to the role after Francis deSouza resigned from the gene-sequencing maker in June amid a fight with regulators.""}, {""date"": ""2023-09-05"", ""headline"": ""Lowe's and Oracle upgrades, Illumina CEO: Market Movers"", ""summary"": ""Stocks trend lower this morning entering the first trading of September, a historically weak month for markets. Lowe's (LOW) stock received an upgrade to Outperform from Bernstein analysts. Oracle (ORCL) shares are rising after Barclays upgraded the stock on the software company's cloud outlook amid AI trends. Illumina (ILMN) names Former Agilent (A) Vice President Jacob Thaysen as its new CEO. Yahoo Finance Live details several trending stocks after Tuesday's opening bell.""}, {""date"": ""2023-09-05"", ""headline"": ""Illumina appoints new CEO after battle with investors"", ""summary"": ""Biotech has been criticised for closing its $8bn acquisition of cancer test company Grail without regulatory approval""}, {""date"": ""2023-09-05"", ""headline"": ""US Stocks Ease As Oil Price Spikes To 10-Month High, Dollar Gains: What's Driving Markets Tuesday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""UPDATE 2-Illumina names Agilent exec Jacob Thaysen as CEO"", ""summary"": ""Illumina Inc's board on Tuesday named Agilent Technologies' executive Jacob Thaysen as the U.S. genetic testing company's CEO, months after its former head stepped down following a proxy fight with billionaire Carl Icahn.  Illumina had repurchased cancer diagnostic test maker Grail in 2021 despite opposition from the U.S. and European antitrust regulators \u2014 a decision that prompted Icahn to pursue a proxy fight, arguing the unit should be divested as it had cost investors billions of dollars.  Illumina's former head Francis deSouza stepped down in June, marking another victory for the activist investor, even though deSouza had secured more than twice the number of shareholder votes than his challenger.""}, {""date"": ""2023-09-05"", ""headline"": ""Illumina names Agilent exec Jacob Thaysen as CEO"", ""summary"": ""Illumina had repurchased cancer diagnostic test maker Grail in 2021 despite opposition from the U.S. and European antitrust regulators \u2014 a decision that prompted Icahn to pursue a proxy fight, arguing the unit should be divested as it had cost investors billions of dollars.  The proxy battle ended with a May vote in which Icahn won enough shareholder support to oust the then board chair, John Thompson, and appoint his nominee, Andrew Teno, on the board.  Illumina's former head Francis deSouza stepped down in June, marking another victory for the activist investor, even though deSouza had secured more than twice the number of shareholder votes than his challenger.""}, {""date"": ""2023-09-05"", ""headline"": ""Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Chief Executive Officer, effective September 25, 2023.""}, {""date"": ""2023-09-05"", ""headline"": ""Illumina appoints Jacob Thaysen as new CEO following proxy battle with Icahn"", ""summary"": ""Investing.com -- Illumina Inc (NASDAQ:ILMN) has named Jacob Thaysen as its new chief executive officer, months after its former board chair was removed following a proxy battle with billionaire activist investor Carl Icahn.""}, {""date"": ""2023-09-05"", ""headline"": ""Video: Nasdaq 100 Movers: ILMN, ABNB"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Illumina names Agilent executive as new CEO"", ""summary"": ""Illumina Inc. on Tuesday announced that its board has appointed Agilent Technologies Inc. senior vice president Jacob Thaysen as its new CEO, effective Sept....""}, {""date"": ""2023-09-05"", ""headline"": ""Illumina appoints Jacob Thaysen as new CEO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Tracking Carl Icahn's Portfolio - Q2 2023 Update"", ""summary"": ""Carl Icahn's 13F portfolio value decreased from $22.03B to $15.48B this quarter. Read more about IEP here.""}, {""date"": ""2023-09-05"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Should You Hold Illumina (ILMN)?"", ""summary"": ""RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its \u201cRiverPark Large Growth Fund\u201d second quarter 2023 investor letter. A copy of the same can be downloaded here. In the second quarter, markets performed well, and the S&P 500 index (\u201cS&P\u201d) and the Russell 1000 Growth Index returned 8.7% [\u2026]""}, {""date"": ""2023-09-06"", ""headline"": ""$100 Invested In Illumina 20 Years Ago Would Be Worth This Much Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Illumina Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Healthequity (HQY), Illumina (ILMN) and Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""Biopharma Bounce-Back: From Policy Pains To Profitable Plains"", ""summary"": ""The legal challenges by big pharma companies against the IRA may derail the implementation of the drug pricing reforms. Click here for a detailed analysis.""}, {""date"": ""2023-09-07"", ""headline"": ""Carl Icahn says new Illumina CEO has his 'full support'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""Icahn expresses 'full support' for Illumina's new CEO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""Illumina Inc. stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""Illumina (ILMN) Down 14.2% Since Last Earnings Report: Can It Rebound?"", ""summary"": ""Illumina (ILMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""2023-09-08"", ""headline"": ""Cathie Wood's Buying These 3 Stocks Hand Over Fist"", ""summary"": ""A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.""}, {""date"": ""2023-09-08"", ""headline"": ""Did Elon Musk Admit 90% Decline In Twitter's Value Since Acquisition?, Apple's Zero-Click Vulnerabilities Uncovered By Internet Watchdog Group, Gas Prices Jump As Strikes Start At Major Chevron Australia LNG Projects: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""Billionaire Activist Investor Carl Icahn Shows Support For Illumina's Newly Appointed CEO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""Illumina Inc. stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-09"", ""headline"": ""Pacific Biosciences: Looks Appealing In The Fast-Growing Long-Read Sequencing Market"", ""summary"": ""Pacific Biosciences of California's expanding portfolio presents a significant upside potential. Read why I am bullish on PACB stock right now.""}, {""date"": ""2023-09-09"", ""headline"": ""Is the Worst Over for Illumina Stock?"", ""summary"": ""With shares of the gene sequencing giant Illumina (NASDAQ: ILMN) collapsing by 53% over the last three years due to a combination of a botched acquisition attempt and weakness in its core business, shareholders are doubtlessly wondering whether the stock's decline is finished, or if it's just getting started.  With the naming of a new chief technology officer (CTO) on August 9 and a new CEO on September 5, at a minimum investors can have confidence that something about the company's strategy is going to change.  The new CEO will take over on September 25, which, in conjunction with the new CTO, will help Illumina break with the management team responsible for its acquisition of Grail, a cancer testing business.""}]",{}
35,2023-09-10,158.36000061035156,2023-09-17,146.14999389648438,-0.07710284583737903,D5+,"[{""date"": ""2023-09-09"", ""headline"": ""Pacific Biosciences: Looks Appealing In The Fast-Growing Long-Read Sequencing Market"", ""summary"": ""Pacific Biosciences of California's expanding portfolio presents a significant upside potential. Read why I am bullish on PACB stock right now.""}, {""date"": ""2023-09-11"", ""headline"": ""Illumina, Inc. (ILMN) Morgan Stanley 21st Annual Global Healthcare Conference - (Transcript)"", ""summary"": ""Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Morgan Stanley 21st Annual Global Healthcare Conference September 11, 2023 12:55 PM ETCompany ParticipantsJoydeep Goswami - Chief Financial Officer,...""}, {""date"": ""2023-09-11"", ""headline"": ""UK Stem Students Get Hands-On Lessons in Biodiversity and Genomics"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / September 11, 2023 / IlluminaOriginally published on Illumina News CenterAccording to the Engineering Development Trust (EDT), a nonprofit organization that provides opportunities for students to develop STEM skills, ...""}, {""date"": ""2023-09-11"", ""headline"": ""AI Integration In Biotech & Pharma: Companies Positioned To Benefit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Illumina Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""Video: Nasdaq 100 Movers: ILMN, INTC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""Illumina Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Insights From Dublin: Fostering Precision Oncology for Better Patient Outcomes"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / September 13, 2023 / IlluminaOriginally published on Illumina News CenterThe 35th European Congress of Pathology (ECP), taking place September 9-13 in Dublin, Ireland, is a focal point for pathologists from over 100 ...""}, {""date"": ""2023-09-13"", ""headline"": ""Illumina Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Cramer Is 'Astonished' That Chewy Is 'Doing This Poorly \u2014 So Many Of Us Use It'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Illumina Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-15"", ""headline"": ""Why Pathogen Surveillance Is Critical During a \u201cTripledemic\u201d"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / September 15, 2023 / IlluminaOn the heels of three new RSV vaccines, an Arizona State University viromics lab identifies many variantsOriginally published on Illumina News CenterThe 2022-23 \""tripledemic\"" season-in which ...""}, {""date"": ""2023-09-15"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
36,2023-09-17,146.14999389648438,2023-09-24,132.44000244140625,-0.09380767723321759,D5+,"[{""date"": ""2023-09-18"", ""headline"": ""Yes, It\u2019s Possible: Students Visit Illumina and See Their Potential Careers"", ""summary"": ""Illumina recently hosted 16 San Diego students for an intensive two-week paid summer program, thanks to a partnership with local nonprofit SD2, which gives underrepresented students unique access to STEM education and mentorships.""}, {""date"": ""2023-09-18"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-19"", ""headline"": ""Is Illumina (ILMN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap"", ""summary"": ""Unpacking the Risks and Rewards of Investing in Illumina (ILMN)""}, {""date"": ""2023-09-19"", ""headline"": ""Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials"", ""summary"": ""Myriad can conduct prospective clinical trials using Illumina\u2019s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera""}, {""date"": ""2023-09-19"", ""headline"": ""Myriad Genetics, Illumina achieve milestones in strategic partnership"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-19"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-20"", ""headline"": ""13 Best Beaten Down Stocks To Buy Now"", ""summary"": ""In this article, we will be taking a look at the 13 best beaten down stocks to buy now. To skip our detailed analysis of the US stock market and recent developments within it, you can go directly to see the 5 Best Beaten Down Stocks To Buy Now. The Two-Day Fed Meeting On September [\u2026]""}, {""date"": ""2023-09-20"", ""headline"": ""Myriad Genetics (MYGN) Secures Key Milestones in Illumina Tie-Up"", ""summary"": ""Myriad Genetics (MYGN) achieves significant milestones in its partnership with Illumina.""}, {""date"": ""2023-09-20"", ""headline"": ""Quant stock news sentiment measure keeps improving - BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-20"", ""headline"": ""Illumina Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-21"", ""headline"": ""Illumina Ventures Announces New Partner, Mara Aspinall, Has Joined Its Investment Team"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-21"", ""headline"": ""Illumina Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-22"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
37,2023-09-24,132.44000244140625,2023-10-01,137.27999877929688,0.03654482217358712,U4,"[{""date"": ""2023-09-25"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-26"", ""headline"": ""Warning: ILMN is at high risk of performing badly"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-26"", ""headline"": ""2 of Carl Icahn's Holdings Approach 52-Week Lows"", ""summary"": ""Some of the investor's picks are on sale""}, {""date"": ""2023-09-26"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 1.90% to $128.91 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-09-26"", ""headline"": ""First Week of January 2026 Options Trading For Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-27"", ""headline"": ""Illumina initiated with an Underperform at Bernstein"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-27"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. rose 3.41% to $133.30 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-27"", ""headline"": ""Summiting Italy\u2019s Stelvio Pass for Cancer Research"", ""summary"": ""Illumina employees and the Illumina Corporate Foundation proudly support Stelvio for Life 2023Originally published on Illumina News CenterNORTHAMPTON, MA / ACCESSWIRE / September 27, 2023 / On September 2, 11 Illumina teammates embarked on a journey ...""}, {""date"": ""2023-09-27"", ""headline"": ""September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-27"", ""headline"": ""First Week of December 2024 Options Trading For Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Illumina price target lowered to $171 from $230 at HSBC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Buy/Sell: Wall Street's top 10 stock calls this week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""15 Recent Activist Investor Campaigns"", ""summary"": ""In this article, we present the list of 15 recent activist investor campaigns. Click to skip ahead and see the 5 Recent Activist Investor Campaigns. It\u2019s never a dull day in the markets with activist investors deploying all kinds of strategies in the race to unlock and maximize hidden value in highly undervalued stocks. Since 2017, [\u2026]""}, {""date"": ""2023-09-28"", ""headline"": ""Illumina Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Illumina Inc. shed 0.71% to $132.35 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-28"", ""headline"": ""Bernstein Initiates Coverage of Illumina (ILMN) with Underperform Recommendation"", ""summary"": """"}, {""date"": ""2023-09-28"", ""headline"": ""Interesting ILMN Put And Call Options For November 10th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Point32Health and GRAIL Expand Pilot Access to Galleri\u00ae Multi-Cancer Early Detection Blood Test"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Expert Ratings for Illumina"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""Stifel Maintains Illumina (ILMN) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-09-29"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. advanced 3.72% to $137.28 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-29"", ""headline"": ""Is Illumina (ILMN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap"", ""summary"": ""Unpacking the Risks and Rewards of Investing in Illumina (ILMN)""}, {""date"": ""2023-09-29"", ""headline"": ""Illumina price target lowered to $170 from $230 at HSBC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""Illumina put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""Guardant Health (GH) Surges 8.8%: Is This an Indication of Further Gains?"", ""summary"": ""Guardant Health (GH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.""}, {""date"": ""2023-09-29"", ""headline"": ""Barclays Maintains Illumina (ILMN) Underweight Recommendation"", ""summary"": """"}, {""date"": ""2023-09-29"", ""headline"": ""Friday\u2019s Top Analyst Upgrades and Downgrades: Agilent, Boeing, GE, Meta, Micron Technology, Redfin, Salesforce and More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""14 Best Depressed Stocks To Buy Now"", ""summary"": ""In this article, we will take a look at the 14 best depressed stocks to buy now. To see more such companies, go directly to 5 Best Depressed Stocks To Buy Now. Legendary value investor Howard Marks started writing memos to investors decades ago. These memos are still very famous and the co-founder of Oaktree [\u2026]""}, {""date"": ""2023-09-29"", ""headline"": ""Illumina price target lowered to $200 from $225 at Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""Illumina price target lowered to $100 from $150 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-30"", ""headline"": ""Bernstein bullish on Thermo, Revvity, Guardant, PacBio; bearish on Illumina"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
38,2023-10-01,137.27999877929688,2023-10-08,140.02000427246094,0.019959247650993328,U2,"[{""date"": ""2023-09-30"", ""headline"": ""Bernstein bullish on Thermo, Revvity, Guardant, PacBio; bearish on Illumina"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-01"", ""headline"": ""BTIG spies tradable momentum longs and shorts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Illumina Inc. shed 0.61% to $136.44 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-10-02"", ""headline"": ""Interesting ILMN Put And Call Options For November 17th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 1.85% to $133.92 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-03"", ""headline"": ""Stifel Nicolaus Sticks to Their Buy Rating for Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Impedimed Limited (OtherIPDQF) and Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Illumina removed from 'Tactical Outperform' list, target lowered at Evercore ISI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Is Illumina (ILMN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap"", ""summary"": ""Unraveling the Mystery Behind Illumina's (ILMN) Stock: A Deep Dive into its Valuation and Risks""}, {""date"": ""2023-10-05"", ""headline"": ""Illumina to Announce Third Quarter 2023 Financial Results on Thursday, November 9, 2023"", ""summary"": ""Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the third quarter 2023 following the close of market on Thursday, November 9, 2023.""}, {""date"": ""2023-10-05"", ""headline"": ""Final Results From PATHFINDER Study of GRAIL\u2019s Multi-Cancer Early Detection Blood Test Published in The Lancet"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""GRAIL LLC announces findings from multi-cancer detection blood test"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-06"", ""headline"": ""Illumina Inc. stock rises Friday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3886, ""bookValue"": 5898, ""cashRatio"": 0.6255060728744939, ""currentRatio"": 1.691, ""ebitPerShare"": -4.7722, ""eps"": -4.7722, ""ev"": 22160.451, ""fcfMargin"": 0.084, ""fcfPerShareTTM"": 1.0633, ""grossMargin"": 0.6113, ""inventoryTurnoverTTM"": 2.9336, ""longtermDebtTotalAsset"": 0.1471, ""longtermDebtTotalCapital"": 0.2016, ""longtermDebtTotalEquity"": 0.2525, ""netDebtToTotalCapital"": 0.0761, ""netDebtToTotalEquity"": 0.0953, ""netMargin"": -0.6738, ""operatingMargin"": -0.6738, ""pb"": 3.662, ""pfcfTTM"": 102.3623, ""pretaxMargin"": -0.6988, ""psTTM"": 4.8373, ""ptbv"": 7.5282, ""quickRatio"": 1.108, ""receivablesTurnoverTTM"": 6.5953, ""roaTTM"": -0.0978, ""roeTTM"": -0.1746, ""roicTTM"": -0.1305, ""rotcTTM"": -0.12, ""salesPerShare"": 7.0823, ""sgaToSale"": 0.3887, ""tangibleBookValue"": 2869, ""totalDebtToEquity"": 0.2525, ""totalDebtToTotalAsset"": 0.1471, ""totalDebtToTotalCapital"": 0.2016, ""totalRatio"": 2.3963, ""period"": ""2023-10-01""}"
39,2023-10-08,140.02000427246094,2023-10-15,129.11000061035156,-0.07791746414233713,D5+,"[{""date"": ""2023-10-08"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-08"", ""headline"": ""Illumina (NASDAQ:ILMN) Slips as EU Regulators Move against It"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-08"", ""headline"": ""EU regulators to order Illumina to divest cancer test firm Grail, FT reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""PRESS DIGEST- Financial Times - Oct. 10"", ""summary"": ""Four businesses, which represent a much wider group action of 900 small firms, are suing National Australia Bank and Clydesdale Bank for charging  unfair break fees on loans sold to small businesses.  - The Bank of Israel said on Monday it plans to sell up to $30 billion of dollar reserves to support the shekel after the market fallout from Hamas' attacks, however, despite the central bank's announcement shekel slumped to a seven-year low against the dollar, weakest level since 2016.""}, {""date"": ""2023-10-09"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Illumina Inc. shed 1.59% to $137.79 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-10-09"", ""headline"": ""NEW YORK MARKET CLOSE: Rate hopes lift Dow, despite Middle East crisis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""PRESS: EU regulators to order Illumina to sell Grail - FT"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""UPDATE 2-EU regulatory order for Illumina to sell Grail could come next week - FT"", ""summary"": ""An order from EU competition regulators for Illumina to sell cancer detection test maker Grail could come as early as next week, the Financial Times reported on Monday, citing people with knowledge of the matter.  The U.S. life sciences company had completed its $7.1 billion takeover of Grail in August 2021, without securing the EU regulatory approval.  The European Commission ordered Illumina last December to unwind the deal, three months after it had blocked the merger on concerns the deal would stifle innovation.""}, {""date"": ""2023-10-09"", ""headline"": ""NVIDIA and Illumina have been highlighted as Zacks Bull and Bear of the Day"", ""summary"": ""NVIDIA and Illumina are part of the Zacks Bull and Bear of the Day article.""}, {""date"": ""2023-10-09"", ""headline"": ""EU regulators to order Illumina to sell $8bn cancer treatment group"", ""summary"": ""EU regulators will order US biotech Illumina to sell cancer test developer Grail after it bought the $8bn company without the approval of Brussels, according to three people with direct knowledge of the matter.  The step is intended to deepen the punishment for Illumina after Brussels fined the world\u2019s largest gene-sequencing company \u20ac432mn in July for defying what regulators described as a \u201ccornerstone\u201d of their authority.  New York-listed Illumina and Brussels have been locked in a legal fight since 2021 when the San Diego-based company completed the purchase of Grail even as EU regulators were still examining whether the deal would hurt competition.""}, {""date"": ""2023-10-09"", ""headline"": ""EU regulators to order Illumina to sell Grail - Financial Times"", ""summary"": ""Investing.com -- European Union competition regulators are set to order U.S. biotech group Illumina (NASDAQ:ILMN) to sell cancer test development unit Grail following an $8 billion purchase of the firm that was unauthorized by Brussels, according to the Financial Times.""}, {""date"": ""2023-10-09"", ""headline"": ""Bear of the Day: Illumina (ILMN)"", ""summary"": ""Contracting margins, antitrust over GRAIL, and the Icahn invasion all crash estimates and shares""}, {""date"": ""2023-10-09"", ""headline"": ""Bear Of The Day: Illumina"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""Illumina Faces Mounting Pressure from Regulators Over $8B Grail Acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""Illumina falls amid reports of an EU order to sell Grail"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""14 Best Cancer Stocks To Buy Now"", ""summary"": ""In this article, we discuss 14 best cancer stocks to buy. If you want to skip our detailed discussion on the oncology industry, head directly to 5 Best Cancer Stocks To Buy Now. The global oncology landscape continues to evolve, with ongoing efforts to discover, develop, and provide innovative treatments aimed at improving outcomes for [\u2026]""}, {""date"": ""2023-10-10"", ""headline"": ""Illumina to get EU order on Thursday to divest Grail, source says"", ""summary"": ""U.S. genetic testing company Illumina will on Thursday get an order from EU antitrust regulators to sell cancer test maker Grail, a year after the $7.1 billion deal was blocked, a person with direct knowledge of the matter said on Tuesday.  The European Commission vetoed the deal, concerned that Illumina would have an incentive to cut off Grail's rivals from accessing its technology to develop blood-based early cancer detection tests to compete with Grail.  The EU competition enforcer slapped a record 432 million-euro ($458 million) fine on Illumina in July for closing the deal before securing the regulatory green light.""}, {""date"": ""2023-10-10"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. inched 0.73% higher to $138.79 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-10-10"", ""headline"": ""Q&A: An Illumina Intern\u2019s Shift From Academia to Industry"", ""summary"": ""What's it like to step into the corporate world? One student describes her summer experienceOriginally published on Illumina News CenterNORTHAMPTON, MA / ACCESSWIRE / October 10, 2023 / When Adee Newman started her summer as a research associate Intern ...""}, {""date"": ""2023-10-10"", ""headline"": ""LGND vs. ILMN: Which Stock Should Value Investors Buy Now?"", ""summary"": ""LGND vs. ILMN: Which Stock Is the Better Value Option?""}, {""date"": ""2023-10-10"", ""headline"": ""MassMutual Launches Innovative Wellness Offerings That Help Policyowners Better Understand and Protect Their Health"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-10"", ""headline"": ""Israel imposes \u2018complete siege\u2019 on Gaza"", ""summary"": ""This is an audio transcript of the FT News Briefing podcast episode: \u2018Israel imposes \u201ccomplete siege\u201d on Gaza\u2019[MUSIC PLAYING]Marc Filippino Good morning from the Financial Times. Today is Tuesday, October 10th, and this is your FT News Briefing.""}, {""date"": ""2023-10-11"", ""headline"": ""UPDATE 1-Illumina to divest Grail if it loses final court appeals in US or EU"", ""summary"": ""Illumina Inc said on Wednesday it will divest cancer test maker Grail if the U.S. life sciences company loses the final appeals in U.S. or European courts.  The divestiture of Grail will take place as expeditiously as possible if the company loses either of the final appeals.  Illumina completed its $7.1 billion takeover of Grail in August 2021, without securing the EU regulatory approval.""}, {""date"": ""2023-10-11"", ""headline"": ""Illumina to divest Grail if it loses final court appeals in US or EU"", ""summary"": ""The divestiture of Grail will take place as expeditiously as possible if the company loses either of the final appeals.  Illumina completed its $7.1 billion takeover of Grail in August 2021, without securing the EU regulatory approval.""}, {""date"": ""2023-10-11"", ""headline"": ""Illumina Posted a Stewardship-Focused Presentation for Investors"", ""summary"": ""Illumina, Inc. (NASDAQ:ILMN) posted a stewardship-focused presentation for investors on the Events & Presentations section of its investor relations website, investor.illumina.com, on Wednesday, October 11, 2023. Members of Illumina's Board of Directors and senior management may use this presentation during meetings with investors.""}, {""date"": ""2023-10-11"", ""headline"": ""Illumina Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. dropped 0.63% to $137.92 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-10-11"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-11"", ""headline"": ""Illumina to quickly divest Grail if it loses EU or US appeal: report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Illumina maintains EC does not have jurisdiction over Grail acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Illumina Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slipped 5.45% to $130.40 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-12"", ""headline"": ""NEW YORK MARKET CLOSE: Dow hit by rate nerves after stubborn inflation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""ChatGPT Parent OpenAI Aims At Budget-Friendly AI Innovations,  Novo Nordisk's Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany: Today's Top Stories"", ""summary"": ""Bloomberg Apple and Suppliers Face Unanticipated Sales Slump Despite New Launches In a surprising turn of events, Apple Inc (NASDAQ: AAPL) and its key suppliers in Taiwan are facing a significant sales slump despite the recent launch of the new iPhone and various Android devices. Taiwan Semiconductor Manufacturing Co (NYSE: TSM), the leading contract chipmaker, experienced a 13.4% sales drop, a figure that, while concerning, is better than initially feared. Arm's Chinese Fortunes in Jeopardy? In""}, {""date"": ""2023-10-12"", ""headline"": ""Icahn: The Hunt For The Billion-Dollar Triumph"", ""summary"": ""Icahn\u00e2\u0080\u0099s past decade's performance has raised questions about its strategy and shaken investor confidence. Find out why IEP stock is a Buy.""}, {""date"": ""2023-10-12"", ""headline"": ""How Do Genetic Factors Play a Role in Chronic Pain and Opioid Use Disorder?"", ""summary"": ""The winner of Illumina's Polygenic Risk Scores Research Grant aims to find outOriginally published on Illumina News CenterNORTHAMPTON, MA / ACCESSWIRE / October 12, 2023 / Emma Johnson, PhD, assistant professor of Psychiatry at Washington University ...""}, {""date"": ""2023-10-12"", ""headline"": ""EU Decree Puts Illumina (NASDAQ:ILMN) and Grail in Trouble"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Stifel Nicolaus Keeps Their Buy Rating on Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Stocks to watch in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Canaccord reiterates Buy rating on Illumina after EC orders Grail be divested"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Illumina Ordered by EU to Unwind Grail Acquisition"", ""summary"": ""The life-sciences maker must unwind its $7.1 billion acquisition of the cancer-test developer, the European Union\u2019s competition watchdog said.""}, {""date"": ""2023-10-12"", ""headline"": ""EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail"", ""summary"": ""The European Union on Thursday ordered U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal without approval of regulators in the 27-nation bloc.  The EU already slapped a $475 million fine on Illumina over the summer for jumping the gun on the acquisition without its consent.  Now, the order to unwind the deal \u201crestores competition in the development of early cancer detection tests,\u201d EU antitrust Commissioner Didier Reynders said.""}, {""date"": ""2023-10-12"", ""headline"": ""European Commission orders Illumina to unwind acquisition of Grail"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Stocks to watch out in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Illumina ordered by EU antitrust regulators to sell Grail"", ""summary"": ""U.S. genetic testing company Illumina has been ordered by EU antitrust regulators to sell cancer test maker Grail after it completed the deal before securing their approval.  The EU competition enforcer subsequently blocked the $7.1 billion deal in 2022 on concerns that Illumina would have an incentive to stop Grail's rivals from accessing its technology to develop competing blood-based early cancer detection tests.  \""With today's decision, the Commission has adopted restorative measures requiring Illumina to divest Grail and restore the situation prevailing before the completion of the acquisition,\"" the European Commission said in a statement on Thursday, confirming a Reuters story.""}, {""date"": ""2023-10-12"", ""headline"": ""Will Illumina Give Up Cancer Test Maker Grail? Mulls $8B Acquisition's Fate Amid Antitrust Pressure"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""TOP NEWS: EU regulators order Illumina to sell cancer test firm Grail"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Most crowded longs and shorts going into earnings season"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Illumina Ordered by EU to Unwind $7.1 Bln Grail Acquisition -- WSJ"", ""summary"": ""By Kim Mackrael BRUSSELS--Illumina must unwind its $7.1 billion acquisition of cancer-test developer Grail Inc., the European Union's competition watchdog...""}, {""date"": ""2023-10-12"", ""headline"": ""Illumina ordered to divest GRAIL unit in EU"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""S&P 500 2023 Q3 Earnings Preview: Earnings Expectation Rise Heading Into Earnings Season"", ""summary"": ""The first half of the year has been far better than expected when comparing expectations at the start of the year.""}, {""date"": ""2023-10-13"", ""headline"": ""UPDATE 1-Illumina to divest Grail within a year if it does not win challenge in EU court"", ""summary"": ""Illumina said on Friday it would divest cancer test maker Grail in 12 months, according to the terms of the order by the European Commission, if it does not win its challenge in court.  Illumina is required to continue to fund Grail until it divests it.""}, {""date"": ""2023-10-13"", ""headline"": ""Illumina to divest Grail within a year if it does not win challenge in EU court"", ""summary"": ""Under the terms of the order, Illumina might extend the timeframe by three months and would be permitted to explore options which include, but are not limited to, a third-party sale or a capital markets transaction.  If Illumina opts for a capital markets transaction, it would have to capitalize Grail at the time of the transaction with two-and-a-half years of funding based on the cancer test maker's long-range plan.  The order also provides for Illumina to retain up to a 14.5% stake in Grail and reestablish the royalty arrangement it previously had in place.""}, {""date"": ""2023-10-13"", ""headline"": ""Illumina responds to European Commission's divestiture order"", ""summary"": ""Illumina, Inc. (NASDAQ:ILMN), has received an order from the European Commission (EC) directing the company to divest GRAIL.""}, {""date"": ""2023-10-13"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 0.99% to $129.11 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-10-13"", ""headline"": ""Is Illumina, Inc. (NASDAQ:ILMN) Trading At A 44% Discount?"", ""summary"": ""Key Insights Illumina's estimated fair value is US$232 based on 2 Stage Free Cash Flow to Equity Current share price of...""}, {""date"": ""2023-10-13"", ""headline"": ""Illumina responds to EC Grail divestiture order"", ""summary"": ""Illumina Inc. responded Friday to an order it received Thursday from the European Commission directing the company to divest its $7.1 billion acquisition of...""}, {""date"": ""2023-10-13"", ""headline"": ""Illumina Gets European Commission Order to Divest Grail"", ""summary"": ""By Ben Glickman Illumina is evaluating divestiture options for Grail after the European Commission ruled the gene-sequencing company had 12 months to sell...""}, {""date"": ""2023-10-13"", ""headline"": ""Stifel Reiterates Illumina (ILMN) Buy Recommendation"", ""summary"": """"}]","{""assetTurnoverTTM"": 0.3886, ""bookValue"": 5898, ""cashRatio"": 0.6255060728744939, ""currentRatio"": 1.691, ""ebitPerShare"": -4.7722, ""eps"": -4.7722, ""ev"": 22160.451, ""fcfMargin"": 0.084, ""fcfPerShareTTM"": 1.0633, ""grossMargin"": 0.6113, ""inventoryTurnoverTTM"": 2.9336, ""longtermDebtTotalAsset"": 0.1471, ""longtermDebtTotalCapital"": 0.2016, ""longtermDebtTotalEquity"": 0.2525, ""netDebtToTotalCapital"": 0.0761, ""netDebtToTotalEquity"": 0.0953, ""netMargin"": -0.6738, ""operatingMargin"": -0.6738, ""pb"": 3.662, ""pfcfTTM"": 102.3623, ""pretaxMargin"": -0.6988, ""psTTM"": 4.8373, ""ptbv"": 7.5282, ""quickRatio"": 1.108, ""receivablesTurnoverTTM"": 6.5953, ""roaTTM"": -0.0978, ""roeTTM"": -0.1746, ""roicTTM"": -0.1305, ""rotcTTM"": -0.12, ""salesPerShare"": 7.0823, ""sgaToSale"": 0.3887, ""tangibleBookValue"": 2869, ""totalDebtToEquity"": 0.2525, ""totalDebtToTotalAsset"": 0.1471, ""totalDebtToTotalCapital"": 0.2016, ""totalRatio"": 2.3963, ""period"": ""2023-10-01""}"
40,2023-10-15,129.11000061035156,2023-10-22,119.63999938964844,-0.07334831675265174,D5+,"[{""date"": ""2023-10-15"", ""headline"": ""Where Illumina Stands With Analysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Piper Sandler Maintains Illumina (ILMN) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-10-16"", ""headline"": ""Illumina Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Illumina Inc. rose 1.76% to $131.38 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-16"", ""headline"": ""Illumina price target lowered to $200 from $275 at Piper Sandler"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), UnitedHealth (UNH) and BeiGene (BGNE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Carl Icahn Criticizes\u00a0Short Sellers at Investor Conference"", ""summary"": ""(Bloomberg) -- Carl Icahn criticized short sellers on Tuesday, months after his firm became the target of one. Most Read from BloombergHundreds Dead at Gaza Hospital as Israel, Hamas Trade BlameIsrael Latest: Biden \u2018Deeply Saddened\u2019 Over Hospital BlastTreasury Yields Climb as Hot Data Fuel Fed Wagers: Markets WrapWill Xi Jinping\u2019s Gamble on Vladimir Putin Pay Off?Putin Arrives in China to Meet Xi on Rare International Trip\u201cI think there\u2019s a place for short sellers without question but to go out""}, {""date"": ""2023-10-17"", ""headline"": ""UPDATE 1-Carl Icahn sues Illumina board for violating 'fiduciary duties'"", ""summary"": ""Activist-investor Carl Icahn sued the board of directors at genetic testing company Illumina and accused them of breaching their fiduciary duties, according to a sealed copy of the complaint on Tuesday.  The publicly available version of the complaint did not contain further details, but Icahn told the 13D investor conference in New York on Tuesday that the lawsuit pertained to Illumina completing its acquisition of cancer detection test maker Grail.  Illumina said it is reviewing the complaint, while Icahn and Grail did not immediately respond to Reuters requests for a comment.""}, {""date"": ""2023-10-17"", ""headline"": ""Carl Icahn sues Illumina board for violating 'fiduciary duties'"", ""summary"": ""The publicly available version of the complaint did not contain further details, but Icahn told the 13D investor conference in New York on Tuesday that the lawsuit pertained to Illumina completing its acquisition of cancer detection test maker Grail.  Illumina said it is reviewing the complaint, while Icahn and Grail did not immediately respond to Reuters requests for a comment.  The gene-sequencing machine maker had repurchased Grail in 2021 despite opposition from U.S. and European antitrust regulators - a decision that prompted Icahn to pursue a proxy fight at Illumina, arguing Grail should be divested as it had cost investors billions of dollars.""}, {""date"": ""2023-10-17"", ""headline"": ""Illumina Inc. stock underperforms Tuesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Illumina Inc. inched 0.37% higher to $131.87 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-10-17"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Clover Health Investments (CLOV), Illumina (ILMN) and Ultragenyx Pharmaceutical (RARE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""HCA Healthcare to offer GRAIL\u2019s Galleri cancer detection test"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""HCA Healthcare and Grail Collaborate to Advance Comprehensive Cancer Care With Multi-Cancer Early Detection Screening"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Carl Icahn reportedly sues former Illumina CEO, board members"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Here\u2019s Why Illumina Stock (NASDAQ:ILMN) Hit a 52-Week Low"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Illumina Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 5.63% to $124.45 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-18"", ""headline"": ""What the Diagnostic Odyssey Looks Like - And How We Can End It"", ""summary"": ""Closing the knowledge gap for health care providers and accelerating access to whole-genome sequencingNORTHAMPTON, MA / ACCESSWIRE / October 18, 2023 / Illumina /Originally published on Illumina News CenterPeople unfamiliar with the world of rare ...""}, {""date"": ""2023-10-19"", ""headline"": ""Illumina Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Illumina Inc. shed 3.59% to $119.98 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-19"", ""headline"": ""Illumina Included on 2023 List of 100 Best Corporate Citizens List"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / October 19, 2023 / Illumina / Illumina has been included on the 2023 100 Best Corporate Citizens list by 3BL Media, recognizing outstanding environmental, social, and governance (ESG) performance among the 1,000 largest ...""}, {""date"": ""2023-10-20"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 0.28% to $119.64 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-10-20"", ""headline"": ""Is the Options Market Predicting a Spike in Illumina (ILMN) Stock?"", ""summary"": ""Investors need to pay close attention to Illumina (ILMN) stock based on the movements in the options market lately.""}]","{""assetTurnoverTTM"": 0.3886, ""bookValue"": 5898, ""cashRatio"": 0.6255060728744939, ""currentRatio"": 1.691, ""ebitPerShare"": -4.7722, ""eps"": -4.7722, ""ev"": 22160.451, ""fcfMargin"": 0.084, ""fcfPerShareTTM"": 1.0633, ""grossMargin"": 0.6113, ""inventoryTurnoverTTM"": 2.9336, ""longtermDebtTotalAsset"": 0.1471, ""longtermDebtTotalCapital"": 0.2016, ""longtermDebtTotalEquity"": 0.2525, ""netDebtToTotalCapital"": 0.0761, ""netDebtToTotalEquity"": 0.0953, ""netMargin"": -0.6738, ""operatingMargin"": -0.6738, ""pb"": 3.662, ""pfcfTTM"": 102.3623, ""pretaxMargin"": -0.6988, ""psTTM"": 4.8373, ""ptbv"": 7.5282, ""quickRatio"": 1.108, ""receivablesTurnoverTTM"": 6.5953, ""roaTTM"": -0.0978, ""roeTTM"": -0.1746, ""roicTTM"": -0.1305, ""rotcTTM"": -0.12, ""salesPerShare"": 7.0823, ""sgaToSale"": 0.3887, ""tangibleBookValue"": 2869, ""totalDebtToEquity"": 0.2525, ""totalDebtToTotalAsset"": 0.1471, ""totalDebtToTotalCapital"": 0.2016, ""totalRatio"": 2.3963, ""period"": ""2023-10-01""}"
41,2023-10-22,119.63999938964844,2023-10-29,109.22000122070312,-0.08709460232450383,D5+,"[{""date"": ""2023-10-23"", ""headline"": ""Video: Nasdaq 100 Movers: ILMN, PDD"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-23"", ""headline"": ""Illumina Inc. stock falls Monday, still outperforms market"", ""summary"": ""Shares of Illumina Inc. slid 0.14% to $119.47 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-10-23"", ""headline"": ""The Future of Sustainable Mining Belongs to the Microbe"", ""summary"": ""The Mining Microbiome Analytics Platform is finding tiny solutions to some of our biggest environmental challengesNORTHAMPTON, MA / ACCESSWIRE / October 23, 2023 / Illumina:Originally published on Illumina News CenterSelenium, element 34 on the periodic ...""}, {""date"": ""2023-10-24"", ""headline"": ""Illumina Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 2.82% to $116.10 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-10-24"", ""headline"": ""Icahn sues to remove Illumina board members, asks for at least $476M in damages"", ""summary"": ""The activist investor claims board members breached their duties in the acquisition of Grail.""}, {""date"": ""2023-10-24"", ""headline"": ""Illumina: Mispriced Jewel At Maximum Pessimism"", ""summary"": ""Illumina is the world leader in gene sequencing. See why I think ILMN is a jewel of a business that you want to own for the long term.""}, {""date"": ""2023-10-25"", ""headline"": ""Illumina Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slipped 1.87% to $113.93 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-25"", ""headline"": ""Top 10 most oversold large-cap stocks on Wall Street"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""Illumina Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 2.02% to $111.63 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-26"", ""headline"": ""LGND vs. ILMN: Which Stock Is the Better Value Option?"", ""summary"": ""LGND vs. ILMN: Which Stock Is the Better Value Option?""}, {""date"": ""2023-10-26"", ""headline"": ""7 F-Rated Stocks to Sell Before November"", ""summary"": ""Halloween may be a scary day for some people. But if you\u2019re an investor with F-rated stocks to sell in your portfolio, then you\u2019re likely looking at some terrifyingly low returns this quarter. F-rated stocks to sell, as ranked by the Portfolio Grader, have all sorts of blemishes that make them unwelcome in any portfolio. Whether it\u2019s a weak financial position, low earnings potential, massive debt, weak profits, or just a poor business; these are businesses that can sink your profits. And why wou""}, {""date"": ""2023-10-26"", ""headline"": ""Ensemble Capital Q3 2023 Investor Letter"", ""summary"": ""The third quarter of 2023 saw positive, and similar, returns for both Ensemble Capital and the S&P 500. Click here to read the full fund letter.""}, {""date"": ""2023-10-26"", ""headline"": ""Ensemble Fund Q3 2023 Investment Update"", ""summary"": ""In Q3 2023, Ensemble Fund declined by 5.96% while the S&P 500 declined 3.27%. Click here to read the full fund letter.""}, {""date"": ""2023-10-27"", ""headline"": ""Illumina Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Illumina Inc. slid 2.16% to $109.22 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-10-27"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Illumina stock hits new 52-week low amid Grail divesture woes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-29"", ""headline"": ""Canaccord sees solid Q3 earnings for medtech; likes Quanterix, Natera, Guardant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
42,2023-10-29,109.22000122070312,2023-11-05,116.91999816894531,0.07049987971234906,U5+,"[{""date"": ""2023-10-29"", ""headline"": ""Canaccord sees solid Q3 earnings for medtech; likes Quanterix, Natera, Guardant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""11 Best Long-term Stocks To Buy For High Returns"", ""summary"": ""In this piece, we will take a look at the 11 best long term stocks to buy for high returns. If you want to skip our introduction to the current drivers of stock market performance, then check out 5 Best Long-term Stocks To Buy For High Returns. The stock market is made up of thousands [\u2026]""}, {""date"": ""2023-10-30"", ""headline"": ""Top 20 Genomics Companies in the World"", ""summary"": ""In this piece, we will take a look at the top 20 genomics companies in the world. If you want to skip our analysis of the genomics industry, then take a look at the Top 5 Genomics Companies in the World. Modern day science has delivered a plethora of advancements that have enabled humans to [\u2026]""}, {""date"": ""2023-10-30"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 1.24% to $107.87 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-30"", ""headline"": ""Revvity's disappointing Q3 report weighs on life sciences tool stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""11 Best Immunotherapy Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 of the best immunotherapy stocks to buy now. If you want to skip our detailed discussion on the cancer and oncology industry, head directly to the 5 Best Immunotherapy Stocks To Buy Now. The global oncology landscape is continually transforming, driven by persistent efforts to explore, create, and deliver [\u2026]""}, {""date"": ""2023-10-31"", ""headline"": ""Illumina Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Illumina Inc. rose 1.44% to $109.42 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-31"", ""headline"": ""Trick or Treat: S&P 500 top and bottom YTD performers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-01"", ""headline"": ""Illumina Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slipped 2.52% to $106.66 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-01"", ""headline"": ""Illumina launches advanced liquid biopsy assay to enable comprehensive genomic profiling of solid tumors"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a new generation of its distributed liquid biopsy assay for genomic profiling. The new TruSight\u2122 Oncology 500 ctDNA v2 (TSO 500 ctDNA v2) is a research assay that enables noninvasive comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) from blood when tissue testing is not available, or to complement tissue-based testing.""}, {""date"": ""2023-11-01"", ""headline"": ""Here\u2019s Why Illumina (ILMN) Declined in Q3"", ""summary"": ""Ensemble Capital Management, an investment management company, released its third quarter 2023 investor letter. A copy of the same can be downloaded here. During the quarter, the strategy declined by 5.68% compared to the S&P 500\u2019s 3.27% decline. The underperformance of the fund was driven by large declines in two holdings that have recently elected activist [\u2026]""}, {""date"": ""2023-11-02"", ""headline"": ""Illumina Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Illumina Inc. rose 5.25% to $112.26 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-11-02"", ""headline"": ""Earnings Preview: Illumina (ILMN) Q3 Earnings Expected to Decline"", ""summary"": ""Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""2023-11-02"", ""headline"": ""Aegis Writes a New Chapter on Pathogen Surveillance"", ""summary"": ""A US lab broadens its surveillance efforts to be able to respond to emerging pathogens and envision a future of improved public healthNORTHAMPTON, MA / ACCESSWIRE / November 2, 2023 / IlluminaOriginally published on Illumina News CenterBefore SARS-CoV-2, ...""}, {""date"": ""2023-11-02"", ""headline"": ""Interesting ILMN Put And Call Options For December 22nd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Jim Cramer Highlights Key Earnings To Watch In The Energy Sector This Coming Week: 'Bullish Herd To Continue To Thunder'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Jim Cramer Highlights Key Earnings To Watch In The Energy Sector This Week: 'Bullish Herd To Continue To Thunder'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. advanced 4.15% to $116.92 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-04"", ""headline"": ""Rare Stock Picks In October 2023 - From 31 Discerning Analysts"", ""summary"": ""This article highlights analysts who made stock recommendations in October, but had made no other recommendations in the past 3 months.""}]",{}
43,2023-11-05,116.91999816894531,2023-11-12,98.37000274658203,-0.15865545426676442,D5+,"[{""date"": ""2023-11-06"", ""headline"": ""Illumina Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 3.49% to $112.84 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-06"", ""headline"": ""Seeking Clues to Illumina (ILMN) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics"", ""summary"": ""Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Illumina (ILMN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2023.""}, {""date"": ""2023-11-06"", ""headline"": ""Several Reasons Hampered Illumina (ILMN) in Q3"", ""summary"": ""Polen Capital, an investment management company, released its \u201cPolen Focus Growth Strategy\u201d third-quarter 2023 investor letter. A copy of the same can be downloaded here. September saw another duration-driven sell-off in equities similar to what the market witnessed in 4Q 2021 and parts of 2022, but Performance for July-August was meaningfully different from September. In the [\u2026]""}, {""date"": ""2023-11-07"", ""headline"": ""Notable earnings after Thursday's close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-07"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. rose 1.47% to $114.50 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-07"", ""headline"": ""Veracyte Announces In Vitro Diagnostic Agreement with Illumina to Broaden Availability of Its Tests for Patients Globally"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-07"", ""headline"": ""The Race Results Are in - And So Is the Marine Genomic Data"", ""summary"": ""Sport sailors can use these environmental DNA collection kits even at full speedNORTHAMPTON, MA / ACCESSWIRE / November 7, 2023 / IlluminaOriginally published on Illumina News CenterIt was Fabrice Amedeo's fourth time sailing the Route de Rhum. The ...""}, {""date"": ""2023-11-07"", ""headline"": ""The Better-Than-Expected Earnings Plus Cautious Commentary Trend Continues"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Illumina down 7% at $99.20 after Q3 results, FY23 guidance cut"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Illumina CEO says 2024 results 'will look very similar to 2023'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Illumina cuts FY23 adjusted EPS view to 60c-70c from 75c-90c"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Illumina Non-GAAP EPS of $0.33 beats by $0.19, revenue of $1.12B misses by $10M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Illumina cuts FY23 adjusted EPS view to 69c-70c from 75c-90c"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Illumina reports Q3 adjusted EPS 33c, consensus 12c"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Illumina options imply 9.7% move in share price post-earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""GLOBAL BRIEFING: China's economy slips back into deflation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Illumina Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 3.32% to $110.70 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-08"", ""headline"": ""6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""These Stocks Are Moving the Most Today: Plug Power, Trade Desk, Doximity, Unity Software, Illumina, Wynn, and More"", ""summary"": ""Plug Power reports a third-quarter loss wider than a year earlier and revenue that misses analysts' expectations, while Trade Desk's outlook for the fourth...""}, {""date"": ""2023-11-09"", ""headline"": ""Illumina (ILMN): A Smart Investment or a Value Trap? An In-Depth Exploration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Illumina downgraded to Hold from Buy at Canaccord"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Biggest stock movers today: Unity Software, The Trade Desk and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""What You Missed On Wall Street On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Illumina (ILMN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates"", ""summary"": ""Although the revenue and EPS for Illumina (ILMN) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.""}, {""date"": ""2023-11-09"", ""headline"": ""Polen Focus Growth Q3 2023 Commentary"", ""summary"": ""The Polen Focus Growth Composite Portfolio declined -3.28% and -3.47%, gross and net of fees, in the Q3 2023. Click here to read the full fund letter.""}, {""date"": ""2023-11-09"", ""headline"": ""Illumina cuts annual profit forecast for second straight quarter"", ""summary"": ""Shares of the San Diego, California-based company fell about 9% to $97.51 in extended trading, after it also missed Wall Street estimates for third-quarter sales.  The U.S. life sciences firm in the last quarter had flagged weakness in demand for its genetic testing tools and diagnostics products over protracted recovery in China, cautious consumer spending and lengthened sales cycles.  Sales at its core business, which advances sequencing instruments, consumables and services for genetic analysis, were $941 million in the third quarter, compared with LSEG estimates of $963.80 million.""}, {""date"": ""2023-11-09"", ""headline"": ""Illumina Reports Financial Results for Third Quarter of Fiscal Year 2023"", ""summary"": ""Illumina, Inc. (Nasdaq: ILMN) (\""Illumina\"" or the \""company\"") today announced its financial results for the third quarter of fiscal year 2023, which include the consolidated financial results for GRAIL.""}, {""date"": ""2023-11-09"", ""headline"": ""Illumina, Inc. (ILMN) Q3 2023 Earnings Call Transcript"", ""summary"": ""Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Q4 2023 Earnings Conference Call November 9, 2023 5:00 PM ETCompany ParticipantsSalli Schwartz - Vice President of...""}, {""date"": ""2023-11-09"", ""headline"": ""Stocks to Watch: Doximity, Illumina, Groupon"", ""summary"": ""By Ben Glickman Doximity lifted its full-year outlook for revenue and adjusted earnings before interest, taxes, depreciation and amortization with fiscal...""}, {""date"": ""2023-11-09"", ""headline"": ""Illumina shares fall as company cuts forecasts"", ""summary"": ""Shares of Illumina Inc. fell after hours on Thursday after the maker of DNA-sequencing technology cut its full-year sales and profit outlook. The company...""}, {""date"": ""2023-11-09"", ""headline"": ""Illumina Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Illumina Inc. shed 3.36% to $106.98 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-09"", ""headline"": ""Illumina lowers guidance but loss narrows in challenging third quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Illumina Expects Sales to Decline, Projects Wider Loss For Year"", ""summary"": ""By Paul Ziobro Illumina expects sales to decline and a wider loss this year as conditions remain challenging for the gene-sequencing company. The San...""}, {""date"": ""2023-11-09"", ""headline"": ""Illumina 3Q Loss Narrows as Goodwill Charges Fall"", ""summary"": ""By Paul Ziobro Illumina reported a narrower loss in its third quarter, aided by a significant drop in goodwill and intangible impairment charges tied to its...""}, {""date"": ""2023-11-09"", ""headline"": ""Illumina: Q3 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Strong week for Illumina (NASDAQ:ILMN) shareholders doesn't alleviate pain of five-year loss"", ""summary"": ""We think intelligent long term investing is the way to go. But unfortunately, some companies simply don't succeed. For...""}, {""date"": ""2023-11-09"", ""headline"": ""Illumina: An Overvalued Fading Monopoly With Many Distractions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Traders Hold Breath For Powell's Remarks, Bitcoin's Wild Ride Unleashed: What's Driving Markets Thursday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Notable companies reporting after market close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Q3 2023 Somalogic Inc Earnings Call"", ""summary"": ""Q3 2023 Somalogic Inc Earnings Call""}, {""date"": ""2023-11-09"", ""headline"": ""December 29th Options Now Available For Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Fly Intel: After-Hours Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell's Speech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Canaccord Genuity Downgrades Illumina (ILMN)"", ""summary"": """"}, {""date"": ""2023-11-10"", ""headline"": ""S&P 500 Gains and Losses Today: Hologic Announces Strong Results, Stock Buyback"", ""summary"": ""The S&P 500 gained 1.6% on Friday, Nov. 10, 2023, rallying back from Thursday's selloff as bond yields retreated from higher levels seen following comments from the Fed chair.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina Shares Hit a 10-Year Low as the Company's Customers Pull Back on Spending"", ""summary"": ""Illumina missed revenue forecasts and cut its full-year outlook, citing \""challenging\"" macroeconomic conditions.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 8.05% to $98.37 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-11-10"", ""headline"": ""Midday Movers: Hologic and Meta Platforms Gain, Illumina Sinks"", ""summary"": ""U.S. equities advanced at midday, bouncing back from Thursday's declines as market participants kept a close eye on Treasury yields and comments from Fed officials.""}, {""date"": ""2023-11-10"", ""headline"": ""DNA-Reading Giant Illumina Crashes As Macro Pressures Guidance \u2014 Again"", ""summary"": ""Illumina stock crashed Friday after the DNA-reading behemoth slashed its outlook as pressures continue to build on life sciences companies.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina Stock Is the Worst Performer in the S&P 500. Grail Isn\u2019t the Only Issue."", ""summary"": ""The gene-sequencing company cuts its financial forecasts, prompting analysts to reduce their stock price targets.""}, {""date"": ""2023-11-10"", ""headline"": ""Stocks to Watch Friday: Illumina, Trade Desk, Meta"", ""summary"": ""**\u2198\ufe0f** [**Illumina (ILMN)**](https://www.wsj.com/market-data/quotes/ILMN): Shares dropped 12% after the maker of gene-sequencing products offered a gloomier outlook for sales and profits. **\u2198\ufe0f** [**Trade Desk (TTD)**](https://www.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina Stock Tumbles. Grail Isn\u2019t the Only Issue."", ""summary"": ""The gene-sequencing company cut its financial forecasts, prompting analysts to cut their targets for the stock price.""}, {""date"": ""2023-11-10"", ""headline"": ""Q3 2023 Illumina Inc Earnings Call"", ""summary"": ""Q3 2023 Illumina Inc Earnings Call""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina (ILMN) Q3 Earnings Surpass Estimates, '23 View Cut"", ""summary"": ""Illumina (ILMN) reports solid earnings in the third quarter of 2023 amid a challenging macro environment.""}, {""date"": ""2023-11-10"", ""headline"": ""Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Hologic, Doximity rise; Trade Desk, Plug Power fall, Friday, 11/10/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina\u2019s stock on track for lowest close in 10 years after cutting guidance"", ""summary"": ""Illumina Inc.\u2019s stock fell 14% Friday to put it on track for its lowest close in 10 years, after the company after the maker of DNA-sequencing technology cut...""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina shares slip after genetic testing group lowers profit guidance"", ""summary"": ""Investing.com -- Shares in Illumina (NASDAQ:ILMN) shed more than a tenth of their value in early U.S. trading on Friday after the genetic testing company lowered its annual income guidance for a second consecutive quarter.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina explores options for Grail, hires advisers"", ""summary"": ""The company, facing pressure from regulators to divest Grail, also formed a special committee to speed decisions on the fate of the liquid biopsy test maker.""}, {""date"": ""2023-11-10"", ""headline"": ""Video: S&P 500 Movers: ILMN, HOLX"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Knight Therapeutics (OtherKHTRF), Tarsus Pharmaceuticals (TARS) and Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Biggest stock movers today: Plug Power, Unity Software, The Trade Desk and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina Shares Drop on Forecast for 2023 Sales Decline, Wider Loss"", ""summary"": ""By Dean Seal Shares of Illumina retreated after the company said it expects sales to decline and its loss to widen this year. The stock was down 11% at...""}, {""date"": ""2023-11-10"", ""headline"": ""Plug Power downgraded, Arm initiated: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina cut to Hold at Canaccord Genuity on soft guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Diageo, Trade Desk, Illumina among premarket losers' pack"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina price target lowered to $140 from $170 at BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Wynn Resorts, Illumina, Plug Power fall premarket; Apple rises"", ""summary"": ""Investing.com -- U.S. futures traded in a mixed fashion Friday, ending the week amid a degree of uncertainty after a relatively hawkish speech by Fed Chair Jerome Powell.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina price target lowered to $160 from $180 at Evercore ISI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""12 Health Care Stocks Moving In Friday's Pre-Market Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Synaptics To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina price target lowered to $144 from $200 at TD Cowen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina price target lowered to $111 from $122 at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""US Stocks Could Wobble As Powell's Inflation Obsession Intensifies Rate Uncertainty: Will Nasdaq Wipe Off Week's Gains?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina (NASDAQ:ILMN) Sinks As FY23 Outlook Disappoints"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina: A Promising Investment Despite Industry Challenges \u2013 An Analyst\u2019s Perspective"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Unity Software, Groupon, Trade Desk And Other Big Stocks Moving Lower In Friday's Pre-Market Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina price target lowered to $109 from $180 at Baird"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-11"", ""headline"": ""Illumina, Inc. (NASDAQ:ILMN) Q3 2023 Earnings Call Transcript"", ""summary"": ""Illumina, Inc. (NASDAQ:ILMN) Q3 2023 Earnings Call Transcript November 9, 2023 Illumina, Inc. beats earnings expectations. Reported EPS is $0.33, expectations were $0.13. Operator: Good day, ladies and gentlemen, and welcome to the Third Quarter 2023 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers\u2019 presentation, there [\u2026]""}, {""date"": ""2023-11-11"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Spotify.""}, {""date"": ""2023-11-12"", ""headline"": ""Illumina price target lowered to $50 from $100 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
44,2023-11-12,98.37000274658203,2023-11-19,94.31999969482422,-0.041171118620290326,D5,"[{""date"": ""2023-11-12"", ""headline"": ""These Stocks Moved the Most Today: Boeing, Tyson Foods, Plug Power, Monday.com, Illumina, Nvidia, and More"", ""summary"": ""A report says China is considering lifting a commercial freeze on Boeing's 737 MAX, Monday.com raises full-year guidance, and Nvidia unveils its newest AI chip.""}, {""date"": ""2023-11-12"", ""headline"": ""Illumina put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-12"", ""headline"": ""Illumina price target lowered to $50 from $100 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""Druckenmiller's Duquesne takes new stakes in Alibaba, Alphabet; exits Meta"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""Worried About Deficit Stan Druckenmiller Is Still Very Bullish On These Stocks"", ""summary"": ""In this article, we discuss worried about the deficit Stan Druckenmiller is still very bullish on these stocks. If you want to see more stocks in this selection, check out Stan Druckenmiller Is Still Very Bullish On These 5 Stocks. Will reckless spending and failure to issue debt at low rates by the federal government [\u2026]""}, {""date"": ""2023-11-13"", ""headline"": ""Illumina Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. shed 5.67% to $92.79 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-11-13"", ""headline"": ""LGND or ILMN: Which Is the Better Value Stock Right Now?"", ""summary"": ""LGND vs. ILMN: Which Stock Is the Better Value Option?""}, {""date"": ""2023-11-13"", ""headline"": ""Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the launch of the Global Health Access Initiative to support access to pathogen sequencing tools for public health in low- and middle-income countries (LMICs). The program, developed with guidance from customers, funders, and market facilitators including the nonprofit FIND, will provide reduced pricing structures for eligible sequencing products from Illumina to qualified global health""}, {""date"": ""2023-11-13"", ""headline"": ""Company News for Nov 13, 2023"", ""summary"": ""Companies In The News Are: ILMN, CTRE, WPM, FLO.""}, {""date"": ""2023-11-13"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""Video: S&P 500 Movers: ILMN, DVA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""Video: Nasdaq 100 Movers: ILMN, DXCM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Illumina, Inc. (ILMN) Investors"", ""summary"": ""Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Illumina, Inc. securities between May 1, 2023 and October 16, 2023,...""}, {""date"": ""2023-11-13"", ""headline"": ""Unveiling Illumina (ILMN)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""Illumina launches Global Health Access Initiative to support LMICs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""Illumina price target lowered to $260 from $318 at RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""Illumina price target lowered to $85 from $150 at Citi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Illumina To Webcast Upcoming Investor Conferences"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences:""}, {""date"": ""2023-11-14"", ""headline"": ""Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Illumina, Inc. (ILMN) Investors"", ""summary"": ""The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Illumina,...""}, {""date"": ""2023-11-14"", ""headline"": ""Illumina Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Illumina Inc. advanced 5.07% to $97.49 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-14"", ""headline"": ""Illumina\u2019s Market Challenges and Strategic Adjustments: Puneet Souda Maintains Buy Rating Amid Lowered Expectations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""As Illumina stock bounces off a 10-year low, analysts see no quick fix"", ""summary"": ""DNA-sequencing company juggles leadership transition, questions about a new product launch, and unwinding of a troubled acquisition""}, {""date"": ""2023-11-14"", ""headline"": ""ValueAct Capital Adjusts Portfolio, Major Reduction in Fiserv Inc by -8.04%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Stifel Nicolaus Reaffirms Their Buy Rating on Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Silk Road Medical (SILK), Illumina (ILMN) and Y-Mabs Therapeutics (YMAB)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-15"", ""headline"": ""ILLUMINA ALERT : Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm"", ""summary"": ""Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Illumina, Inc. in the United States District Court for...""}, {""date"": ""2023-11-15"", ""headline"": ""ROSEN, A LEADING LAW FIRM, Encourages Illumina, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 ILMN"", ""summary"": ""WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Illumina, Inc. between May 1, 2023 and October 16,...""}, {""date"": ""2023-11-15"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. advanced 2.75% to $100.17 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-15"", ""headline"": ""Illumina, Inc. (ILMN) Investor Notice : Robbins LLP Reminds Investors of Class Action Filed Against Illumina, Inc."", ""summary"": ""Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Illumina, Inc. securities between May 1, 2023 and...""}, {""date"": ""2023-11-15"", ""headline"": ""Tracking Baillie Gifford's 13F Portfolio - Q3 2023 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-15"", ""headline"": ""Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc. (ILMN)"", ""summary"": ""Glancy Prongay & Murray LLP reminds investors of the upcoming January 9, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise...""}, {""date"": ""2023-11-15"", ""headline"": ""Expedia gains amid report of activist ValueAct stake"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-15"", ""headline"": ""ValueAct adds Roblox, Alarm.com, Danaher, exits Altus Power in Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""Notable Friday Option Activity: ILMN, QLYS, ALNY"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""ROSEN, NATIONAL TRIAL LAWYERS, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN"", ""summary"": ""NEW YORK, Nov. 16, 2023 /PRNewswire/ --\u00a0 WHY:\u00a0Rosen Law Firm, a global investor...""}, {""date"": ""2023-11-16"", ""headline"": ""Illumina Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 4.96% to $95.20 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-16"", ""headline"": ""Deadline Reminder : Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc. (ILMN)"", ""summary"": ""Law Offices of Howard G. Smith reminds investors of the upcoming January 9, 2024 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Illumina, Inc. ...""}, {""date"": ""2023-11-16"", ""headline"": ""Illumina (ILMN) Launches Initiative on Pathogen Sequencing"", ""summary"": ""Illumina (ILMN) introduces a new initiative to drive more equitable access to genomics globally.""}, {""date"": ""2023-11-16"", ""headline"": ""Levi & Korsinsky Notifies Illumina, Inc.(ILMN) Investors of a Class Action Lawsuit and Upcoming Deadline"", ""summary"": ""NEW YORK, Nov. 16, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Illumina, Inc. of a class action securities lawsuit. ...""}, {""date"": ""2023-11-17"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 0.92% to $94.32 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-17"", ""headline"": ""ILMN Investor Announcement : Kessler Topaz Meltzer & Check, LLP Announces January 9, 2024 Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed Against Illumina, Inc. (ILMN)"", ""summary"": ""The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California...""}, {""date"": ""2023-11-17"", ""headline"": ""Weaker Guidance Dragged Illumina (ILMN) in Q3"", ""summary"": ""RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its \u201cRiverPark Large Growth Fund\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, markets performed poorly, and the S&P 500 index (\u201cS&P\u201d) and the Russell 1000 Growth Index (RLG) declined [\u2026]""}, {""date"": ""2023-11-18"", ""headline"": ""Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Illumina, Inc."", ""summary"": ""RADNOR, Pa., Nov. 18, 2023 /PRNewswire/ -- The law firm of\u00a0Kessler Topaz Meltzer & Check, LLP\u00a0 \u00a0informs investors that a securities class action lawsuit has been filed in the United States...""}, {""date"": ""2023-11-18"", ""headline"": ""ILLUMINA SHAREHOLDER ACTION REMINDER : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Illumina To Contact Him Directly To Discuss Their Options"", ""summary"": ""If you purchased or acquired securities in Illumina between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at...""}, {""date"": ""2023-11-18"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Spotify.""}]",{}
45,2023-11-19,94.31999969482422,2023-11-26,98.33999633789062,0.042620829686951245,U5,"[{""date"": ""2023-11-20"", ""headline"": ""Half Of S&P 500 Stocks Still Below 200-Day Average, Ignoring Covid-Like Rally: 10 Bargain Plays For Latecomer Bulls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""Half Of S&P 500 Stocks Still Below 200-Day Average: 10 Bargain Plays For Latecomer Bulls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. rose 3.49% to $97.61 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-11-20"", ""headline"": ""ILMN Stock News : Shareholders with Significant Losses Should Contact Robbins LLP for Information About Their Rights and Remedies Against Illumina, Inc."", ""summary"": ""Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Illumina, Inc. securities between May 1, 2023 and...""}, {""date"": ""2023-11-20"", ""headline"": ""GRAIL To Initiate REACH Study To Evaluate Clinical Impact Of Galleri\u24c7 Multi-Cancer Early Detection (MCED) Test Among The Medicare Population"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""The Law Offices of Vincent Wong Remind Illumina Investors of a Lead Plaintiff Deadline of January 9, 2024"", ""summary"": ""NEW YORK, Nov. 20, 2023 /PRNewswire/ -- Attention Illumina, Inc. shareholders: ...""}, {""date"": ""2023-11-21"", ""headline"": ""Veracyte's Strategic Growth Amid Volatility And Evolution In Genomic Diagnostics"", ""summary"": ""Veracyte's Q3 2023 shows robust revenue growth driven by increased testing revenue and volume. Find out why I have a hold rating on VCYT stock.""}, {""date"": ""2023-11-21"", ""headline"": ""Illumina Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 1.68% to $95.97 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-11-21"", ""headline"": ""10 large-cap stocks that are the furthest below the 200-day MA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""QQQ ETF Update, 11/22/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 - (NASDAQ : ILMN)"", ""summary"": ""NEW YORK, Nov. 21, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Illumina, Inc.. ...""}, {""date"": ""2023-11-22"", ""headline"": ""ILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit"", ""summary"": ""BENSALEM, Pa., Nov. 22, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities\u00a0fraud class action lawsuit...""}, {""date"": ""2023-11-23"", ""headline"": ""QQQ ETF Update, 11/24/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-23"", ""headline"": ""ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Illumina, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ILMN"", ""summary"": ""NEW YORK, Nov. 23, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor...""}, {""date"": ""2023-11-24"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. inched 0.59% higher to $98.34 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-11-24"", ""headline"": ""Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-25"", ""headline"": ""ILLUMINA DEADLINE ALERT : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Illumina To Contact Him Directly To Discuss Their Options"", ""summary"": ""If you purchased or acquired securities in\u00a0Illumina between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at...""}, {""date"": ""2023-11-26"", ""headline"": ""12 Best Medical Technology Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 of the best medical device stocks to buy now. If you want to skip our detailed healthcare and medical technology industry discussion, head directly to the 5 Best Medical Technology Stocks To Buy Now. The medical technology (MedTech) sector plays a significant role in healthcare, focusing primarily on developing [\u2026]""}]",{}
46,2023-11-26,98.33999633789062,2023-12-03,109.79000091552734,0.11643283510297442,U5+,"[{""date"": ""2023-11-26"", ""headline"": ""12 Best Medical Technology Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 of the best medical device stocks to buy now. If you want to skip our detailed healthcare and medical technology industry discussion, head directly to the 5 Best Medical Technology Stocks To Buy Now. The medical technology (MedTech) sector plays a significant role in healthcare, focusing primarily on developing [\u2026]""}, {""date"": ""2023-11-27"", ""headline"": ""Illumina receives outside interest in Grail business, Endpoints News reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-27"", ""headline"": ""Illumina has been contacted by parties interested in Grail: report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-27"", ""headline"": ""Illumina Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 3.75% to $94.65 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-11-27"", ""headline"": ""The Law Offices of Vincent Wong Remind Illumina Investors of a Lead Plaintiff Deadline of January 9, 2024"", ""summary"": ""NEW YORK, Nov. 27, 2023 /PRNewswire/ -- Attention Illumina, Inc. shareholders: ...""}, {""date"": ""2023-11-27"", ""headline"": ""Unveiling Illumina (ILMN)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""Pomerantz Law Firm Investigates Claims On Behalf of Investors of Illumina, Inc. - ILMN"", ""summary"": ""NEW YORK, Nov. 28, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Illumina, Inc. \u00a0. Such investors are advised to contact Robert S. Willoughby...""}, {""date"": ""2023-11-28"", ""headline"": ""ILMN Bronstein, Gewirtz & Grossman LLC Announces that Illumina, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"", ""summary"": ""Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Illumina, Inc. and certain of its...""}, {""date"": ""2023-11-28"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. rallied 2.00% to $96.54 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-28"", ""headline"": ""Illumina, Inc. (ILMN) Evercore ISI 6th Annual HealthCONx Conference"", ""summary"": ""Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Evercore ISI 6th Annual HealthCONx Conference November 28, 2023 10:50 AM ETCompany ParticipantsJoydeep Goswami - Chief...""}, {""date"": ""2023-11-28"", ""headline"": ""Kessler Topaz Meltzer & Check, LLP Reminds Illumina, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm"", ""summary"": ""RADNOR, Pa., Nov. 28, 2023 /PRNewswire/ --\u00a0The law firm of Kessler Topaz Meltzer & Check, LLP\u00a0 \u00a0informs investors that a securities class action lawsuit has been filed in the United States...""}, {""date"": ""2023-11-28"", ""headline"": ""QQQ ETF Update, 11/28/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""Leerink pharmaceuticals analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 - (NASDAQ : ILMN)"", ""summary"": ""NEW YORK, Nov. 28, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Illumina, Inc.. ...""}, {""date"": ""2023-11-29"", ""headline"": ""Factbox-US Supreme Court case on SEC could have wide impact on agency enforcement"", ""summary"": ""The U.S. Supreme Court on Wednesday heard arguments on whether the U.S. Securities and Exchange Commission (SEC) has the power to pursue defendants in its own in-house tribunal rather than in federal court.  The outcome of the case could affect how the SEC and other U.S. federal agencies enforce regulations.  Here's a look at some of the current cases that are awaiting the Supreme Court's decision, which is expected by the end of June.""}, {""date"": ""2023-11-29"", ""headline"": ""ROSEN, SKILLED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ILMN"", ""summary"": ""NEW YORK, Nov. 29, 2023 /PRNewswire/ -- WHY:\u00a0Rosen Law Firm, a global investor...""}, {""date"": ""2023-11-29"", ""headline"": ""Illumina, Inc. (ILMN) Piper Sandler 35th Annual Healthcare Conference (Transcript)"", ""summary"": ""Illumina, Inc. (NASDAQ:NASDAQ:ILMN) Piper Sandler 35th Annual Healthcare Conference November 29, 2023 11:30 AM ETCompany ParticipantsJacob Thaysen - Chief...""}, {""date"": ""2023-11-29"", ""headline"": ""US Supreme Court case on SEC could have wide impact on agency enforcement"", ""summary"": ""The U.S. Supreme Court on Wednesdayheard arguments on whether the U.S. Securities and ExchangeCommission has the power to pursue defendants in its ownin-house tribunal rather than in federal...""}, {""date"": ""2023-11-30"", ""headline"": ""Illumina Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.37% higher to $101.95 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-11-30"", ""headline"": ""ILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit"", ""summary"": ""LOS ANGELES, Nov. 30, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against...""}, {""date"": ""2023-11-30"", ""headline"": ""Video: Merging Discovery With Clinical Care at Ontario Institute for Cancer Research"", ""summary"": ""Inside the Canadian icon pushing the boundaries of precision oncologyNORTHAMPTON, MA / ACCESSWIRE / November 30, 2023 / IlluminaOriginally published on Illumina News CenterIn the middle of downtown Toronto, surrounded by major universities and hospitals, ...""}, {""date"": ""2023-11-30"", ""headline"": ""ILLUMINA Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Illumina To Contact Him Directly To Discuss Their Options"", ""summary"": ""If you purchased or acquired securities in Illumina between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at...""}, {""date"": ""2023-11-30"", ""headline"": ""ILMN Shareholders Upcoming Deadline : Bronstein, Gewirtz & Grossman LLC Reminds Investors of The Illumina, Inc. to Contact the Firm"", ""summary"": ""Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Illumina, Inc. and certain of its...""}, {""date"": ""2023-12-01"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. rallied 7.69% to $109.79 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-01"", ""headline"": ""Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Illumina, Inc. (ILMN) Investors and Encourages Investors to Contact the Firm Before January 9, 2024"", ""summary"": ""The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Illumina,...""}, {""date"": ""2023-12-01"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), Karuna Therapeutics (KRTX) and Argenx Se (ARGX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
47,2023-12-03,109.79000091552734,2023-12-10,112.94000244140625,0.028691151285284322,U3,"[{""date"": ""2023-12-04"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. rallied 4.14% to $114.34 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-12-04"", ""headline"": ""Early notable gainers among liquid option names on December 4th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 - (NASDAQ : ILMN)"", ""summary"": ""NEW YORK, Dec. 4, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of\u00a0Illumina, Inc.. ...""}, {""date"": ""2023-12-05"", ""headline"": ""Illumina Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slid 2.26% to $111.76 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-12-05"", ""headline"": ""ILLUMINA SHAREHOLDER ACTION REMINDER : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options"", ""summary"": ""If you suffered losses exceeding $100,000 investing in\u00a0Illumina securities between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...""}, {""date"": ""2023-12-05"", ""headline"": ""Levi & Korsinsky Notifies Illumina, Inc.(ILMN) Investors of a Class Action Lawsuit and Upcoming Deadline"", ""summary"": ""NEW YORK, Dec. 5, 2023 /PRNewswire/ --\u00a0Levi & Korsinsky, LLP notifies investors in Illumina, Inc. of a class action securities lawsuit. ...""}, {""date"": ""2023-12-06"", ""headline"": ""Illumina Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Illumina Inc. rallied 2.00% to $113.99 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-06"", ""headline"": ""Validation Data on a Novel Prognostic Test Developed by GRAIL in Stage I Lung Cancer Presented at North America Conference on Lung Cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""ILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit"", ""summary"": ""BENSALEM, Pa., Dec. 6, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities\u00a0fraud class action lawsuit...""}, {""date"": ""2023-12-07"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. advanced 2.75% to $117.13 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-07"", ""headline"": ""ILMN CLASS ACTION ANNOUNCEMENT : Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Illumina, Inc. (ILMN)"", ""summary"": ""RADNOR, Pa., Dec. 7, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP\u00a0 informs investors that a securities class action lawsuit has been filed in the United States District...""}, {""date"": ""2023-12-07"", ""headline"": ""Illumina: Conditions Are Met For A Rebound"", ""summary"": ""After the divestment of Grail, Illumina's core business could become highly cash-generative again. Find out if ILMN stock is a buy.""}, {""date"": ""2023-12-08"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 3.58% to $112.94 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-08"", ""headline"": ""ROSEN, A TOP RANKED LAW FIRM, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN"", ""summary"": ""NEW YORK, Dec. 8, 2023 /PRNewswire/ -- WHY:\u00a0Rosen Law Firm, a global investor...""}, {""date"": ""2023-12-09"", ""headline"": ""ROSEN, LEADING TRIAL ATTORNEYS, Encourages Illumina, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ILMN"", ""summary"": ""WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. between May 1, 2023 and October 16, 2023, both dates inclusive , of the important January 9,...""}, {""date"": ""2023-12-10"", ""headline"": ""Tracking Carl Icahn's 13F Report - Q3 2023 Update"", ""summary"": ""Carl Icahn's 13F filing decreased from 15 to 14 holdings this quarter. Click here for a detailed review.""}, {""date"": ""2023-12-10"", ""headline"": ""12 Best Genomics Stocks To Buy Now"", ""summary"": ""In this piece, we will take a look at the 12 best genomics stocks to buy now. If you want to skip our introduction to the genomics industry and all the latest trends, then take a look at 5 Best Genomics Stocks To Buy Now. If there\u2019s one thing that can be said with certainty [\u2026]""}, {""date"": ""2023-12-10"", ""headline"": ""ILLUMINA DEADLINE ALERT : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options"", ""summary"": ""If you suffered losses exceeding $100,000 investing in Illumina securities between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...""}, {""date"": ""2023-12-10"", ""headline"": ""Pomerantz Law Firm Investigates Claims On Behalf of Investors of Illumina, Inc. - ILMN"", ""summary"": ""NEW YORK, Dec. 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Illumina, Inc. \u00a0.\u00a0\u00a0 Such investors are advised to contact Robert S. Willoughby...""}]",{}
48,2023-12-10,112.94000244140625,2023-12-17,127.0999984741211,0.12537626816557856,U5+,"[{""date"": ""2023-12-10"", ""headline"": ""Illumina just upgraded at Citi, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-10"", ""headline"": ""Illumina announces SEC filing to divest GRAIL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-10"", ""headline"": ""Tracking Carl Icahn's 13F Report - Q3 2023 Update"", ""summary"": ""Carl Icahn's 13F filing decreased from 15 to 14 holdings this quarter. Click here for a detailed review.""}, {""date"": ""2023-12-10"", ""headline"": ""12 Best Genomics Stocks To Buy Now"", ""summary"": ""In this piece, we will take a look at the 12 best genomics stocks to buy now. If you want to skip our introduction to the genomics industry and all the latest trends, then take a look at 5 Best Genomics Stocks To Buy Now. If there\u2019s one thing that can be said with certainty [\u2026]""}, {""date"": ""2023-12-10"", ""headline"": ""ILLUMINA DEADLINE ALERT : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options"", ""summary"": ""If you suffered losses exceeding $100,000 investing in Illumina securities between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...""}, {""date"": ""2023-12-10"", ""headline"": ""Pomerantz Law Firm Investigates Claims On Behalf of Investors of Illumina, Inc. - ILMN"", ""summary"": ""NEW YORK, Dec. 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Illumina, Inc. \u00a0.\u00a0\u00a0 Such investors are advised to contact Robert S. Willoughby...""}, {""date"": ""2023-12-11"", ""headline"": ""Illumina Fights EU to Bring $7 Billion Grail Bid Back From Brink"", ""summary"": ""(Bloomberg) -- Illumina Inc.\u2019s struggle to save its $7 billion acquisition of cancer-test provider Grail Inc. enters the final stages on Tuesday in a court challenge to the European Union\u2019s power to probe deals that once flew under the radar.Most Read from BloombergJPMorgan Is in a Fight Over Its Client's Lost $50 Million FortuneAbu Dhabi Is the World\u2019s Newest Wealth Haven for BillionairesHarvard\u2019s Deepening Disunity Pits Alumni Against FacultyJack Ma\u2019s Biggest E-Commerce Rival Is Coming for Ama""}, {""date"": ""2023-12-11"", ""headline"": ""Illumina initiated with bullish view at Wolfe Research"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""Illumina Versus European Commission: Legal Battle Over Grail Acquisition Reaches Critical Stage"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""UPDATE 1-Illumina files registration statement for potential Grail divestiture"", ""summary"": ""Illumina said on Monday it had filed a registration statement with the U.S. securities regulator related to a potential divestiture of Grail, even as it challenges a European Union order to divest the cancer test maker in court.  Submission of the registration statement \""is an important next step in evaluating divestiture options for GRAIL\"", Illumina said.""}, {""date"": ""2023-12-11"", ""headline"": ""Citigroup Upgrades Illumina (ILMN)"", ""summary"": """"}, {""date"": ""2023-12-11"", ""headline"": ""Illumina submits Form 10 to the Securities and Exchange Commission"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN) has confidentially submitted a draft registration statement on Form 10 related to its potential divestiture of GRAIL to the U.S. Securities and Exchange Commission, pursuant to an order Illumina received from the European Commission (EC) directing the company to divest GRAIL.""}, {""date"": ""2023-12-11"", ""headline"": ""Illumina (ILMN) Expands Globally Despite Macroeconomic Woes"", ""summary"": ""The NovaSeq X launch strengthens Illumina's (ILMN) competitive position in high-throughput sequencing.""}, {""date"": ""2023-12-11"", ""headline"": ""Illumina Submits SEC Form For Grail Divestiture"", ""summary"": ""By Ben Glickman Illumina has submitted paperwork for its potential divestiture of its subsidiary Grail, after being ordered by the European Commission to shed the recent acquisition. The...""}, {""date"": ""2023-12-11"", ""headline"": ""Illumina\u2019s Strategic Shift and Market Positioning: A Buy Rating Perspective"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""Illumina submits Form 10 to SEC related to potential GRAIL divestiture"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""Unveiling Illumina (ILMN)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""Analyst Expectations for Illumina's Future"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Illumina initiated with bullish view at Stephens, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""B of A Securities Downgrades Illumina (ILMN)"", ""summary"": """"}, {""date"": ""2023-12-12"", ""headline"": ""Illumina Named to the Dow Jones Sustainability Indices for the Fifth Consecutive Year"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / December 12, 2023 / Illumina has been named to the Dow Jones Sustainability World Index and the North America Index for 2023 in the Life Sciences Tools & Services Industry. This is the fifth consecutive year the company ...""}, {""date"": ""2023-12-12"", ""headline"": ""Madryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company\u2019s Proposed Merger with Standard BioTools"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Illumina Inc. stock remains steady Tuesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. were unchanged Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising...""}, {""date"": ""2023-12-12"", ""headline"": ""Illumina battles EU regulators over Grail deal"", ""summary"": ""Illumina (ILMN) seeks to resolve it's battle with EU regulators regarding acquisition of biotech company Grail. Earlier this year, Illumina received a $476 million fine from EU authorities over the deal. It comes as Pfizer (PFE) says it has received all the necessary regulatory approvals for its acquisition of Seagen (SGEN). Yahoo Finance's Anjalee Khemlani breaks down the biggest pharma stories of the day in the video above. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-12-12"", ""headline"": ""Zillow upgraded, Airbnb downgraded: Wall Street's top analyst calls"", ""summary"": ""Zillow upgraded, Airbnb downgraded: Wall Street's top analyst calls""}, {""date"": ""2023-12-12"", ""headline"": ""Illumina: Grail's Divestment Could Unlock Significant Shareholder Value"", ""summary"": ""Despite its challenges with Grail, Illumina remains a monopoly with strong competitive advantages. Find out if ILMN stock is a buy.""}, {""date"": ""2023-12-12"", ""headline"": ""UPDATE 1-Illumina accuses EU of over-extending its powers in assessing Grail deal"", ""summary"": ""Illumina on Tuesday accused EU antitrust regulators of over-extending their powers in their scrutiny of its $7.1 billion for Grail while regulators accused the U.S. life sciences company of seeking to rewrite the EU merger rule book.  The case underlines the European Commission's determination to apply a rarely used power called Article 22 to examine deals by large companies that may aim to shut down smaller rivals, even if the deals are below the EU merger revenue threshold.  Illumina took its fight to the Court of Justice of the European Union (CJEU) after it lost its challenge at a lower tribunal last year against the EU competition authority's 2021 decision to review the deal that it subsequently blocked.""}, {""date"": ""2023-12-12"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Illumina slams EU for over-extending power to assess Grail deal"", ""summary"": ""Illumina on Tuesday slammed EU antitrust regulators for over-extending their powers when they scrutinised the U.S. life sciences company's $7.1 billion for Grail even though the deal was outside the scope of EU merger rules.  The case underlines the European Commission's determination to apply a rarely used power called Article 22 to examine so-called killer acquisitions, in which large companies buy smaller rivals in order to shut them down, even if the deals are below the EU merger revenue threshold.  Illumina took its fight to the Court of Justice of the European Union (CJEU) after it lost its challenge at a lower tribunal last year against the EU competition authority's 2021 decision to review the deal that it subsequently blocked last year.""}, {""date"": ""2023-12-12"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Illumina cut to Underperform at BofA on growth concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Illumina initiated with bullish view at Wolfe Research, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Levi & Korsinsky Notifies Illumina, Inc.(ILMN) Investors of a Class Action Lawsuit and Upcoming Deadline"", ""summary"": ""NEW YORK, Dec. 12, 2023 /PRNewswire/ --\u00a0Levi & Korsinsky, LLP notifies investors in Illumina, Inc. of a class action securities lawsuit. ...""}, {""date"": ""2023-12-12"", ""headline"": ""Illumina just downgraded at BofA, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""These Stocks Are Moving the Most Today: Moderna, Rivian, SolarEdge, Adobe, Opendoor, Illumina, Foot Locker, and More"", ""summary"": ""Moderna reports more promising data on its personalized cancer treatment, AT&T will be buying Rivian vehicles in a pilot program, SolarEdge and other solar...""}, {""date"": ""2023-12-13"", ""headline"": ""Wolfe Research Initiates Coverage of Illumina (ILMN) with Outperform Recommendation"", ""summary"": """"}, {""date"": ""2023-12-13"", ""headline"": ""Illumina initiated with bullish view at Guggenheim, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Stephens starts Illumina at overweight, cites continuing sector dominance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. rose 7.68% to $126.67 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-13"", ""headline"": ""Bottom U.S. Triple Momentum stocks - BofA Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Illumina prepares to divest Grail with Form 10 filing"", ""summary"": ""The DNA sequencer is preparing to unwind its 2021 acquisition of the liquid biopsy test maker while still appealing orders to do so from regulators in the U.S. and Europe.""}, {""date"": ""2023-12-13"", ""headline"": ""GLOBAL BROKER RATINGS: UBS raises BASF; JPMorgan cuts LVMH"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Illumina just upgraded at Bernstein, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Stephens & Co. Initiates Coverage of Illumina (ILMN) with Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-12-14"", ""headline"": ""Guggenheim Initiates Coverage of Illumina (ILMN) with Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-12-14"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. rallied 3.81% to $131.49 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-14"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""ILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit"", ""summary"": ""LOS ANGELES, Dec. 14, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against...""}, {""date"": ""2023-12-14"", ""headline"": ""Illumina Analyst Optimistic On Company's Prospects For 'Accelerated Growth'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Foot Locker upgraded, Deckers downgraded: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-15"", ""headline"": ""Illumina $7.1B deal for Grail sent back to FTC by appeals court"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-15"", ""headline"": ""US court strikes down FTC order against Illumina's purchase of Grail"", ""summary"": ""(Reuters) -A U.S. appeals court on Friday struck down a Federal Trade Commission order against Illumina's purchase of cancer diagnostic test maker Grail, a former subsidiary, saying the agency had applied a wrong legal standard.  The New Orleans-based panel of the 5th U.S. Circuit Court of Appeals issued a 34-page order that will require the FTC to reconsider the deal.  The three-judge panel said the agency had substantial evidence to show the deal would lessen competition as companies seek to bring to market a blood test to detect many kinds of cancer.""}, {""date"": ""2023-12-15"", ""headline"": ""UPDATE 2-US court strikes down FTC order against Illumina's purchase of Grail"", ""summary"": ""A U.S. appeals court on Friday struck down a Federal Trade Commission order against Illumina's purchase of cancer diagnostic test maker Grail , a former subsidiary, saying the agency had applied a wrong legal standard.  The New Orleans-based panel of the 5th U.S. Circuit Court of Appeals issued a 34-page order that will require the FTC to reconsider the deal.  The three-judge panel said the agency had substantial evidence to show the deal would lessen competition as companies seek to bring to market a blood test to detect many kinds of cancer.""}, {""date"": ""2023-12-15"", ""headline"": ""Illumina Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Illumina Inc. shed 3.34% to $127.10 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-12-15"", ""headline"": ""GE upgraded, Northrop Grumman downgraded: Wall Street's top analyst calls"", ""summary"": ""GE upgraded, Northrop Grumman downgraded: Wall Street's top analyst calls""}, {""date"": ""2023-12-16"", ""headline"": ""Illumina to sell cancer-test maker Grail latest after antitrust ruling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-16"", ""headline"": ""Illumina plans to divest Grail after U.S. Appeals Court decision"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-16"", ""headline"": ""Court Sides With FTC Finding Illumina-Grail Deal Anticompetitive"", ""summary"": ""A federal appeals court said the U.S. government was right to challenge  Illumina  purchase of cancer-test developer Grail, but still sent the case back to the Federal Trade Commission for reconsideration.  A three-judge panel found the deal to be anticompetitive, but said the FTC erred in how it considered Illumina\u2019s proposed fix for its drawbacks.  The judges ordered the FTC to reconsider its opinion on the troubled deal, which the European Commission has already ordered Illumina to unwind.""}, {""date"": ""2023-12-16"", ""headline"": ""ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN"", ""summary"": ""NEW YORK, Dec. 16, 2023 /PRNewswire/ -- WHY:\u00a0Rosen Law Firm, a global investor...""}, {""date"": ""2023-12-16"", ""headline"": ""ILMN Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Illumina, Inc. (ILMN)"", ""summary"": ""RADNOR, Pa., Dec. 16, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP\u00a0 informs investors that a securities class action lawsuit has been filed in the United States District...""}, {""date"": ""2023-12-17"", ""headline"": ""Biotech giant Illumina will unwind takeover of cancer-screening company Grail"", ""summary"": ""Biotech giant Illumina says it will undo its $7.1 billion purchase of the cancer-screening company Grail after losing legal battles with antitrust enforcers in the U.S. and Europe.  San Diego-based Illumina said in a Sunday statement that it made its decision to divest Grail after a U.S. appeals court ruled Friday that the merger could violate antitrust laws.  The European Union in October ordered the deal to be unwound because it closed in 2021 without regulatory approval from the 27-nation bloc.""}, {""date"": ""2023-12-17"", ""headline"": ""Illumina To Sell Grail After U.S. Antitrust Ruling"", ""summary"": ""Illumina said Sunday it will the sell cancer detection startup after a U.S. appeals court said the $7.1 billion deal violated antitrust laws,""}, {""date"": ""2023-12-17"", ""headline"": ""REFILE-UPDATE 3-Illumina to divest cancer test maker Grail after antitrust battles"", ""summary"": ""Gene sequencing company Illumina said on Sunday it will divest cancer diagnostic test maker Grail after the companies battled both U.S. and European antitrust enforcers for more than two years and faced fierce opposition from activist investor Carl Icahn.  The divestiture will be executed through a third-party sale or capital markets transaction, San Diego-based Illumina said in a statement, adding that it would finalize the terms by second quarter of 2024.  Grail will continue to be held separate with committed funding from Illumina for the company's business through the divestment process, the former said in a separate statement.""}, {""date"": ""2023-12-17"", ""headline"": ""Illumina to divest cancer test maker Grail after antitrust battles"", ""summary"": ""The divestiture will be executed through a third-party sale or capital markets transaction, San Diego-based Illumina said in a statement, adding that it would finalize the terms by second quarter of 2024.  Grail will continue to be held separate with committed funding from Illumina for the company's business through the divestment process, the former said in a separate statement.  Grail, valued at $7.1 billion under Illumina's deal, is seeking to market a blood test that can diagnose many kinds of cancer, known as a liquid biopsy.""}, {""date"": ""2023-12-17"", ""headline"": ""Illumina Announces Decision to Divest GRAIL"", ""summary"": ""Today, Illumina, Inc. (NASDAQ: ILMN) announced that the company will divest GRAIL.""}, {""date"": ""2023-12-17"", ""headline"": ""Illumina to sell cancer-test maker Grail after latest antitrust ruling"", ""summary"": ""Illumina Inc. said Sunday it will sell its Grail unit, after a federal appeals court on Friday found the $7.1 billion acquisition in 2021 to be anticompetitive.""}, {""date"": ""2023-12-17"", ""headline"": ""Illumina to divest cancer test maker Grail"", ""summary"": ""Illumina said on Sunday thatit would divest cancer diagnostic test maker Grailafter the companies battled both U.S. and European antitrustenforcers for more than two years and faced fierce...""}, {""date"": ""2023-12-17"", ""headline"": ""Illumina (NASDAQ:ILMN) Divests Grail Following Years-Long Antitrust Battle"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-17"", ""headline"": ""ROSEN, NATIONAL TRIAL LAWYERS, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN"", ""summary"": ""WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. between May 1, 2023 and October 16, 2023, both dates inclusive , of the important January 9,...""}, {""date"": ""2023-12-17"", ""headline"": ""Fly Intel: Top five weekend stock stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-17"", ""headline"": ""Court sides with FTC finding Illumina-Grail deal anticompetitive, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
49,2023-12-17,127.0999984741211,2023-12-24,140.0,0.10149489914042364,U5+,"[{""date"": ""2023-12-16"", ""headline"": ""Illumina to sell cancer-test maker Grail latest after antitrust ruling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-16"", ""headline"": ""Illumina plans to divest Grail after U.S. Appeals Court decision"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-17"", ""headline"": ""These Stocks Are Moving the Most Today: U.S. Steel, Apple, Adobe, SunPower, VF Corp, NIO, and More"", ""summary"": ""U.S. Steel is being acquired by Nippon Steel for $55 a share, reports say Apple soon will be halting sales of its smartwatch to comply with a U.S. import...""}, {""date"": ""2023-12-17"", ""headline"": ""4 Can\u2019t Miss Stocks Highlight Monday\u2019s Top Wall Street Upgrades and Downgrades"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-17"", ""headline"": ""Carl Icahn calls for removal of Illumina legacy directors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-17"", ""headline"": ""TOP NEWS: Illumina to divest Grail after regulatory pushback"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-17"", ""headline"": ""Illumina to Shed Cancer-Test Maker Grail After Antitrust Battle"", ""summary"": ""Gene-sequencing company  Illumina  said Sunday it will divest itself of cancer blood test maker Grail, following Illumina\u2019s loss in its legal battle against U.S. antitrust regulators.  Illumina said it will pursue the divestiture through a third-party sale or capital markets transaction, with a goal of completing terms by the middle of next year.  The decision represents a victory for antitrust authorities in the U.S. and Europe, and their tougher scrutiny of corporate combinations.""}, {""date"": ""2023-12-17"", ""headline"": ""Biotech giant Illumina will unwind takeover of cancer-screening company Grail"", ""summary"": ""Biotech giant Illumina says it will undo its $7.1 billion purchase of the cancer-screening company Grail after losing legal battles with antitrust enforcers in the U.S. and Europe.  San Diego-based Illumina said in a Sunday statement that it made its decision to divest Grail after a U.S. appeals court ruled Friday that the merger could violate antitrust laws.  The European Union in October ordered the deal to be unwound because it closed in 2021 without regulatory approval from the 27-nation bloc.""}, {""date"": ""2023-12-17"", ""headline"": ""Illumina To Sell Grail After U.S. Antitrust Ruling"", ""summary"": ""Illumina said Sunday it will the sell cancer detection startup after a U.S. appeals court said the $7.1 billion deal violated antitrust laws,""}, {""date"": ""2023-12-17"", ""headline"": ""REFILE-UPDATE 3-Illumina to divest cancer test maker Grail after antitrust battles"", ""summary"": ""Gene sequencing company Illumina said on Sunday it will divest cancer diagnostic test maker Grail after the companies battled both U.S. and European antitrust enforcers for more than two years and faced fierce opposition from activist investor Carl Icahn.  The divestiture will be executed through a third-party sale or capital markets transaction, San Diego-based Illumina said in a statement, adding that it would finalize the terms by second quarter of 2024.  Grail will continue to be held separate with committed funding from Illumina for the company's business through the divestment process, the former said in a separate statement.""}, {""date"": ""2023-12-17"", ""headline"": ""Illumina to divest cancer test maker Grail after antitrust battles"", ""summary"": ""The divestiture will be executed through a third-party sale or capital markets transaction, San Diego-based Illumina said in a statement, adding that it would finalize the terms by second quarter of 2024.  Grail will continue to be held separate with committed funding from Illumina for the company's business through the divestment process, the former said in a separate statement.  Grail, valued at $7.1 billion under Illumina's deal, is seeking to market a blood test that can diagnose many kinds of cancer, known as a liquid biopsy.""}, {""date"": ""2023-12-17"", ""headline"": ""Illumina Announces Decision to Divest GRAIL"", ""summary"": ""Today, Illumina, Inc. (NASDAQ: ILMN) announced that the company will divest GRAIL.""}, {""date"": ""2023-12-17"", ""headline"": ""Illumina to sell cancer-test maker Grail after latest antitrust ruling"", ""summary"": ""Illumina Inc. said Sunday it will sell its Grail unit, after a federal appeals court on Friday found the $7.1 billion acquisition in 2021 to be anticompetitive.""}, {""date"": ""2023-12-17"", ""headline"": ""Illumina to divest cancer test maker Grail"", ""summary"": ""Illumina said on Sunday thatit would divest cancer diagnostic test maker Grailafter the companies battled both U.S. and European antitrustenforcers for more than two years and faced fierce...""}, {""date"": ""2023-12-17"", ""headline"": ""Illumina (NASDAQ:ILMN) Divests Grail Following Years-Long Antitrust Battle"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-17"", ""headline"": ""ROSEN, NATIONAL TRIAL LAWYERS, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN"", ""summary"": ""WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. between May 1, 2023 and October 16, 2023, both dates inclusive , of the important January 9,...""}, {""date"": ""2023-12-17"", ""headline"": ""Fly Intel: Top five weekend stock stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-17"", ""headline"": ""Court sides with FTC finding Illumina-Grail deal anticompetitive, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (ILMN), Axsome Therapeutics (AXSM) and Glaukos (GKOS)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""Illumina Ends Its Controversial Grail Battle With A Divestiture; Shares Rise"", ""summary"": ""Illumina stock rose Monday after the company said it would divest its cancer detection outfit, Grail, following a lengthy court battle.""}, {""date"": ""2023-12-18"", ""headline"": ""US Steel & Nippon, Adobe, Illumina: Top M&A announcements"", ""summary"": ""Japanese steel producer Nippon Steel (5401.T) is set to acquire United States Steel (X) in a deal valued at up to $14.9 billion when accounting for debt. Adobe (ADBE) relinquishes its $20 billion takeover bid of collaborative design app Figma. Lastly, biotech company Illumina (ILMN) plans to divest cancer test developer GRAIL following antitrust headwinds, planning to sell it for up to $7.1 billion. For more expert insight and the latest market action, click\u00a0here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-12-18"", ""headline"": ""Illumina-Grail $8B Saga Ends After It Battles Regulators For 3 Years"", ""summary"": ""On Sunday, gene-sequencing company Illumina Inc (NASDAQ: ILMN) agreed to divest cancer diagnostic test maker Grail Inc as the companies battled with the U.S. and European antitrust regulators for almost three years after announcing the acquisition. In August 2021, in defiance of FTC and EU scrutiny, Illumina completed its $8 billion acquisition of Grail. The divestiture will be executed through a third-party sale or capital markets transaction, consistent with the European Commission's divestitu""}, {""date"": ""2023-12-18"", ""headline"": ""Antitrust Regulators Issue New Merger Rules Amid Crackdown"", ""summary"": ""Mergers in sectors that have few big competitors or are in highly concentrated markets will be scrutinized more closely.""}, {""date"": ""2023-12-18"", ""headline"": ""Illumina Gives Up Fight With Regulators, Will Divest GRAIL"", ""summary"": ""Illumina has decided to end its controversial purchase of GRAIL, and will divest itself of the cancer diagnostic test maker.""}, {""date"": ""2023-12-18"", ""headline"": ""These Stocks Are Moving the Most Today"", ""summary"": ""U.S. Steel is being acquired by Nippon Steel for $55 a share, Adobe terminates purchase of Figma, SunPower issues a going concern warning, and VF Corp says a security breach will impact its business.Read ...""}, {""date"": ""2023-12-18"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. advanced 1.57% to $129.10 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-18"", ""headline"": ""Heard on the Street: Illumina Nears the End of Its Painful Grail Saga"", ""summary"": ""Grail\u2019s screening test, called Galleri, could one day help save countless lives by catching cancer in the bloodstream early.  After losing in court [against the Federal Trade Commission](https://www.wsj.com/health/healthcare/court-sides-with-ftc-finding-illumina-grail-deal-anticompetitive-ad2efe8d), the company has finally [thrown in the towel](https://www.wsj.com/health/healthcare/illumina-to-divest-itself-of-cancer-test-maker-grail-3f74f1e8) on keeping Grail.  The maker of gene-sequencing machines said Sunday it will pursue the divestiture of Grail through a third-party sale or capital markets transaction, with a goal of completing terms by the middle of 2024.""}, {""date"": ""2023-12-18"", ""headline"": ""NEW YORK MARKET CLOSE: S&P marches on shrugging aside Fed caution"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""Pomerantz Law Firm Investigates Claims On Behalf of Investors of Illumina, Inc. - ILMN"", ""summary"": ""NEW YORK, Dec. 18, 2023 /PRNewswire/ --\u00a0Pomerantz LLP is investigating claims on behalf of investors of Illumina, Inc. . Such investors are advised to contact Danielle Peyton at...""}, {""date"": ""2023-12-18"", ""headline"": ""Activist Icahn prepares a second board challenge at Illumina -letter"", ""summary"": ""(Reuters) -Activist investor Carl Icahn said on Monday that he plans to oust directors at Illumina, laying the groundwork for a second board challenge at the gene-sequencing company months after shareholders elected one of his director candidates.  Icahn disclosed his plans without offering details in a letter to other shareholders less than 24 hours after Illumina said it will divest blood test maker Grail.  The billionaire investor had long been critical of Illumina's $7 billion Grail acquisition and made it a centrepiece of his previous proxy fight in which Andrew Teno, a portfolio manager working for Icahn, won a seat on the 11-member board.""}, {""date"": ""2023-12-18"", ""headline"": ""Adobe-Figma Breakup Isn\u2019t Just a Win for Regulators. Why Consumers Should Be Cheering Too."", ""summary"": ""The DOJ praised the collapse of Adobe and Figma\u2019s proposed merger. Why it\u2019s consumers that benefit most.""}, {""date"": ""2023-12-18"", ""headline"": ""Stocks to Watch Monday: U.S. Steel, Apple, Illumina, NIO"", ""summary"": ""[**U.S. Steel (X)**](https://www.wsj.com/market-data/quotes/X): The company [agreed to sell itself to Japan's Nippon Steel for $14.1 billion](https://www.wsj.com/business/earnings/nippon-steel-to-acquire-u-s-steel-for-55-shr-854c6f73).""}, {""date"": ""2023-12-18"", ""headline"": ""3 Charts For Investors to Watch Monday: Illumina, Roku, Bitcoin"", ""summary"": ""Here's our daily look at three charts connected to recent news-driven price moves, with key technical levels to monitor.  Illumina, Inc. (ILMN) shares tumbled 3.3% on Friday but were rising in premarket trading Monday after the gene sequencing company announced over the weekend that it will divest its Grail unit, which manufactures blood test kits to detect early signs of cancer.  The decision follows Friday\u2019s finding by the federal appeals court that the company's $7.1 billion acquisition of Grail in 2021 was anticompetitive.""}, {""date"": ""2023-12-18"", ""headline"": ""United States Steel, NIO rise; Masonite, Mirum Pharmaceuticals fall, Monday, 12/18/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""Kessler Topaz Meltzer & Check, LLP Reminds Illumina, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the Firm"", ""summary"": ""The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California...""}, {""date"": ""2023-12-18"", ""headline"": ""US Steel, Illumina, Nio rise premarket; Apple, Southwest, Roku fall"", ""summary"": ""Investing.com -- U.S. futures largely edged higher Monday at the start of the final full trading week of the year, continuing the recent rally with more Fed policymakers due to speak.""}, {""date"": ""2023-12-18"", ""headline"": ""Treasury Yield Curve May Flip in 2024. The Fallout for Recession and Stocks."", ""summary"": ""Fed\u2019s Goolsbee says it\u2019s premature to declare inflation tamed, senators push forward on border security and Ukraine funding, and other news to start your day.""}, {""date"": ""2023-12-18"", ""headline"": ""These Stocks Are Moving the Most Today: U.S. Steel, NIO, Illumina, Affirm, Roku, Uber, Broadcom, and More"", ""summary"": ""U.S. Steel is being acquired by Nippon Steel for $55 a share, NIO gets a $2.2 billion investment, and Illumina plans to sell its Grail unit.""}, {""date"": ""2023-12-18"", ""headline"": ""Illumina to part with Grail, ending battle with regulators"", ""summary"": ""Activist investor\u00a0Carl Icahn, who is suing the company over its acquisition of Grail, continued to push for the removal of several board members in a letter to fellow shareholders.""}, {""date"": ""2023-12-18"", ""headline"": ""Icahn aims to remove Illumina's legacy directors - letter"", ""summary"": ""Dec 18 - Activist investor Carl Icahn said on Monday that he plans tooust directors at Illumina, signalling plans to mount asecond board...""}, {""date"": ""2023-12-18"", ""headline"": ""Illumina to Sell Grail. It\u2019s Giving Up on Its Biotech Antitrust Battle."", ""summary"": ""The biotech firm  Illumina  said it would sell or spin off subsidiary Grail after a battle with regulators.  Grail, which is seeking to market blood tests for cancer, was wholly acquired by San Diego-based Illumina in 2021 for $7.1 billion.  U.S. and European regulators objected to the deal, arguing it would stifle medical innovation.""}, {""date"": ""2023-12-18"", ""headline"": ""The market is second-guessing its dovish reaction to Powell. This analyst says the Fed could slash rates by as much as 4 percentage points."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""S&P 500 Futures Rise in Premarket Trading; US Steel, Cleveland-Cliffs Lead"", ""summary"": ""With U.S. stock markets set to open in two hours, (X) was up 28.6% in pre-market trading, and (CLF) was up 6.4%. (ILMN), (STLD), and (NUE) were all posting...""}, {""date"": ""2023-12-18"", ""headline"": ""Wall Street Breakfast Podcast: Illumina To Divest Grail"", ""summary"": ""Illumina plans to divest Grail after U.S. Appeals Court decision. IBM to acquire StreamSets and webMethods platforms from Software AG for \u00e2\u0082\u00ac2.13B. Chuck E. Cheese reportedly exploring a sale.""}, {""date"": ""2023-12-18"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), Palatin Technologies (PTN) and Medtronic (MDT)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""Illumina rises premarket after gene-sequencing group announces Grail divestiture"", ""summary"": ""Investing.com -- Illumina (NASDAQ:ILMN) shares edged higher in premarket trading in New York on Monday, after the gene-sequencing device maker said it will offload cancer screening start-up Grail.""}, {""date"": ""2023-12-18"", ""headline"": ""Illumina (ILMN) Receives a Buy from Stifel Nicolaus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""PRESS DIGEST- Wall Street Journal - Dec 18"", ""summary"": ""The following are the top stories in the Wall Street Journal.  - Gene-sequencing company Illumina said on Sunday it will divest itself of cancer blood test maker Grail, following Illumina's loss in its legal battle against U.S. antitrust regulators and facing fierce opposition from activist investor Carl Icahn.  - Mitsubishi UFJ Financial Group agreed to buy Link Administration in a deal valuing the Australian financial technology company's equity at A$1.2 billion ($805.20 million).""}, {""date"": ""2023-12-18"", ""headline"": ""Futures edge up, Illumina to divest Grail - what's moving markets"", ""summary"": ""Investing.com -- U.S. stock futures are in the green prior to the beginning of the last full trading week before the Christmas holiday, with investors eyeing the outlook for potential Federal Reserve interest rate cuts next year. Elsewhere, gene-sequencing group Illumina (NASDAQ:ILMN) announces plans to divest blood cancer-test seller Grail following intense antitrust scrutiny and shares in China's SenseTime slip after it announces the death of its founder.""}, {""date"": ""2023-12-18"", ""headline"": ""Scotiabank gets more bullish on Illumina, upgrades shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""The market is second-guessing its dovish reaction to Powell. This analyst says the Fed could slash rates by as much as 75%."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 - (NASDAQ : ILMN)"", ""summary"": ""NEW YORK, Dec. 18, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of\u00a0Illumina, Inc.. ...""}, {""date"": ""2023-12-18"", ""headline"": ""Icahn prepares to launch fight to control Illumina board, Bloomberg reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""S&P 500 Gains and Losses Today: Enphase's Cost Cutting Charges Up Solar Stocks"", ""summary"": ""The S&P 500 gained 0.6% on Tuesday, Dec. 19, 2023, amid optimism on Fed rate cuts, strong housing data, and the traditional \""Santa Claus rally.\""""}, {""date"": ""2023-12-19"", ""headline"": ""Illumina To Webcast Upcoming Investor Conference"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:""}, {""date"": ""2023-12-19"", ""headline"": ""FTC, DOJ finalize merger guidelines that could impede healthcare M&A"", ""summary"": ""The new guidelines should give regulators sharper teeth in going after vertical and cross-market deals that have historically been difficult to challenge.""}, {""date"": ""2023-12-19"", ""headline"": ""Illumina Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Illumina Inc. advanced 8.08% to $139.53 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-19"", ""headline"": ""Carl Icahn to initiate proxy battle with Illumina \u2014 again"", ""summary"": ""Activist investor Carl Icahn is gearing up to initiate another proxy fight at gene sequencing giant Illumina (ILMN) , aiming to appoint additional nominees to the company's board. This comes just months after shareholders elected one of his candidates amid criticisms of Illumina's acquisition of Grail. Now, Icahn is looking to elect more of his representatives in the boardroom as Illumina faces challenges following the Grail deal. Yahoo Finance's Ines Ferr\u00e9 breaks down all the details. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-12-19"", ""headline"": ""A Lesser-Known Application of Genomics: Reducing Cow Burp Intensity"", ""summary"": ""DataGene's Sustainability Index for dairy cattle herds combats this significant driver of global warmingNORTHAMPTON, MA / ACCESSWIRE / December 19, 2023 / IlluminaOriginally published on Illumina News CenterMethane is 28 times more powerful a greenhouse ...""}, {""date"": ""2023-12-19"", ""headline"": ""Scotiabank Upgrades Illumina (ILMN)"", ""summary"": """"}, {""date"": ""2023-12-19"", ""headline"": ""Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""The 2023 stock market rally isn't just about 7 stocks anymore"", ""summary"": ""The market rally over the last month hasn't been driven by the \""Magnificent Seven\"" tech stocks, a promising sign that it has legs.""}, {""date"": ""2023-12-19"", ""headline"": ""The 2023 stock market rally isn't just about seven stocks anymore"", ""summary"": ""The market rally over the last month hasn't been driven by the Magnificent 7 tech stocks, a promising sign that it actually has legs.""}, {""date"": ""2023-12-19"", ""headline"": ""Grail CEO predicts \u2018transformative\u2019 2024 amid Illumina split"", ""summary"": ""The liquid biopsy maker, which Illumina plans to\u00a0divest,\u00a0said it has made progress on a PMA\u00a0application with the FDA for its Galleri\u00a0multi-cancer early detection test.""}, {""date"": ""2023-12-19"", ""headline"": ""Amgen upgraded, PepsiCo downgraded: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""Illumina price target lowered by $2 at RBC Capital, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""Carl Icahn Escalates Boardroom Battle At Illumina, Seeks To Remove More Directors After Grail Divestiture"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""Illumina upgraded to Outperform yesterday at Scotiabank after Grail news"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""Levi & Korsinsky Notifies Illumina, Inc.(ILMN) Investors of a Class Action Lawsuit and Upcoming Deadline"", ""summary"": ""NEW YORK, Dec. 19, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Illumina, Inc. of a class action securities lawsuit. ...""}, {""date"": ""2023-12-19"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), Dexcom (DXCM) and Masimo (MASI)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""Could the \u2018trustbusters\u2019 be making a comeback?"", ""summary"": ""One scoop to start: Activist investor Cevian Capital has taken a \u20ac1.2bn stake in UBS, betting that the Swiss bank can double its valuation over the next three to five years.  Global regulators had been on a losing streak lately, with back-to-back losses including Amgen\u2019s $28bn takeover of fellow drugmaker Horizon Therapeutics and Microsoft\u2019s $75bn purchase of game developer Activision Blizzard.  Adobe on Monday abandoned its proposed $20bn acquisition of product design software company Figma, saying there was \u201cno clear path to receive necessary regulatory approvals\u201d from UK and EU watchdogs.""}, {""date"": ""2023-12-20"", ""headline"": ""Illumina Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slipped 1.88% to $136.90 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-20"", ""headline"": ""Early notable gainers among liquid option names on December 20th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""Illumina Reaches Analyst Target Price"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-21"", ""headline"": ""Illumina Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Illumina Inc. rose 2.43% to $140.23 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-21"", ""headline"": ""Nucleus Genomics Wants To Make Personalized Health Care a Reality"", ""summary"": ""NORTHAMPTON, MA / ACCESSWIRE / December 21, 2023 / Illumina A New York-based startup is on a mission to bring the power of whole-genome sequencing to the world Originally published on Illumina News Center Nucleus Genomics is realizing the dream set ...""}, {""date"": ""2023-12-21"", ""headline"": ""ILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit"", ""summary"": ""BENSALEM, Pa.\u00a0, Dec. 21, 2023 /PRNewswire/ --\u00a0Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit...""}, {""date"": ""2023-12-21"", ""headline"": ""ILLUMINA INVESTOR DEADLINE APPROACHING : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options"", ""summary"": ""If you suffered losses exceeding $100,000 investing in Illumina securities between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...""}, {""date"": ""2023-12-22"", ""headline"": ""Madryn Asset Management Reiterates Alternative Path to SomaLogic\u2019s Value-Destructive Proposed Merger with Standard BioTools"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-22"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 0.16% to $140.00 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-12-23"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Spotify.""}]",{}
50,2023-12-24,140.0,2023-12-31,139.24000549316406,-0.005428532191685265,D1,"[{""date"": ""2023-12-26"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. inched 0.46% higher to $140.64 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-12-26"", ""headline"": ""Important January 9, 2024 Deadline Reminder for Illumina, Inc. Investors : Kessler Topaz Meltzer & Check, LLP Reminds Illumina, Inc. (ILMN) Investors of Securities Fraud Class Action Lawsuit"", ""summary"": ""RADNOR, Pa., Dec. 26, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP\u00a0 \u00a0informs investors that a securities class action lawsuit has been filed in the United States...""}, {""date"": ""2023-12-26"", ""headline"": ""ROSEN, NATIONAL TRIAL COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN"", ""summary"": ""NEW YORK, Dec. 26, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor...""}, {""date"": ""2023-12-26"", ""headline"": ""Small Caps Are On A Tear Including Speculative Biotechs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-27"", ""headline"": ""Illumina Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Illumina Inc. rose 1.34% to $142.53 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-27"", ""headline"": ""Levi & Korsinsky Notifies Illumina, Inc.(ILMN) Investors of a Class Action Lawsuit and Upcoming Deadline"", ""summary"": ""NEW YORK, Dec. 27, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Illumina, Inc. of a class action securities lawsuit. ...""}, {""date"": ""2023-12-28"", ""headline"": ""SomaLogic board urges shareholders to approve Standard Bio Tools merger"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-28"", ""headline"": ""Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc. of Class Action Lawsuit and Upcoming Deadline - ILMN"", ""summary"": ""NEW YORK, Dec. 28, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Illumina, Inc. . The class action, filed in the United States District Court for...""}, {""date"": ""2023-12-28"", ""headline"": ""Here's Why You Should Retain Illumina (ILMN) Stock for Now"", ""summary"": ""Investors are optimistic about Illumina's (ILMN) strength in the genomics market and strong solvency position.""}, {""date"": ""2023-12-28"", ""headline"": ""Illumina Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. shed 0.28% to $142.13 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-28"", ""headline"": ""ILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit"", ""summary"": ""LOS ANGELES, Dec. 28, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against...""}, {""date"": ""2023-12-28"", ""headline"": ""ILLUMINA INVESTOR DEADLINE APPROACHING : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options"", ""summary"": ""If you suffered losses exceeding $100,000 investing in\u00a0Illumina securities between September 21, 2020 and November 9, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner...""}, {""date"": ""2023-12-29"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. shed 2.03% to $139.24 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-12-29"", ""headline"": ""NEW YORK MARKET CLOSE: Top tech names dominate bumper year for stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-29"", ""headline"": ""Should You Think About Buying Illumina, Inc. (NASDAQ:ILMN) Now?"", ""summary"": ""Let's talk about the popular Illumina, Inc. ( NASDAQ:ILMN ). The company's shares led the NASDAQGS gainers with a...""}, {""date"": ""2023-12-29"", ""headline"": ""SomaLogic sent letter to stockholders on transaction with Standard BioTools"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
51,2023-12-31,139.24000549316406,2024-01-07,130.47999572753906,-0.06291302370032636,D5+,"[{""date"": ""2024-01-02"", ""headline"": ""Ensemble Fund 2023 Annual Letter"", ""summary"": ""The Ensemble Fund (ENSBX) returned 3.32% for the fiscal year ended October 31, 2023. Click here to read the full fund letter.""}, {""date"": ""2024-01-02"", ""headline"": ""SHAREHOLDER ALERT: Potential Recovery for Illumina, Inc. (ILMN) Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Illumina put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""ROSEN, NATIONAL TRIAL COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN"", ""summary"": ""NEW YORK, Jan. 2, 2024 /PRNewswire/ --\u00a0 WHY: Rosen Law Firm, a global investor...""}, {""date"": ""2024-01-02"", ""headline"": ""Illumina Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. shed 1.17% to $137.61 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2024-01-02"", ""headline"": ""Levi & Korsinsky Notifies Illumina, Inc.(ILMN) Investors of a Class Action Lawsuit and Upcoming Deadline"", ""summary"": ""NEW YORK, Jan. 2, 2024 /PRNewswire/ --\u00a0Levi & Korsinsky, LLP notifies investors in Illumina, Inc. of a class action securities lawsuit. ...""}, {""date"": ""2024-01-03"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), Pfizer (PFE) and Neurogene (NGNE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Warning: ILMN is at high risk of performing badly"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Illumina Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 5.28% to $130.34 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2024-01-03"", ""headline"": ""Video: Nasdaq 100 Movers: ILMN, TMUS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""Illumina to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 8, 2024"", ""summary"": ""Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the fourth quarter and full year 2023 following the close of market on Thursday, February 8, 2024.""}, {""date"": ""2024-01-04"", ""headline"": ""Illumina Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.84% higher to $131.43 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2024-01-04"", ""headline"": ""The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced three new members of the Alliance for Genomic Discovery (AGD).""}, {""date"": ""2024-01-04"", ""headline"": ""ILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit"", ""summary"": ""LOS ANGELES, Jan. 4, 2024 /PRNewswire-PRWeb/ --\u00a0The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit...""}, {""date"": ""2024-01-04"", ""headline"": ""ILLUMINA Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options"", ""summary"": ""If you suffered losses exceeding $100,000 investing in Illumina securities between September 21, 2020 and November 9, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner...""}, {""date"": ""2024-01-04"", ""headline"": ""Illumina downgraded to Market Perform after 40% rally at TD Cowen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""Deep Dive Into Illumina Stock: Analyst Perspectives (9 Ratings)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""TD Cowen gets more bearish on Illumina, downgrades shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slumped 0.72% to $130.48 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2024-01-05"", ""headline"": ""Illumina expands collaboration with Janssen to advance molecular residual disease cancer test"", ""summary"": ""Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has signed an agreement with Janssen Research & Development, LLC (Janssen). This collaboration will be the first relating to the development of Illumina's novel molecular residual disease (MRD) assay, a whole-genome sequencing (WGS) multi-cancer research solution that detects circulating tumor DNA (ctDNA) to better understand the persistence or recurrence of disease following clinical""}, {""date"": ""2024-01-05"", ""headline"": ""Illumina's MRD Technology For Cancer Testing Collaborates With Johnson & Johnson Unit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Illumina expands collaboration with Janssen on cancer test"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Illumina expands collaboration with Janssen R&D"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Analysts Are Bullish on These Healthcare Stocks: Conmed (CNMD), Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 - (NASDAQ : ILMN)"", ""summary"": ""NEW YORK, Jan. 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of\u00a0Illumina, Inc.. ...""}, {""date"": ""2024-01-06"", ""headline"": ""It's JPM time! Which medtechs are expected to issue updates this week?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-06"", ""headline"": ""Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc. of Class Action Lawsuit and Upcoming Deadline - ILMN"", ""summary"": ""NEW YORK, Jan. 6, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Illumina, Inc .\u00a0\u00a0 The class action, filed in the United States District Court for...""}, {""date"": ""2024-01-06"", ""headline"": ""ILMN DEADLINE : ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN"", ""summary"": ""WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. between May 1, 2023 and October 16, 2023, both dates inclusive , of the important January 9,...""}]",{}
52,2024-01-07,130.47999572753906,2024-01-14,138.0399932861328,0.057939897349323255,U5+,"[{""date"": ""2024-01-06"", ""headline"": ""It's JPM time! Which medtechs are expected to issue updates this week?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""These Stocks Are Moving the Most Today: Juniper Networks, HPE, JetBlue, Illumina, Nvidia, Extreme Networks, Unity, and More"", ""summary"": ""Juniper Networks stock surges following a report that says Hewlett Packard Enterprise is in advanced talks to buy the networking-equipment company.""}, {""date"": ""2024-01-08"", ""headline"": ""Illumina (ILMN) Extends Partnership to Advance Cancer Test"", ""summary"": ""Illumina (ILMN) aims to work with other pharmaceutical industry leaders to enhance and expand the utility of its WGS MRD assay.""}, {""date"": ""2024-01-08"", ""headline"": ""Illumina Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Illumina Inc. advanced 2.44% to $133.66 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2024-01-08"", ""headline"": ""The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc. (ILMN)"", ""summary"": ""The Law Offices of Frank R. Cruz reminds investors of the upcoming January 9, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Illumina,...""}, {""date"": ""2024-01-09"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Sarepta Therapeutics (SRPT) and Illumina (ILMN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""Biden administration\u2019s antitrust victories are much-needed wins for consumers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""Biden administration\u2019s antitrust victories are major wins for consumers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""Match Group, Juniper- HPE talks, Illumina: Trending Tickers"", ""summary"": ""Activist investor Elliot Management has taken a $1 billion stake in Match Group (MTCH), owner of top dating apps like Tinder, reports the Wall Street Journal. Juniper Networks (JNPR) is close to a $13 billion acquisition by Hewlett Packard Enterprise (HPE) to augment its AI capabilities, per WSJ sources. Shares of gene sequencing giant Illumina (ILMN) closed Tuesday higher after beating preliminary fourth-quarter revenue estimates under new CEO Jacob Thaysen. 2023 brought major upheaval for Illumina after failed efforts to acquire cancer testing firm Grail spawned regulatory disputes. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Angel Smith.""}, {""date"": ""2024-01-09"", ""headline"": ""Illumina Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Illumina Inc. rallied 4.55% to $139.74 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2024-01-09"", ""headline"": ""Illumina, Inc. (ILMN) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)"", ""summary"": ""Illumina, Inc. (NASDAQ:NASDAQ:ILMN) J.P.""}, {""date"": ""2024-01-09"", ""headline"": ""Illumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023"", ""summary"": ""Illumina, Inc. (Nasdaq: ILMN) (\""Illumina\"" or the \""company\"") today announced unaudited preliminary financial results for the fourth quarter and fiscal year 2023 ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024 at 9:00am Pacific Time (12:00pm Eastern Time). The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com.""}, {""date"": ""2024-01-09"", ""headline"": ""Why Illumina Rallied 36.6% in December"", ""summary"": ""The beaten-down gene sequencing company is getting a further shakeup.""}, {""date"": ""2024-01-09"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""llumina sees FY24 results 'very similar' to FY23"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""Illumina unveils preliminary fourth-quarter revenue that tops estimates"", ""summary"": ""Investing.com -- Illumina (NASDAQ:ILMN) has said it will report consolidated revenue in the fourth quarter that will top analysts' estimates, sending shares in the gene-sequencing products maker higher in early U.S. trade on Tuesday.""}, {""date"": ""2024-01-09"", ""headline"": ""Illumina Shares Rise 6.9% With FY23 Sales Expected to Top Guidance"", ""summary"": ""By Ben Glickman Shares of Illumina rose Tuesday after the company said it expected full-year sales to beat guidance. The stock was up 6.9% at $142.85 in...""}, {""date"": ""2024-01-09"", ""headline"": ""Illumina Sees FY23 Sales Declining Less Than Forecast"", ""summary"": ""By Ben Glickman Illumina is expecting its full-year sales to decline less than most recently forecast by the company. The San Diego-based gene-sequencing...""}, {""date"": ""2024-01-09"", ""headline"": ""Susan Tousi leaves Illumina to become CEO of liquid biopsy firm Delfi"", ""summary"": ""Tousi is in charge of commercializing the lead liquid biopsy from a company that could compete with\u00a0Grail, the multi-cancer early detection test maker Illumina plans to divest.""}, {""date"": ""2024-01-09"", ""headline"": ""Levi & Korsinsky Notifies Illumina, Inc.(ILMN) Investors of a Class Action Lawsuit and Upcoming Deadline"", ""summary"": ""NEW YORK, Jan. 9, 2024 /PRNewswire/ -- Levi &\u00a0Korsinsky, LLP notifies investors in Illumina, Inc. of a class action securities lawsuit. ...""}, {""date"": ""2024-01-10"", ""headline"": ""Thursday Sector Leaders: Healthcare, Technology & Communications"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-10"", ""headline"": ""Illumina Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.64% higher to $140.63 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2023 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2023 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2022 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2023 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2022 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2022 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2021 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2021 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2021 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2021 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2020 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2020 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2020 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2020 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2019 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2019 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2019 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2019 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2018 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2022 Illumina Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Illumina Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Illumina Inc. inched 0.27% higher to $141.01 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2024-01-11"", ""headline"": ""What Happens When a Virus Becomes a Permanent Part of Your Genome?"", ""summary"": ""To uncover links between an endogenous retrovirus and cancer, Illumina sequenced five generations of San Diego Zoo koalas NORTHAMPTON, MA / ACCESSWIRE / January 11, 2024 / Illumina Originally published on Illumina News Center The San Diego Zoo cares ...""}, {""date"": ""2024-01-11"", ""headline"": ""Illumina Stock Buy Rating: Strong Q4 Performance and Strategic GRAIL Resolution as Catalysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Illumina Ventures Labs Launches in the US and the UK to Enable More Rapid Value-Creation for Start-Ups Advancing Human Health"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""BeniComp to Offer GRAIL\u2019s Multi-Cancer Early Detection Test for Employee Health Screening"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Illumina Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Illumina Inc. slid 2.11% to $138.04 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2024-01-12"", ""headline"": ""What 5000 Ancient Human Genomes Can Reveal About European Health and Heritage"", ""summary"": ""Four new papers map out ancient migrations and the disease variants these newcomers brought with them NORTHAMPTON, MA / ACCESSWIRE / January 12, 2024 / Illumina Originally published on Illumina News Center Call it archaeology by other means. Rather ...""}, {""date"": ""2024-01-12"", ""headline"": ""BeniComp to Offer GRAIL's Multi-Cancer Early Detection Test for Employee Health Screening"", ""summary"": ""Menlo Park - GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, and BeniComp, a customized health plan provider, today announced the availability of...""}]",{}
53,2024-01-14,138.0399932861328,2024-01-21,133.55999755859375,-0.032454331682361115,D4,"[{""date"": ""2024-01-14"", ""headline"": ""Biotech Playbook: Small Caps Show Momentum Peaking During"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-15"", ""headline"": ""Concentric by Ginkgo and Illumina join hands for pathogen monitoring programs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-15"", ""headline"": ""Concentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world"", ""summary"": ""Concentric by Ginkgo, the biosecurity and public health unit of Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it has entered into a Co-Marketing Agreement with Illumina, Inc. (Nasdaq: ILMN), a global leader in DNA sequencing and array-based technologies, to partner on expanding biosecurity capabilities globally.""}, {""date"": ""2024-01-15"", ""headline"": ""Concentric by Ginkgo enters into co-marketing agreement with Illumina"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-16"", ""headline"": ""Illumina Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slipped 2.10% to $135.14 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2024-01-16"", ""headline"": ""Illumina (ILMN) Shares Down 1.2% Post Preliminary Q4 Results"", ""summary"": ""Illumina's (ILMN) fourth-quarter 2023 results are likely to reflect the impacts of the adoption of its new generation of distributed liquid biopsy assay.""}, {""date"": ""2024-01-16"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-17"", ""headline"": ""Oxford Nanopore: Ultra-Long Reads In A Short-Term Slump"", ""summary"": ""Oxford Nanopore shares declined 33% due to slower growth, but positive prospects and unique product features offer potential. See more on ONTTF stock here.""}, {""date"": ""2024-01-17"", ""headline"": ""Illumina Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Illumina Inc. slipped 1.17% to $133.56 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2024-01-17"", ""headline"": ""7 Mighty Healthcare Stocks Changing the Game of Medicine"", ""summary"": ""With so many question marks facing the viability of the equities sector, concerned investors may want to turn their attention to compelling healthcare stocks. Primarily, the sector benefits from permanent relevance. It\u2019s in a nation\u2019s best interest to keep its citizenry healthy and productive, meaning that there will always be funds directed toward the broader health and wellness space. Another factor that could bolster healthcare stocks is its relative insulation from the economy. Now, don\u2019t ge""}, {""date"": ""2024-01-18"", ""headline"": ""Illumina Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Illumina Inc. inched 0.51% higher to $134.24 Thursday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2024-01-18"", ""headline"": ""Ensemble Fund Q4 2023 Investment Update"", ""summary"": ""The fourth quarter saw very strong absolute and relative performance in the fund. Read more to see the full fund letter.""}, {""date"": ""2024-01-18"", ""headline"": ""Here\u2019s How the New AI Algorithm Helps Illumina (ILMN)"", ""summary"": ""Ensemble Capital Management, an investment management company, released its fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The fund saw exceptionally excellent absolute and relative performance in the fourth quarter. The fund was up 16.00% in the quarter while the S&P 500 appreciated 11.69%. The fund was up 21.75% for [\u2026]""}, {""date"": ""2024-01-18"", ""headline"": ""The Top 3 Stocks in the High-Potential \u2018Cancer Testing\u2019 Market"", ""summary"": ""Blood tests for dozens of types of cancer have been invented. These tests, known as liquid biopsies, could save tens of millions of lives. That\u2019s because there\u2019s currently no good screening procedures for many types of cancers, such as pancreatic cancer and lung cancer. And by the time the tumors cause symptoms, it\u2019s usually too late to save the patients\u2019 lives. Also noteworthy is that these diagnostics, or multi-cancer early detection tests (MCEDs), can save hospitals and health insurers a grea""}, {""date"": ""2024-01-19"", ""headline"": ""Illumina Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Illumina Inc. rallied 1.22% to $135.88 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2024-01-19"", ""headline"": ""Here\u2019s Why Polen Focus Growth Sold Illumina (ILMN)"", ""summary"": ""Polen Capital, an investment management company, released its \u201cPolen Focus Growth Strategy\u201d fourth quarter 2023 investor letter. A copy of the same can be downloaded here. In the quarter the fund returned 14.43% (net) compared to 14.16% for the Russell 1000 Growth Index and 11.69% for the S&P 500 Index. For the full year, the fund [\u2026]""}, {""date"": ""2024-01-19"", ""headline"": ""Illumina, Inc. (NASDAQ:ILMN) is largely controlled by institutional shareholders who own 90% of the company"", ""summary"": ""Key Insights Institutions' substantial holdings in Illumina implies that they have significant influence over the...""}, {""date"": ""2024-01-19"", ""headline"": ""Illumina: Volatility Galore, But Not Much Prospect Of Progress In 2024"", ""summary"": ""Illumina's stock price has been in decline since its failed attempt to acquire Grail, leading to a 75% decline in share price. Read more on ILMN stock here.""}]",{}
